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Effector translocation is a common strategy used by bacteria to promote pathogenesis via 
disruption of the immune response, prevention of phagocytosis, or induction of toxicity in the 
infected cell. The Gram-positive bacterium Streptococcus pyogenes utilizes a unique effector 
translocation system termed cytolysin-mediated translocation (CMT) to introduce the NAD+ 
glycohydrolase SPN into host cells during infection, resulting in cytotoxicity. Host cell 
membrane recognition by the cholesterol-dependent cytolysin (CDC) Streptolysin O (SLO) is a 
requisite step in this process, but the canonical cholesterol-dependent pore-forming activity of 
SLO is unnecessary, indicating that SLO is a bifunctional toxin. SLO exhibits extensive 
homology to other CDCs, yet CMT is highly specific for SLO. SLO lacking its conserved N-
terminal extension or SLO chimeras encoding the membrane-binding domains of homologous 
CDCs are functional cytolysins but do not translocate SPN, demonstrating that these domains 
have evolved to allow SLO to maintain both lytic and CMT activities. While cholesterol was 
considered the sole host cell receptor for SLO, we have demonstrated that cholesterol is not 
required for SLO’s ability to bind host membranes or translocate SPN during infection. Instead, 
SLO requires the co-expression and membrane localization of SPN to achieve cholesterol-
independent membrane binding and CMT. SPN’s membrane localization also requires SLO, and 
mutants of SLO that cannot perform CMT do not permit SPN-membrane binding, suggesting 
 ix 
that a co-dependent mode of binding to an alternative receptor results in SPN translocation. 
SPN’s conserved non-enzymatic domain, predicted to adopt the structure of a carbohydrate-
binding module, plays an active role in this process and may directly bind the CMT receptor. 
Consistent with structural prediction, mutation of predicted carbohydrate-binding or cation-
binding residues abolishes SPN’s recognition of the host cell membrane and translocation. We 
also investigated the cholesterol-dependent mechanism of binding of SLO and demonstrated that 
while cholesterol is necessary for the completion of pore formation and sustained membrane 
binding of SLO, it does not serve as the initial host cell receptor. SLO encodes a carbohydrate-
binding site within its membrane-binding domain, and studies of SLO carbohydrate-binding site 
mutants and carbohydrate-defective host cell lines revealed that recognition of a galactose-
containing glycoconjugate is a prerequisite to pore formation in the absence of SPN. However, 
the SPN-mediated mode of binding also promotes pore formation by SLO, demonstrating that 
pore formation can occur by distinct pathways during infection. The SPN-dependent mode of 
binding can be distinguished from the canonical galactose- and cholesterol-dependent mode by 
differential extraction with the detergent saponin, indicating that SPN mediates SLO’s 
localization to a more soluble fraction of the plasma membrane or modulates its level of 
oligomerization or membrane insertion. Binding and translocation of SPN is an important 
virulence mechanism, particularly in host cell types that are resistant to SLO-induced membrane 
damage in the absence of SPN. 
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CHAPTER 1 
 
Introduction 
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Streptococcus pyogenes classification 
Streptococcus pyogenes, or group A streptococcus (GAS), is a Gram-positive bacterium 
and a strict human pathogen. It lacks an environmental reservoir, and therefore relies on human-
to-human transmission for colonization and spread [1]. It is a member of the phylum Firmicutes 
and the order Lactobacillales, and as a lactic acid bacterium it generates energy solely by 
fermentative metabolism via the homolactic and mixed-acid pathways [2]. Species within the 
Streptococcus genus are characterized by Lancefield serotyping based on the identity of their cell 
well polysaccharides. S. pyogenes presents the Group A polysaccharide on its surface, comprised 
of N-acetyl-β-D-glucosamine residues attached to a rhamnose polymer backbone [3]. S. 
pyogenes is also characterized as a β-hemolytic bacterium, as it produces exotoxins that result in 
the complete lysis of red blood cells [3].  
More detailed strain classification is based on the determination of M protein type, a 
major adhesin and anti-phagocytic cell wall-associated protein that exhibits extensive variability 
among strains [4]. There are currently over 200 different known M types, determined by 
sequencing the 5’ hypervariable region of the emm gene (emm-typing) [5]. Certain M protein 
types correlate with clinical manifestations of disease, with M18 strains associated with acute 
rheumatic fever, and M1 and M3 strains over-represented in invasive disease [3,6]. M types are 
further grouped by emm pattern (A-C, D, E), based on the number and chromosomal 
organization of emm and emm-like genes [1,7,8]. emm pattern strongly correlates with the type of 
infection, with pattern A-C strains more likely to cause pharyngitis, and pattern D strains more 
likely to cause skin infection. Therefore, these strains are designated as throat or skin specialists, 
respectively, in contrast to emm pattern E strains, which are “generalists” and thus equally able 
to cause infection at both tissue sites [1]. In addition to M protein, S. pyogenes encodes several 
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other adhesins including lipotechoic acid and multiple fibronectin binding proteins [9]. These 
proteins are important virulence factors, as S. pyogenes adherence to host cells is critical for the 
establishment of colonization and infection [6]. 
  
Disease manifestations and burden 
S. pyogenes is one of the most versatile bacterial pathogens, capable of causing numerous 
superficial and invasive diseases in addition to damaging post-infection sequelae. Combined, 
these diseases cause a global health burden of over 500,000 deaths annually [5]. The most 
common disease manifestation is bacterial pharyngitis (“strep throat”), with over 600 million 
cases per year [10]. This disease is usually mild and self-limiting, although it can result in the 
development of scarlet fever [5]. Another common GAS disease (over 111 million cases per 
year) is the superficial skin infection impetigo, which is spread by skin-to-skin contact and 
causes pustules that eventually rupture and form thick scabs [10]. More rare but serious types of 
GAS infection are the invasive diseases such as cellulitis, necrotizing fasciitis, bacteremia, and 
streptococcal toxic shock syndrome, resulting in approximately 660,000 cases and 160,000 
deaths per year [10]. Cellulitis is defined as infection of subcutaneous tissue, whereas necrotizing 
fasciitis (“flesh-eating disease”) is a more severe infection causing damage to both the deep soft 
tissue and muscle layers [3]. Toxic shock syndrome develops in response to streptococcal 
superantigen production, resulting in a T cell cytokine storm and multiorgan failure [5].  
In addition to the acute diseases caused by S. pyogenes, GAS infection can also lead to 
damaging post-infection sequelae including acute poststreptococcal glomerulonephritis, acute 
rheumatic fever and heart disease, reactive arthritis, and pediatric autoimmune neuropsychiatric 
disorders associated with streptococcal infections (PANDAS) [5]. The most common is acute 
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rheumatic fever, an autoimmune disorder resulting from untreated streptococcal pharyngitis 
causing joint, central nervous system, and heart inflammation due to cross-reactivity of anti-
streptococcal antibodies with host tissues [3]. Extended inflammation causes extensive damage 
to the heart tissue, resulting in the development of rheumatic heart disease and causing 232,000 
deaths annually [5]. Acute poststreptococcal glomerulonephritis is an immune complex-mediated 
kidney disorder, and PANDAS encompasses Tourette’s syndrome and other obsessive-
compulsive disorders, although this basis for these disorders is unclear [5].  
S. pyogenes remains highly sensitive to penicillin despite its heavy use over the past 50 
years to treat the numerous infections caused by this bacterium. However, GAS resistance to 
macrolide antibiotics, fluoroquinolones, and tetracycline has been demonstrated, and in some 
cases the rate of resistance can be as high as 40% of isolates [5]. Despite the current sensitivity 
of S. pyogenes to penicillin, the prevalence and spread of antibiotic resistance is a growing 
concern. A detailed understanding of pathogenic mechanisms will be important for the 
development of novel therapeutics, which may become necessary if streptococcal resistance to 
penicillin emerges. 
 
S. pyogenes NAD+ glycohydrolase (SPN) 
 S. pyogenes produces a wide range of cell-associated and secreted virulence factors that 
contribute to its ability to cause disease in disparate anatomical sites [11] (Figure 1). Among the 
arsenal of secreted virulence factors is SPN, an effector protein that is translocated into host cells 
during infection via a process termed cytolysin-mediated translocation (CMT) [12]. SPN is 
present in all sequenced S. pyogenes isolates [13-15], indicating that the production of this 
effector is likely beneficial to the bacterium. This has been corroborated by evaluating the 
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pathogenicity of an S. pyogenes SPN deletion strain, which exhibits a virulence defect compared 
to wild-type GAS in an invasive soft tissue model, intraperitoneal inoculation septicemia model, 
and multiple cell culture models of infection [12,16-18].  
 SPN is a potent NAD+ glycohydrolase that cleaves β-NAD+ into nicotinamide and 
adenosine diphosphoribose at a rapid rate (kcat of 8,390 s-1) [19]. It was originally believed to also 
possess ADP-ribosyl cyclase and ADP-ribosyl transferase activities [14,20] (Figure 2), but a 
more rigorous enzymatic characterization using recombinant SPN revealed that SPN is a strict 
NAD+ glycohydrolase [19]. Due to SPN’s robust enzymatic activity, S. pyogenes encodes an 
endogenous SPN inhibitor, Immunity Factor for SPN (IFS), encoded immediately downstream of 
spn in the same operon. SPN is secreted from the bacterium via the general secretory pathway, 
whereas IFS lacks a signal sequence and remains localized to the bacterial cytosol.  The presence 
of IFS is critical for maintaining the bacterium’s supply of NAD+ prior to SPN’s secretion, which 
IFS achieves by acting as a competitive inhibitor and occupying SPN’s NAD+ binding site 
[21,22]. As a NAD+ glycohydrolase, SPN’s role as an effector protein was believed to be limited 
to depletion of β-NAD+ inside host cells following translocation, resulting in signaling changes 
and the inhibition of cellular processes reliant on NAD+. However, it is now clear that SPN’s role 
during infection extends beyond its NAD+ glycohydrolase activity.  
The hypothesis that SPN possesses a NADase-independent function was born from the 
discovery that there are two distinct alleles of spn and ifs [14,21]. This allelic variation was first 
characterized using the frequently studied S. pyogenes strains JRS4 and HSC5, which encode for 
SPN variants that differ by 9 amino acids. Additionally, HSC5’s ifs gene has a premature stop 
codon, whereas the full-length protein is produced by JRS4 [21]. This allelic analysis was 
extended to a set of 113 S. pyogenes strains isolated from both invasive and non-invasive disease 
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from varied tissue sites, which demonstrated that both spn and ifs alleles are equally represented 
in these isolates [15]. The HSC5-like allele and truncated ifs gene were found to correlate with a 
lack of observable NAD+ glycohydrolase activity [14,21], and a detailed analysis of the 
polymorphic residues in SPN revealed that the HSC5-like allele is enzymatically inactive. This 
finding explained the presence of the ifs pseudogene; without an enzymatically active version of 
SPN, there is no selective pressure to maintain a functional inhibitor [15,23]. NADase activity 
could be conferred to the HSC5 allele by changing three amino acids in the enzymatic domain to 
the residues present in JRS4’s allele [23]. Conversely, introducing the three HSC5 residues into 
the JRS4 allele rendered SPN inactive. The evaluation of sequenced S. pyogenes isolates 
revealed that there was no correlation between SPN’s enzymatic activity and invasiveness of 
disease [15], but there was an association between NADase activity and site of infection. 
NADase inactive versions of SPN were encoded primarily by skin and throat specialist strains, 
whereas NADase active SPN was associated with generalist emm pattern E strains [15]. 
Despite their disparate activity, both alleles were equally prevalent in sequenced isolates. 
In addition, detailed sequence analyses revealed that SPN is under purifying selection, with the 
exception of the residues that contribute to enzymatic activity [15], indicating that the 
conservation of both enzymatically active and inactive SPN is of benefit to the bacterium. This 
was supported by the discovery that both variants of SPN are translocated into host cells, and 
NADase activity is not required for SPN-mediated cytotoxicity of infected cells [23], 
demonstrating that enzymatically inactive SPN is also a virulence determinant. While the target 
and mechanism of toxicity by the NADase inactive version of SPN has not been determined, the 
pathways leading to cell death by these variants have been characterized [24]. Enzymatically 
active SPN leads to the depletion of NAD+ and poly ADP-ribose, whereas the inactive version of 
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SPN leads to their accumulation. These differences correlate with changes in different 
inflammatory markers, with HMGB1 release triggered by active SPN, and IL-8 and TNFα 
production triggered by inactive SPN [24]. While occurring by different mechanisms, both 
versions of SPN result in cell death. This cytotoxicity is also dependent on the co-expression and 
pore-forming activity of Streptolysin O (SLO), the protein that mediates the translocation of SPN 
into the host cell cytosol during infection. 
 
Streptolysin O and cholesterol-dependent cytolysins 
 Streptolysin O is a member of the cholesterol-dependent cytolysin (CDC) family of 
proteins, which is one of the largest and most well characterized families of bacterial pore-
forming toxins. CDCs are produced by numerous pathogenic Gram-positive bacteria including 
Streptococcus pyogenes, Clostridium perfringens, and Listeria monocytogenes, although they 
have also recently been identified in two Gram-negative species [25,26]. As is evident by their 
name, these proteins exhibit a strict requirement for cholesterol in host cell membranes to 
accomplish their cytolytic activity. Proteins are defined as CDCs based on this cholesterol 
dependence for pore formation in addition to several conserved primary sequence and structural 
features. Crystal structures have been solved for a small subset of these proteins, which 
demonstrate a high degree of similarity [27]. This class of bacterial toxins is part of a larger 
protein superfamily, exhibiting structural and functional similarity to membrane attack complex 
and perforin-like proteins [28].  
 CDCs vary in size from 471 to 665 amino acids and are comprised of four domains. 
Domains 1-3 are discontinuous, but the C-terminal membrane-binding domain 4 is encoded by a 
continuous primary sequence and can be purified independently [29] (Figure 3). Nearly all CDCs 
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encode a cleavable N-terminal signal sequence to direct secretion from the bacterial cell, with the 
exception of pneumolysin, produced by Streptococcus pneumoniae, which lacks a signal peptide 
[27]. The mechanism of secretion of this CDC remains controversial [30]. Once CDCs are 
secreted from the bacterial cell as soluble monomers, they contact the host cell membrane via the 
tip of domain 4 (Figure 3), triggering structural changes that facilitate oligomerization and 
insertion of the transmembrane pore [31]. Membrane binding is critical for the conformational 
changes leading to monomer-monomer interactions, and oligomerization is not observed in 
solution even at very high concentrations of protein [32,33].  
The initial interaction between a CDC monomer and the host cell membrane triggers the 
rotation of the β5/α1 loop, exposing the edge of the β4 strand within domain 3, which is then 
able to make contacts with the β1 strand of a neighboring monomer (Figure 3) [33]. This process 
continues until a completed ring structure comprised of 35-50 monomers is formed, termed the 
prepore complex [27]. Completion of the prepore complex instigates the unfurling of 2 α-helices 
in domain 3, creating two transmembrane β-hairpins (TMH1 and TMH2 in Figure 3) that insert 
into the membrane to form the large (~30nm) transmembrane β-barrel pore (Figure 4) 
[31,34,35]. The longstanding theory was that the CDC-membrane interaction is mediated 
primarily by the undecapeptide, a highly conserved tryptophan-rich 11 amino acid sequence that 
forms one of the four loops at the tip of domain 4 (Figure 3). This has been refuted since the 
discovery that two adjacent residues in loop 1 mediate the interaction with cholesterol [36-38]. 
However, the undecapeptide is critical for CDC function, as it does insert into the membrane to 
strengthen the CDC-membrane interaction and propagate the structural transitions that lead to 
oligomerization [39].  
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The two amino acids in loop 1 that bind to cholesterol comprise the cholesterol-
recognition motif (CRM) [36], which is strictly conserved in all known CDCs. Cholesterol was 
considered the sole host cell receptor for CDCs due to the cholesterol requirement for pore 
formation and the fact that most CDCs can bind directly to cholesterol-rich model membranes. 
However, there is more diversity with respect to the initial CDC-membrane binding event than 
previously appreciated. While many CDCs bind directly to cholesterol, such as PFO from 
Clostridum perfringens, some CDCs utilize the human-specific GPI-anchored protein CD59 as 
their host cell receptor instead of cholesterol, and therefore only exhibit lytic activity on human 
cells [40]. This CDC subset is exemplified by intermedilysin (ILY) produced by Streptotoccus 
intermedius, but vaginolysin (VLY) from Gardnerella vaginalis and lectinolysin (LLY) from 
Streptococcus mitis have also been recently characterized as CD59-binding CDCs [40-42]. For 
these proteins, CD59 recognition mediates the interaction with the membrane, and this 
interaction triggers the conformational changes required for oligomerization, instead of being 
propagated by the undecapeptide [37]. However, they remain cholesterol-dependent and encode 
a conserved CRM, as dissociation from CD59 and binding to cholesterol is a critical step in the 
transition from prepore to pore insertion [32,36]. In the absence of cholesterol, these proteins 
disengage from their receptor and lose association with the membrane. SLO is presumed to 
resemble PFO and bind directly to cholesterol, as it does not exhibit human cell specificity like 
ILY and does not encode the CD59-binding motif.  
In addition to receptor diversity, there is also sequence diversity among CDCs despite an 
overall high level of amino acid identity (40-70%) [27]. The N-terminus is the most variable 
region of these proteins due to differing signal peptides and the presence of unique domains. A 
primary example is LLY, which encodes an N-terminal lectin domain that recognizes the 
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difucosylated glycans Lewis y and Lewis b antigens on the host cell surface. Glycan binding by 
LLY’s lectin domain enhances the lytic activity of this protein, likely by clustering LLY 
molecules in close proximity at the membrane to facilitate oligomerization [43]. Listeriolysin O 
(LLO), produced by Listeria monocytogenes, encodes an N-terminal PEST-like sequence that 
regulates the activity of this CDC and is critical for the virulence of this pathogen, although the 
mechanism by which this occurs remains controversial [44]. In addition, SLO encodes a 63 
amino acid N-terminal domain termed the N-terminal extension (NTE), which is not present in 
any other characterized CDCs. This domain is highly conserved and present in all sequenced S. 
pyogenes isolates, but does not have any shared motifs or predicted secondary structure, and was 
cleaved from the full-length protein during crystallization of SLO [45].  
The unique features of CDCs may influence their distinct pore-dependent and pore-
independent effects on host cells. While all CDCs exhibit lytic activity, many have been shown 
to be multifunctional and disrupt cellular activity by other mechanisms. For example, LLO, PLY, 
and PFO trigger an altered transcriptional program through the dephosphorylation of Ser10 on 
histone H3 [46]. LLO also induces changes in host cell signaling due to the aggregation of 
membrane rafts, which is not dependent on LLO’s pore-forming activity [47]. Similarly, PLY 
can induce the production of nitric oxide and IFN-γ even in the absence of cholesterol binding 
[48]. For SLO, one of its major activities is the translocation of SPN into host cells during 
infection by the process of cytolysin-mediated translocation (CMT), resulting in greater 
cytotoxicity than is observed with pore formation alone and triggering different pathways leading 
to cell death [24]. 
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Cytolysin-mediated translocation 
Cytolysin-mediated translocation (CMT) was discovered by investigating the localization 
pattern of SLO from infected HaCaT keratinocytes cells following detergent fractionation. 
Probing the soluble and insoluble fractions with anti-SLO antiserum revealed cross-reactivity of 
the antibody with a 52 kDa band in the soluble fraction, which was identified as SPN by N-
terminal sequencing [12]. SPN localization to the host cell cytosol was not observed following 
infection with a SLO deletion strain, implicating SLO as the translocator [12]. The original 
model for this process proposed that SPN passively diffuses through the interior of 
transmembrane pores formed by SLO to gain access to the host cell cytosol. While theoretically 
possible based on the size of CDC pores, it has been demonstrated that CMT is a more complex 
process and that SLO’s translocation activity can be uncoupled from its pore-forming function. 
This was discovered through the study of monomer-locked and prepore-locked mutants 
of SLO that bind to the host cell membrane but are incapable of forming pores. The monomer-
locked variant was generated by mutating two adjacent glycine residues (the CDC diglycine 
motif), which prevents the rotation of the β5 strand away from β4, a critical structural change 
required for monomer-monomer interactions [27,49]. The prepore-locked variant was generated 
by mutating a tyrosine residue in domain 3 that forms an intermolecular pi-stacking interaction 
with an adjacent monomer, necessary for insertion of the pore [49]. Both of these SLO variants 
were defective for pore formation but remained competent for SPN translocation during infection 
[49]. However, the monomer-locked variant was a less efficient translocator, indicating that 
oligomerization of SLO is not required for CMT but does enhance its activity. These data 
demonstrated that pore formation by SLO was not necessary for its SPN translocation activity, 
suggesting that CMT may be a pore-independent function of SLO. 
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Several additional findings have also contributed to our understanding of the complexity 
of CMT. For example, a requirement for SPN translocation is that the bacteria adhere to the host 
cell, also refuting the passive diffusion model. SLO in solution is able to contact host cell 
membrane and form pores, but CMT was not observed when HaCaT keratinocytes were infected 
with an M protein mutant strain, which is completely unable to adhere to this cell type [12]. This 
suggests that SPN and SLO must be secreted in close proximity to the host cell membrane in 
order for CMT to occur. In addition, both SPN and SLO must be secreted by the same bacterial 
cell; a co-infection with a SPN deletion strain and a SLO deletion strain does not result in SPN 
translocation, despite both proteins being produced by adherent bacteria [12]. These data suggest 
that CMT is a highly coordinated process, and that SPN and SLO may interact at the host cell 
surface immediately following secretion from the bacterium.  
Another unexpected discovery is that SLO’s translocation activity appears to be specific 
to SPN. To our knowledge, no other bacterial proteins are translocated into the host cytosol, 
despite the secretion of numerous bacterial proteins. This specificity may result from the 
chromosomal organization of SPN and SLO, which are encoded in the same operon and are 
under the control of a single promoter [50]. SPN and SLO are also both secreted from the 
bacterium via the signal recognition particle arm of the general secretory pathway, indicating that 
their transcription and translation are tightly coupled with secretion [51]. Together these findings 
indicate that the expression and secretion of SPN and SLO are tightly controlled, and that there 
are strict local protein concentration or temporal requirements that must be met before CMT can 
occur. 
Further demonstrating the specificity of CMT, both SPN and SLO encode domains that 
facilitate translocation but do not affect the other activities of these proteins. SLO seems to be 
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specialized for CMT, as the highly homologous CDC PFO is unable to translocate SPN when 
secreted from S. pyogenes despite its potent pore-forming activity in this context [52]. SLO and 
PFO exhibit a high level of sequence identity, but an obvious difference between these proteins 
is the presence of SLO’s N-terminal extension. Removing this sequence from SLO had no effect 
on pore formation but abolished its ability to translocate SPN, indicating that this domain is a 
CMT determinant. While necessary for CMT, it has not been possible to assess the sufficiency of 
this domain. Appending SLO’s NTE sequence to the N-terminus of PFO rendered this chimeric 
protein non-lytic, indicating extensive conformational defects [52]. As pore formation requires 
conformational changes throughout the majority of the protein, it is likely that SLO’s NTE 
sequence was not compatible with the downstream PFO sequence, and its presence disrupted 
critical structural changes necessary for oligomerization or insertion of the prepore complex. 
This fact that SLO maintains this NTE sequence suggests that it has adapted for both CMT and 
pore-forming activities. 
SPN also encodes a domain that is critical for its translocation. SPN’s C-terminal domain 
encodes its enzymatic activity, and its N-terminal domain can be removed without impacting 
NAD+ cleavage [53]. However, deletion of the entire N-terminal domain or short sequences 
within this domain renders SPN incompetent for translocation, demonstrating that SPN plays an 
active role in its translocation. Appending this domain to another secreted bacterial protein, 
mitogenic factor (MF), did not result in the translocation of this chimera, indicating that this 
domain is necessary but not sufficient for translocation [53]. Making MF translocation-
competent required fusing the sequence of full-length SPN to the N-terminus of MF. How SPN’s 
N-terminal domain plays a role in translocation is unclear, but it is predicted to adopt a “jelly 
roll” fold common to carbohydrate-binding proteins [22,53]. 
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Aim and scope of thesis 
 The aim of this thesis was to gain a greater understanding of how SPN and SLO associate 
at the host cell membrane to facilitate the translocation of SPN, and to determine sequence 
and/or structural features of these proteins that dictate the specificity of this effector translocation 
system. Since SLO requires cholesterol for pore formation, but pore formation is not required for 
CMT, we assessed the role for cholesterol in the membrane recognition and translocation activity 
of SLO. By generating mutations in SLO’s cholesterol-recognition motif and depleting 
membrane cholesterol we discovered that SLO engages in a cholesterol-independent mode of 
binding during infection that correlates with its translocation activity. Additionally, SLO’s N-
terminal extension plays a critical role in this alternative mode of binding. We also determined 
that SPN localizes to the host cell membrane in a SLO-dependent manner, and SLO’s 
cholesterol-independent mode of binding required the membrane localization of SPN, suggesting 
that SPN and SLO may form a complex at the host cell surface that recognizes an alternative 
receptor to promote CMT. 
 While recognition of this alternative receptor likely promotes SPN translocation, 
cholesterol was still believed to be the receptor facilitating SLO’s pore-forming activity. 
However, in addition to SLO’s cholesterol-recognition motif it was also shown to encode a 
putative carbohydrate-binding site within domain 4, implicating a host cell glycan as a potential 
receptor. By generating mutations within SLO’s predicted carbohydrate-binding site and 
utilizing glycan-deficient cell lines, we demonstrated that SLO does recognize a galactose-
containing glycoconjugate as a receptor preceding an interaction with cholesterol, although 
cholesterol is still necessary for the completion of pore formation. However, SLO’s recognition 
 15 
of this receptor is not required when SLO is co-expressed with SPN. SPN-mediated binding 
results in an equivalent level of pore formation by SLO, SPN translocation, and cytotoxicity. 
 We investigated SPN’s non-enzymatic N-terminal domain to understand how SPN was 
playing an active role in its own membrane targeting and translocation. Computational modeling 
based on structural homology predicted that this domain adopts the structure of a carbohydrate-
binding module. The mutation of a potential carbohydrate-binding residue or residues predicted 
to comprise a metal ion-dependent adhesion site rendered SPN nonfunctional for membrane 
recognition, translocation, and pore formation by SLO in the absence of its galactose-containing 
receptor, suggesting that SPN may be a cation-dependent carbohydrate-binding protein. Further 
analysis revealed that extracellular calcium is required for the membrane recognition and 
translocation of SPN. 
 While SPN is able to mediate a SLO-membrane interaction, it was unclear if SPN-
dependent binding normally occurs during infection. To address this question we developed a 
saponin solubilization assay that distinguishes peripherally associated from integral membrane 
proteins. SLO co-secreted with SPN is readily solubilized from the host cell membrane following 
infection, similar to a peripheral membrane protein. However, in the absence of SPN, SLO’s 
membrane association resembles an integral membrane protein and is not susceptible to 
solubilization, demonstrating that these two modes of membrane binding are distinct, and that 
SPN does influence SLO’s membrane association during infection. Further emphasizing an 
important role for both SPN and SLO in pathogenesis, we assessed SLO’s cytotoxic effects in 
the absence of SPN on various cell lines, and found that SPN is critical for effective SLO-
mediated membrane damage on some cell types. 
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Figure 1. S. pyogenes produces myriad cell-associated and secreted virulence factors. 
Among the virulence factors produced by S. pyogenes are several adhesion proteins, 
superantigens, inhibitors of complement, proteases, and hemolysins including Streptolysin O 
(SLO). Not shown on this figure is the secreted NAD+ glycohydrolase effector protein SPN. 
Adapted from Reference 11. 
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Figure 2. SPN is a strict NAD+ glycohydrolase. SPN was initially thought to possess ADP-
ribosyl transferase (A), ADP-ribosyl cyclase (B), and NAD+ glycohydrolase activities (C). 
However, a more detailed enzymatic characterization using purified enzyme demonstrated that 
SPN functions as a strict NAD+ glycohydrolase (C). Adapted from Reference 19. 
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Figure 3. Domain architecture and conserved features of CDCs. Shown at the left is the 
crystal structure of PFO from Clostridium perfringens, with conserved structural features 
highlighted. Domains 1-4 are labeled as D1-D4. The helices that unfurl to form transmembrane 
hairpins 1 and 2, which span the plasma membrane bilayer, are labeled as TMH1 and TMH2. 
The undecapeptide and loops 1-3 (L1-L3) are labeled at the tip of domain 4. Shown at the right is 
the crystal structure of SLO, which adopts a very similar structure. Not shown is the N-terminal 
extension (NTE) of SLO, which was cleaved from the full-length protein during crystallization. 
Adapted from Reference 27 (PFO structure) and Reference 45  (SLO structure). 
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Figure 4. Model of pore formation by cholesterol-dependent cytolysins. Domains 1-4 are 
labeled. In step I, a soluble monomer binds to the host cell membrane via the tip of domain 4. In 
The beginning stage of oligomerization is shown in Step II with the formation of a stable dimer. 
In Step III, oligomerization continues until 35-50 monomers assemble to form the prepore 
complex. In Step IV, conformational changes are propagated throughout the molecule, leading to 
the vertical collapse and insertion of the transmembrane hairpins to form the large β-barrel pore. 
Adapted from Reference 31.  
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CHAPTER 2 
 
A novel cholesterol-insensitive mode of membrane binding promotes 
cytolysin-mediated translocation by Streptolysin O 
 
 
 
Adapted from 
Mozola, C.C., Magassa, N., and Caparon, M.G. A novel cholesterol-insensitive mode of 
membrane binding promotes cytolysin-mediated translocation by Streptolysin O. 2014. Mol 
Microbiol. 94(3): 675-687. 
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SUMMARY 
Cytolysin-mediated translocation (CMT), performed by Streptococcus pyogenes, utilizes the 
cholesterol-dependent cytolysin Streptolysin O (SLO) to translocate the NAD+-glycohydrolase 
(SPN) into the host cell during infection. SLO is required for CMT and can accomplish this 
activity without pore formation, but the details of SLO’s interaction with the membrane 
preceding SPN translocation are unknown. Analysis of binding domain mutants of SLO and 
binding domain swaps between SLO and homologous cholesterol-dependent cytolysins revealed 
that membrane binding by SLO is necessary but not sufficient for CMT, demonstrating a specific 
requirement for SLO in this process. Despite being the only known receptor for SLO, this 
membrane interaction does not require cholesterol. Depletion of cholesterol from host 
membranes and mutation of SLO’s cholesterol recognition motif abolished pore formation but 
did not inhibit membrane binding or CMT. Surprisingly, SLO requires the co-expression and 
membrane localization of SPN to achieve cholesterol-insensitive membrane binding; in the 
absence of SPN, SLO’s binding is characteristically cholesterol-dependent. SPN’s membrane 
localization also requires SLO, suggesting a co-dependent, cholesterol-insensitive mechanism of 
membrane binding occurs, resulting in SPN translocation.  
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INTRODUCTION  
The translocation of toxic effector proteins into the host cell during infection is a 
common strategy used by bacteria to promote pathogenesis. Delivery of bacterial toxins requires 
a secretion system with a dedicated translocator. Many Gram-negative bacteria direct toxins 
across the host cell membrane into the cytosol through the specialized needle apparatus of Type 
III secretion systems [1]. Other toxins, including anthrax and diphtheria toxins, gain access to the 
host cytosol through the endocytic pathway after the translocator binds to the plasma membrane, 
allowing endocytosis of the translocator-toxin complex [2-4]. The Gram-positive bacterium 
Streptococcus pyogenes uses a different method of effector delivery termed cytolysin-mediated 
translocation (CMT) to transport an effector into the host cell during infection [5].   
The process of CMT requires the cholesterol-dependent cytolysin (CDC) Streptolysin O 
(SLO) for the directed translocation of the S. pyogenes NAD+-glycohydrolase (SPN) across the 
host cell membrane [5,6]. After gaining access to the host cell cytosol, SPN cleaves β-NAD+ to 
produce nicotinamide and ADP-ribose [7]. SPN and SLO are members of the large repertoire of 
virulence factors produced by S. pyogenes, which can result in varied clinical manifestations of 
disease including impetigo, pharyngitis, and necrotizing fasciitis [8]. Previous work has shown 
that S. pyogenes mutants deficient in either SPN or SLO exhibit decreased cytotoxicity, 
implicating CMT in pathogenesis [5,6,9,10]. Although it has been shown that SLO is required 
for the translocation of SPN, the mechanism by which this process occurs is unknown.  
The original model of CMT predicted that SPN diffuses through pores in the host 
membrane created by SLO. However, several subsequent findings suggest the mechanism is 
more complex. First, the highly homologous CDC Perfringolysin O (PFO) is not CMT 
competent when expressed from a SLO- strain of S. pyogenes, despite having robust pore-
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forming activity [10]. Second, SLO has an additional 66 residues at its amino terminus (N-
terminal extension) not found in related CDCs, and removal of this sequence abrogates the 
ability of SLO to translocate SPN without inhibiting pore formation [10]. Third, a recent study of 
SLO mutants unable to form pores led to the discovery that pore formation by SLO is not 
required for CMT [11], suggesting that pore formation and SPN translocation may be 
independent processes performed by SLO. The ability to translocate SPN in the absence of a 
pore indicates that specific contacts between SLO and the host cell membrane may be essential 
for CMT.  
SLO, PFO, and intermedilysin (ILY) are representatives of the CDC family of proteins, 
which are oligomeric pore-forming proteins secreted by several species of pathogenic Gram-
positive bacteria [12,13], and have also recently been discovered in two Gram-negative species 
[14]. These proteins share 40% to 70% identity, and previous analysis of resolved structures 
illustrates that all members of this family likely have an analogous structure and a similar pore-
forming mechanism [15-19]. Each cytolysin monomer initially contacts the host cell membrane 
via Domain 4 of the protein, which contains three small hydrophobic loops (the first of which 
constitutes the cholesterol recognition motif) and the undecapeptide, which is a stretch of eleven 
amino acids that are important for stabilizing cytolysins in the host cell membrane upon binding, 
coordinating membrane binding with monomer-monomer interactions in most CDCs [15,20], 
and facilitating structural changes required for pore formation [21-25].  
As their name suggests, cholesterol plays an important role in the function of cholesterol-
dependent cytolysins. It is absolutely required by all CDCs for pore formation, as recognition of 
cholesterol triggers the insertion of the hydrophobic loops—a prerequisite for insertion of the b-
barrel pore [15]. However, the role of cholesterol in initial membrane binding by these cytolysins 
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is not universal. Many studies have shown that cholesterol is the sole receptor for PFO, and both 
PFO membrane binding and pore formation are inhibited by cholesterol depletion [24,26-29]. 
However, the primary receptor for ILY (and a small subset of CDCs similar to ILY) is CD59, a 
human-specific membrane-anchored regulatory protein that inhibits the membrane attack 
complex of the complement pathway [15,30,31]. Consequently, depletion of cholesterol from the 
membrane prevents pore formation by ILY but does not inhibit membrane binding [27].  
To date, cholesterol remains the only identified receptor for SLO, and specific mutations 
in the cholesterol recognition motif of SLO significantly impair its ability to bind to cholesterol 
[21]. In this study we explore the role for cholesterol binding by SLO in CMT by extracting it 
from the membrane and by mutating SLO’s cholesterol recognition motif. The results 
demonstrate that the efficiency of CMT is unaffected by the concentration of membrane 
cholesterol, and altering SLO’s cholesterol recognition motif does not inhibit CMT. These 
manipulations also do not significantly affect SLO’s localization to the host cell membrane, 
revealing a novel cholesterol-insensitive mode of SLO membrane binding that occurs during 
infection. Surprisingly, this cholesterol-insensitive binding requires the co-expression and 
membrane localization of SPN, suggesting that CMT may be a cholesterol-insensitive process 
that occurs following an interaction between SPN and SLO at the host cell membrane. 
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RESULTS 
Membrane binding by SLO is necessary but not sufficient for CMT   
To evaluate the role of SLO’s membrane-binding Domain 4 in CMT, an internal deletion 
in slo was generated to create a mutant protein lacking this domain (SLOΔD4, Table S1). 
Immunoblot analysis of cell-free culture supernatants demonstrated that the truncated protein is 
secreted and stable (Figure S1). To verify that the deletion of this domain abrogates membrane 
binding, total membranes from A549 cells (human lung fibroblasts) were harvested following 
infection with strains encoding wild-type SLO, SLO- [32], or SLOΔD4. Wild-type SLO localized 
to the host cell membrane fraction, whereas, as expected, SLOΔD4 was not detected (Figure 1). 
Membrane binding is also necessary for SLO’s cytolytic activity, as cell-free culture supernatant 
from wild-type bacteria lysed rabbit erythrocytes while no lysis was detected with culture 
supernatant containing SLOΔD4 (Figure 1). To determine if membrane binding by SLO is 
necessary for its CMT activity, the cytosolic fractions of A549 cells infected with wild-type, 
SLO-, or the SLOΔD4-expressing strain were analyzed post-infection for the presence of SPN. 
The wild-type strain is CMT competent as shown by the presence of SPN in the host cell cytosol, 
but SLOΔD4 is deficient for CMT despite equivalent production and secretion of SLOΔD4 as well 
as SPN (Figure S1), indicating that membrane binding by SLO is required for CMT.  
To determine if membrane binding is sufficient for SLO to translocate SPN, SLO 
chimeras were generated that encode the membrane-binding Domain 4 sequences from the 
homologous CDCs ILY and PFO (SLO/ILYD4 and SLO/PFOD4, Table S1). Based on an 
alignment of Domain 4 primary sequences, SLO and ILY are 34.7% identical and 49.6% similar, 
while SLO and PFO are 64.5% identical and 74.5% similar (Figure 2). The SLO/ILYD4 and 
SLO/PFOD4 chimeras are expressed and secreted (Figure S1), and are localized to the host cell 
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membrane fraction following infection, although binding of SLO/ILYD4 is significantly reduced 
compared to wild-type SLO (Figure 1). As expected, SLO/ILYD4 from culture supernatants was 
unable to lyse rabbit erythrocytes, which lack ILY’s CD59 receptor, but retained hemolytic 
activity against human erythrocytes, indicating that this chimera adopted the cell binding 
specificity of ILY. Similarly, SLO/PFOD4 exhibited more robust lytic activity characteristic of 
PFO [10] (Figure 1). To determine if membrane recognition by these chimeras is sufficient to 
promote CMT, the cytosolic fractions of A549 cells infected with the SLO/ILYD4- and 
SLO/PFOD4-expressing strains were analyzed post-infection for the presence of SPN. Despite 
retaining membrane-binding ability, SLO/ILYD4 and SLO/PFOD4 were unable to translocate SPN 
into the host cell cytosol (Figure 1), although SPN is expressed in these strains (Figure S1). This 
defect for SLO/ILYD4 was not due to the variant undecapeptide of ILY, which has three amino 
acid differences in the undecapeptide compared to other CDCs [33], since a SLO/ILYD4 chimera 
with a canonical undecapeptide sequence (SLO/ILYD4-ECW, Table S1) also could not translocate 
SPN despite more efficient binding to host cell membranes than wild-type SLO (Figure 1). Thus, 
even though the SLO/ILYD4, SLO/ILYD4-ECW, and SLO/PFOD4 proteins maintain the ability to 
bind to host cells, it is apparent that solely binding the membrane is not sufficient for CMT.  
 
Membrane cholesterol reduction does not inhibit SLO binding or CMT  
The only known receptor for SLO is cholesterol, yet PFO’s membrane binding domain, 
which binds solely to cholesterol [24,26-29], cannot substitute for SLO’s Domain 4 to perform 
CMT. To evaluate the role for membrane cholesterol in SLO binding during an infection and its 
ability to conduct CMT, A549 cells were treated prior to infection with 5mM MβCD, a standard 
concentration used to remove cholesterol from A549 cells [34] and to study the role of 
 32 
cholesterol in CDC-membrane interactions [35]. Quantifying the level of cholesterol remaining 
after this treatment demonstrated that 5mM MβCD consistently removes ~60-70% of cholesterol 
from these cells, yet cells maintain full membrane integrity and viability (Figure S2). To 
determine if SLO binding and CMT efficiency correlate with the level of membrane cholesterol, 
untreated or MβCD-treated cells were infected with strains expressing wild-type SLO or 
SLO/PFOD4, and total host membranes and cytosolic fractions were harvested post-infection. As 
expected, SLO/PFOD4 did not bind to host membranes that had been treated with MβCD (Figure 
3A). However, membrane binding of wild-type SLO was not significantly affected by cholesterol 
depletion (Figure 3A). Additionally, SPN was translocated to wild-type levels into MβCD-
treated cells  (Figure 3A), indicating that CMT is not sensitive to the amount of cholesterol 
available for binding by SLO. 
To verify that MβCD treatment removed a sufficient amount of cholesterol from these 
cells to prohibit pore formation, membrane integrity of untreated cells or cells pretreated with 
MβCD was assessed post-infection with strains expressing wild-type SLO or SLO/PFOD4 using a 
membrane-impermeable fluorescent probe (Figure 3B). MβCD treatment prevented the cytolytic 
activity of both wild-type SLO and SLO/PFOD4 as demonstrated by the retention of membrane 
integrity. These data, corroborating the findings from experiments with SLO mutants deficient 
for pore formation [11], indicate that pore formation is not necessary for SLO’s CMT activity. 
To further investigate a role for cholesterol in CMT, point mutations in Domain 4 of 
wild-type SLO and SLO/PFOD4 were introduced that have been shown to alter the concentration 
of cholesterol required for binding. A recent study generated a PFO derivative with aspartate 434 
mutated to serine and found that this mutation decreased the concentration of cholesterol in 
model membranes required for binding by this purified PFO variant [35]. Since SLO’s native 
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residue at the equivalent position (508) is a serine, it was mutated to aspartate (SLOS508D, Table 
S1) to determine if this mutation would inhibit the ability of SLO to bind host membranes or 
conduct CMT. The reciprocal mutation was also made in SLO/PFOD4 (SLO/PFOD4 D508S, Table 
S1) to see if membrane binding under cholesterol-limiting conditions or CMT would be 
enhanced. However, analyzing membrane binding by these mutants to untreated or MβCD-
treated cells revealed no difference in membrane binding from their parent strains, and the 
SLOS508D mutation did not affect the level of SPN that was translocated or confer CMT activity 
to SLO/PFOD4 (Figure S3). Together these data indicate that the CMT activity of SLO is not 
sensitive to the concentration of cholesterol in the host cell membrane. 
 
An intact cholesterol recognition motif is not required for SLO membrane binding or CMT 
Treating A549 cells with MβCD only removes up to 70% of cellular cholesterol. 
Therefore, it remains a possibility that cholesterol is required for SLO to perform CMT, and the 
level remaining after MβCD treatment is sufficient for this process. To further investigate a 
potential role for SLO-cholesterol binding in CMT, mutations were generated in the cholesterol-
recognition motif (CRM), comprised of a threonine-leucine pair within loop 1 of the membrane-
binding domain that is critical for cholesterol binding [21] (Figure 2). Previous work has 
demonstrated that mutation of this leucine residue in PFO (PFOL491G) nearly abolishes binding of 
purified PFO to erythrocytes and decreases its hemolytic activity to 0.4%, indicating that this 
mutation results in nearly a complete loss of association with cholesterol [24]. Similarly, it has 
been shown that mutation of both the threonine and leucine residues in SLO (SLOT564G L565G) 
inhibits binding of this purified variant to erythrocytes, cholesterol-containing liposomes, and 
purified cholesterol [21].  Single and/or double point mutations were generated in SLO 
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(SLOL565G, SLOT564G L565G, Table S1) and the SLO/PFOD4 chimera (SLO/PFOD4 L565G, Table S1) 
to assess a requirement for cholesterol in binding and CMT. As expected, SLOL565G and 
SLOT564G L565G are completely non-lytic, and SLO/PFOD4 L565G has severely impaired activity, 
suggesting they cannot interact well with cholesterol to create the transmembrane pore (Figure 
4). To determine if these mutations in SLO result in a loss of membrane binding and CMT 
activity, host cell membranes were harvested post-infection with strains expressing SLO, 
SLOL565G, SLOT564G L565G, SLO/PFOD4, and SLO/PFOD4 L565G, and membrane association was 
detected by immunoblotting.  As expected from previous work [24], SLO/PFOD4 bearing this 
CRM mutation does not bind to host cell membranes (Figure 4). However, SLOL565G binds to the 
membrane to the same extent as wild-type SLO, and binding of SLOT564G L565G is impaired but 
not completely inhibited, confirming the results using MβCD that SLO binding to A549 cells 
during infection is not solely dependent on cholesterol. Additionally, the CMT activity of 
SLOL565G and SLOT564G L565G is identical to wild-type SLO (Figure 4). These data indicate that a 
direct interaction with cholesterol is not required for SLO membrane binding during infection or 
the translocation of SPN, and that the low level of membrane binding exhibited by SLOT564G 
L565G is sufficient for CMT activity. 
 
SLO’s N-terminal extension and residues in Domain 4 are required for cholesterol-
insensitive binding and CMT  
The sequences of SLO and PFO were compared to identify potential regions of SLO 
responsible for its cholesterol-insensitive mode of binding. The most obvious difference between 
these two CDCs is the N-terminal extension of SLO—the extra 66 amino acids at the amino 
terminus of SLO that have previously shown to be essential for the translocation of SPN, but not 
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pore formation by SLO [10]. Additionally, inspection of the Domain 4 sequences of SLO and 
PFO revealed that there are clusters of variable residues within this region between the second 
and third Domain 4 loops, and near the first loop, which contains the cholesterol recognition 
motif (Figure 2).  To determine if these unique regions of SLO influence its cholesterol-
insensitive mode of binding and CMT, we analyzed the membrane binding ability of SLO 
lacking its N-terminal extension (SLOΔNTE, Table S1) as well as three mutants generated by 
swapping clusters of PFO sequence in the SLO/PFOD4 chimera with the corresponding SLO 
residues (SLO/PFOD4-swap1 (S1), SLO/PFOD4-swap2 (S2), and SLO/PFOD4-swap3 (S3), Table S1). 
Immunoblot analysis of overnight culture supernatants demonstrated that the N-terminal deletion 
and all swap chimeras are produced and secreted like wild-type SLO and SLO/PFOD4 (Figure 
S1).  
To evaluate a potential contribution of these regions to SLO’s cholesterol-insensitive 
mode of binding, membranes from untreated or MβCD-treated cells were harvested post-
infection with strains expressing SLO, SLOΔNTE, SLO/PFOD4, or the SLO/PFOD4 swap chimeras. 
SLOΔNTE and the chimeric swap proteins localized to the total membrane fraction post-infection 
in the absence of MβCD treatment, albeit to varying extents (Figure 5 and Table S3). However, 
treatment with MβCD revealed that these mutants exhibit varying levels of cholesterol 
dependency. SLOΔNTE and SLO/PFOD4-swap1 (S1) were completely unable to bind to host cells 
with low levels of cholesterol following MβCD treatment (Figure 5). Conversely, the chimeras 
encoding more native SLO residues between the second and third hydrophobic loops 
(SLO/PFOD4-swap2 (S2) and SLO/PFOD4-swap3 (S3)) exhibit binding to cell membranes treated with 
MβCD (Figure 5).  
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Analysis of host cell cytosolic fractions post-infection with the indicated strains confirms 
that SLOΔNTE lacks CMT activity and demonstrates that the cholesterol-insensitive binding of the 
SLO/PFOD4-swap 2  (S2) and SLO/PFOD4-swap3 (S3) mutants correlates with CMT activity. Similar 
to SLO- and SLO/PFOD4, SLO/PFOD4-swap1 (S1) was unable to translocate SPN. In contrast, the 
SLO residues introduced in the SLO/PFOD4-swap2 (S2) and SLO/PFOD4-swap3 (S3) chimeras confer 
CMT activity to these proteins (Figure 5). This activity correlates with the extent of membrane 
binding to cholesterol-depleted membranes, with the SLO/PFOD4-swap3 (S3) mutant exhibiting 
more robust CMT activity.  Further supporting a pore-independent pathway for SPN uptake, 
cholesterol-insensitive binding and CMT activity exhibited by these chimeric swap proteins are 
inversely correlated with hemolytic activity.  SLO/PFOD4-swap1 (S1) is the most hemolytic but is 
completely defective for SPN translocation, whereas SLO/PFOD4-swap3 (S3) has no pore forming 
activity but is competent for CMT. Together, these data demonstrate that SLO’s cholesterol-
insensitive mode of membrane binding and CMT activity require both its N-terminal extension 
as well as specific residues within the C-terminal membrane-binding Domain 4, and that 
cholesterol-insensitive membrane binding correlates with CMT competence. 
 
SLO’s N-terminal extension and residues in Domain 4 are required for SPN-membrane 
association  
Since SLO membrane binding is necessary for the translocation of SPN into host cells, it 
seemed likely that SPN and SLO co-associate at the host cell surface prior to the translocation of 
SPN. To ascertain whether SPN localizes to the host cell membrane during infection, total 
membrane fractions were harvested following a 3h infection with wild-type bacteria and probed 
for the presence of SPN. Like SLO, SPN localized to the membrane fraction (Figure 6A). 
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However, this localization is SLO-dependent, as SPN was not detected at host membranes post-
infection with the SLO- strain (Figure 6A). Similarly, SPN did not localize to the host cell 
membrane during infection with strains expressing SLOΔNTE, SLO/PFOD4, or SLO/PFOD4-swap1 
(S1)—all of which are versions of SLO that are defective for CMT and require wild-type 
cholesterol levels for membrane binding. In contrast, SPN was detected in the total membrane 
fraction post-infection with strains expressing the SLO/PFOD4-swap2 (S2) and SLO/PFOD4-swap3 
(S3) chimeras, which exhibit intermediate levels of CMT activity and binding to cholesterol-
depleted membranes (Figure 6A).  
 The total membrane fraction is comprised of both plasma membrane and intracellular 
vesicles, so SPN’s localization was further assessed by a protease protection assay conducted on 
intact infected cells just prior to preparation of the total membrane fraction. Following infection, 
cells were treated with proteinase K, which was then removed and cells lysed and fractionated to 
obtain the total membrane fraction. Immunoblot analysis was then used to determine if 
membrane-associated SPN was protected by a membrane-bound vesicle or was susceptible to 
protease cleavage due to localization at the cell surface. As expected, cytosolic (translocated) 
SPN, actin, and GAPDH were protected from degradation (cytosol, Figure 6B), while the 
exposed membrane protein E-cadherin was efficiently degraded by proteinase K, as 
demonstrated by the decrease in the amount of full-length protein and the appearance of multiple 
degradation products (membrane, Figure 6B). Similarly, the amount of SPN in the total 
membrane fraction was decreased and a prominent degradation product was observed following 
proteinase K treatment (arrow, Figure 6B). This result indicates that SPN in the total membrane 
fraction is exposed at the plasma membrane, although it cannot be ruled out that it subsequently 
enters into an endocytic vesicle prior to its entry into the cytosol. Together, these data 
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demonstrate that SPN interacts with the host cell membrane, but only when it is co-secreted with 
CMT-competent SLO that is capable of cholesterol-insensitive membrane binding. 
 
SLO’s cholesterol-insensitive mode of membrane binding requires SPN  
SPN was not detected at cell membranes when secreted with mutants of SLO that are 
restricted to cholesterol-dependent membrane binding, leading to the hypothesis that a co-
dependent interaction between SPN and SLO at the host cell surface is necessary for SLO’s 
cholesterol-insensitive mode of binding. To evaluate a role for SPN in SLO’s cholesterol-
insensitive mode of membrane binding, untreated or MβCD-treated cells were infected with 
wild-type bacteria expressing both SPN and SLO, or with a SPN deletion strain [5] (Table S1). 
Total host membranes were harvested post-infection, and membrane-localized SLO was detected 
by immunoblotting. As demonstrated in Figure 3, SLO is able to bind to cholesterol-depleted 
host cell membranes when expressed from the wild-type strain that also produces SPN. 
However, SLO loses the ability to bind cholesterol-depleted host cell membranes in the absence 
of SPN (Figure 7). These data demonstrate that SPN is essential for SLO’s atypical cholesterol-
insensitive interaction with the host membrane that occurs during infection. 
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DISCUSSION 
 The data presented in this study contribute to an emerging literature demonstrating that 
the CMT activity of SLO is dependent on a unique interaction with the host cell membrane, one 
that extends beyond the characteristic cholesterol-dependent cytolytic properties of the CDC 
family. This study has revealed a novel second mode of membrane binding for SLO that is 
insensitive to cholesterol but dependent on the co-expression of SPN. Furthermore, the ability of 
SPN to bind the host membrane is dependent on SLO, and co-dependent binding is associated 
with competence for CMT. Thus, despite being an archetypal CDC, SLO is uniquely adapted to 
perform CMT. 
As an archetypical CDC, SLO shares the signature characteristics of this large and widely 
distributed family of bacterial toxins, identified in seven different genera of Gram-positive 
bacteria and two species of Gram-negative bacteria [14,15]. These toxins share a similar domain 
architecture, cholesterol-recognition motif, and a conserved cholesterol-dependent mechanism 
for triggering pore formation on host cells [15]. However, SLO’s adaptation for CMT has 
involved several gain-of-function adaptations that are neither required for pore formation nor 
inhibit its ability to form a pore. Analysis of these multiple adaptations has shown that they are 
related by their ability to promote the cholesterol-insensitive mode of binding, which itself is 
directly associated with competence for CMT. In prior work, it had been shown that SLO 
possesses a unique N-terminal extension that is required for CMT, but dispensable for classical 
cholesterol-dependent membrane binding [10]. However, the function of this N-terminal 
extension in CMT was not established. In this study, it is revealed to be crucial for promoting 
cholesterol-insensitive membrane binding. Furthermore, the N-terminal extension was required 
for the ability of SPN to associate with the membrane, which was also important for SLO’s 
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cholesterol-insensitive membrane binding. Competence for CMT also required adaptation of 
residues in SLO’s Domain 4, and these were shown to promote cholesterol-insensitive binding, 
thus altering SLO’s membrane binding characteristics relative to other CDCs. Remarkably, none 
of these adaptations interfere with SLO’s canonical CDC pore-forming function, revealing SLO 
to be a bifunctional toxin.   
The dual nature of SLO was most dramatically illustrated by the analysis of various CDC 
chimeric proteins. In contrast to SLO, which possesses both cytolytic and CMT activities, most 
chimeric proteins were only able to accomplish a single function. Among the various SLO/PFO 
chimeras, SLO/PFOD4 and SLO/PFOD4-swap1 exhibited potent hemolytic activity but no CMT 
activity, whereas the SLO/PFOD4-swap3 chimera regained CMT activity but lost hemolytic activity. 
Similarly, mutation of SLO’s cholesterol-recognition motif abolished pore formation and 
impaired membrane binding but had no effect on the level of SPN translocated. Since CMT does 
require Domain 4, these data highlight its important role in both pore formation and CMT, but 
reveal that each of these processes involves a unique interaction with the host cell membrane. 
For pore formation, receptor engagement mediated by Domain 4 initiates a complex series of 
significant structural changes between multiple domains (reviewed in [12]). For example, 
following the initial binding event mediated by the cholesterol-recognition motif, the short 
hydrophobic loops 2 and 3 insert into the membrane to anchor the monomer in a perpendicular 
orientation for the subsequent insertion of the undecapeptide. This event is then conformationally 
coupled to structural changes in Domain 3 that promote oligomerization and pore formation [20].  
The failure of various chimeras to preserve both CMT and pore-forming activities suggest that 
SLO’s adaptation for CMT required additional modifications in Domain 4 to maintain 
conformational coupling. Based on the location of the swapped residues, the failure of 
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SLO/PFOD4-swap3 to function in pore formation may have resulted from an incompatibility 
between the swapped region and residues within or near the short hydrophobic loops 2 and 3.  
Taken together, the observation that CMT and pore-forming activities can be separated among 
the various chimeras supports the idea that wild-type SLO has evolved to participate in two 
distinct modes of membrane binding: the conventional recognition of cholesterol leading to pore 
formation, and a unique alternative interaction that promotes CMT.  In addition, the fact that 
SLO’s adaptation for CMT was accompanied by extensive alterations to maintain pore-forming 
activity indicates that both activities are critical for pathogenesis.   
Since SLO’s cholesterol-insensitive mode of binding also involves the membrane 
association of SPN, it seems likely that these two proteins co-associate at the host cell surface to 
form a complex capable of recognizing an alternative receptor(s). While numerous models of 
interaction are possible, the behavior of the various chimeras suggests that SLO may make an 
initial low-affinity contact with the host cell membrane analogous to the non-specific binding of 
the Staphylococcus aureus alpha toxin that is observed at high concentrations [36]. In the 
absence of SPN, SLO would be free to engage cholesterol by the canonical mechanism. 
However, in the presence of SPN, Domain 4 may undergo a different structural rearrangement 
that promotes a more stable interaction with the alternative receptor. This model of alternative 
conformational changes would explain why various chimeras were proficient at either CMT or 
pore formation, but not both, depending on which sub-domain of SLO’s Domain 4 they possess. 
It would also explain why SLO does not sustain binding to cholesterol-depleted membranes in 
the absence of SPN, why SLO does not require cholesterol to bind to membranes in the presence 
of SPN, and why non-membrane associated SLO and SPN do not interact. It would also predict 
 42 
that SLO’s CMT-adapted Domain 4 residues conformationally couple SPN binding and 
recognition of the alternative receptor.   
While SLO is capable of both pore-forming and CMT activities, it is unlikely that an 
individual molecule can engage in both activities simultaneously. Thus, events that occur 
immediately following the initial binding event will be critical for driving SLO into one of these 
pathways. Since it seems likely that the default pathway will be the recognition of cholesterol 
leading to pore formation, a key node in directing the fate of SLO will be the status of SPN.  One 
model would predict that CMT is dependent on the efficient co-delivery of SPN to SLO prior to 
its recognition of cholesterol in order to initiate the events that result in CMT.  In support of this 
model, it has been shown that CMT requires delivery of both toxins from the same bacterial cell, 
as a co-infection with SLO- and SPN- mutants does not result in translocation of SPN [5]. There 
is also considerable evidence that S. pyogenes has evolved multiple mechanisms to optimize the 
co-delivery of SLO and SPN to the membrane.  First, expression of SLO and SPN is under tight 
co-ordinate control, as the genes that encode both these proteins are organized in an operon 
under the control of a single promoter [37]. Second, unusual for non-membrane secretory 
proteins in bacteria, secretion of both SPN and SLO occurs via the signal recognition particle 
(SRP) arm of the general secretory (Sec) pathway [38], which tightly couples transcription and 
translation with secretion [39]. Finally, secretion of extracellular toxins in S. pyogenes proceeds 
through the ExPortal, a dedicated microdomain of the bacterial cellular membrane that is 
dedicated to protein secretion by clustering the Sec translocons and accessory biogenesis factors 
into a single highly organized membrane microdomain [40]. Together, these indicate that the 
transcription, translation, secretion, and post-secretion targeting of SPN and SLO are highly 
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coordinated. This level of organization provides additional support to the idea that S. pyogenes is 
highly adapted to perform CMT.  
Also consistent with high level of adaptation required for CMT is that it has not been 
possible to reconstitute CMT using purified components in vitro. This could reflect a strict 
requirement for temporal and spatial coordination of toxin delivery to the cell surface. 
Alternatively, CMT may require additional post-secretion processing of SLO and/or SPN, or 
involve bacterial components that have not yet been identified. In this regard, it has been noted 
that SLO can be isolated from the bacterial cell wall [41], and we have found that SPN also may 
bind to the streptococcal cell wall (unpublished), raising the possibility that interaction at the cell 
wall is a necessary precursor to reorientation for interaction at the host cell membrane.  Similar 
to SLO, SPN itself is highly adapted for CMT and possesses a dedicated N-terminal domain that 
is dispensable for its enzymatic NADase activity but required for its translocation [42]. Structural 
modeling predicts that this domain resembles a carbohydrate-binding domain [43], not unlike the 
N-terminal lectin domain of the CDC lectinolysin, suggesting that it may directly participate in 
recognition of a cell surface receptor.  SPN’s association with the membrane is presumably 
transient, as it is rapidly introduced into the host cell cytosol by an unknown mechanism while 
SLO remains associated with the cell membrane.  In examining the accessibility of SPN at the 
membrane to protease treatment, the degradation of SPN was not as extensive as cleavage of E-
cadherin, suggesting that SPN in this total membrane fraction may represent two populations, 
plasma membrane-bound, surface-exposed SPN that is susceptible to proteinase K, and SPN that 
is protected within an intracellular vesicle.  This suggests that following its association with the 
cell membrane, SPN may be internalized in a membrane-bound vesicle subsequent to its release 
into the cytosol.  
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Recognition of an alternative receptor by a CDC is not without precedent. ILY was the 
first CDC characterized that makes initial contact with the host membrane through a non-
cholesterol receptor by recognizing the human-specific protein CD59 [30]. Another CD59-
binding CDC, lectinolysin (LLY), also exhibits a cholesterol-independent mode of binding by 
recognizing difucosylated Lewis b and Lewis y antigens through its unique lectin domain, which 
similar to SLO’s N-terminal extension is located distal to Domain 4 [44,45]. Glycan recognition 
by LLY has been shown to augment the hemolytic activity of this protein, likely by clustering 
LLY monomers to enhance oligomerization and subsequent pore formation [44]. However, in 
contrast to the glycan-binding function of LLY that supports lytic activity, recognition of a 
second receptor by SLO for CMT appears to be a separate event from cholesterol binding and 
pore formation. 
In the present study, we have shown that SLO is an example of a growing number of 
toxins that bind to multiple receptors, which may allow these toxins to target different cell types, 
maintain activity under varied conditions, or exert disparate effects on the target cell. Among 
these are the potent vacuolating cytotoxin VacA of Helicobacter pylori, which engages different 
receptors to elicit varied cellular responses [46-50]. Additionally, anthrax toxin [4], diphtheria 
toxin [51], and botulinum neurotoxin B [52,53] require the simultaneous engagement of co-
receptors for binding and/or internalization. It remains to be determined whether similar 
mechanisms are responsible for the interactions between SLO, SPN and the host cell membrane. 
However, future studies into the details of membrane binding and identification of the alternative 
membrane receptor will provide important insight into the mechanism of CMT.   
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MATERIALS AND METHODS 
Bacterial Strains:  Escherichia coli TOP10 cultured in Luria-Bertani broth at 37°C was used for 
molecular cloning experiments. The S. pyogenes strain used was JRS4 (M serotype 6) [54]. 
Todd-Hewitt broth supplemented with 0.2% autolysed yeast extract was used for the routine 
culture of S. pyogenes. Where appropriate, erythromycin was added to media to final 
concentrations of 750 mg ml-1 for E. coli and 1 mg ml-1 for S. pyogenes. 
 
Manipulation and computational analyses of DNA:  Plasmid DNA was isolated and used to 
transform E. coli using standard techniques. Electroporation was used to transform S. pyogenes 
as previously described [55]. Restriction endonucleases, ligases, and polymerases were used 
according to the manufacturers’ recommendations. The alignment of Domain 4 sequences was 
generated using ClustalW. 
 
Construction of SLO mutants:  The nucleotide coding sequence of the SLO/PFOD4 (SLO 
residues 1-463, PFO residues 390-500) and SLO/ILYD4 (SLO residues 1-463, ILY residues 417-
532) mutants were created by custom gene synthesis in the pUC57 vector (Genscript; 
Piscataway, NJ, USA). The nucleotide sequences were then removed from pUC57 and inserted 
into the pJRS233 temperature-sensitive shuttle vector containing an erythromycin resistance 
cassette using the restriction endonucleases XhoI and ClaI [56]. Inverse PCR was used to 
generate the SLOΔD4 and SLO/ILYD4-ECW mutants from the SLO/ILYD4 nucleotide sequence, the 
SLO/PFOD4-swap1 and SLO/PFOD4-swap2 mutants from the SLO/PFOD4 nucleotide sequence, and 
the SLOL565G mutant from the wild-type SLO nucleotide sequence present in pJRS233. The 
SLO/PFOD4 L565G and SLO/PFOD4 D508S mutants were made from the SLO/PFOD4 sequence in 
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pJRS233 and the SLOS508D and SLOT564G L565G mutants were made from the wild-type SLO 
sequence in pJRS233 using the Quikchange XL II mutagenesis kit (Agilent Technologies). 
Sequence overlap extension mutagenesis [57] was used to make the SLO/PFOD4-swap3 mutant 
from the SLO/PFOD4 nucleotide sequence in pJRS233. The product of the second round of PCR 
was cleaved with XhoI and ClaI and inserted into pJRS233. For the strain expressing SLOΔNTE, 
the sequence from [10] was cloned into pJRS233 at the XhoI and ClaI sites. The JRS4 (WT) 
wild-type slo allele was replaced with the mutants as previously described [58]. All primer 
sequences are listed in Table S2 with restriction endonuclease sites underlined. The fidelity of all 
DNA sequences generated by PCR was validated by DNA sequencing analyses performed by a 
commercial vendor (Genewiz; South Plainfield, NJ, USA).  
 
Analysis of hemolytic activity:  Cell-free overnight S. pyogenes culture supernatants were used 
to measure the ability of various SLO mutants to lyse rabbit defibrinated erythrocytes (Hemostat 
Laboratories) or human red blood cells obtained from a healthy human volunteer [5]. Hemolytic 
titer is defined as the reciprocal of the dilution that produced 50% lysis [5,10]. If no detectable 
lysis was observed in the presence of undiluted supernatant, it was concluded that the hemolytic 
titer was below the limit of detection and was reported as “not detected” (ND). Data presented 
are representative of at least three independent experiments, with the exception of hemolysis 
experiments using human red blood cells, which were performed once. 
 
Analysis of CMT: A549 cells (ATCC CCL-185) were grown in 75 cm2 tissue culture flasks in 
the presence of Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 50 mM 
HEPES, 8 mM L-glutamine, and 10% fetal bovine serum. Confluent cells were infected with 
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various streptococcal strains as mentioned in the text. Streptococcal cultures were grown 
overnight in ThyB, back-diluted in fresh ThyB the morning of the infection to achieve an OD600 
of 0.08 in 30mL media, and were allowed to double twice before washing the cells with PBS and 
resuspending the pellet in medium to an OD600 of 0.3. The A549 cells were incubated with 1mL 
of the resuspended streptococcal strains plus 14mLs of fresh medium for 3 hours at 37°C in the 
presence of 5% CO2. Total membranes and cytosolic fractions were harvested (see below), and 
the translocation of SPN into the host cytosol was detected by immunoblotting using commercial 
anti-SPN (Cosmo Bio Co.). GAPDH antibody (Biovision) and actin AC-40 (Sigma) were used as 
loading controls for the cytosolic fraction. Images shown are representative of at least three 
independent experiments. 
 
A549 cell membrane extraction and cytosolic fractionation: Total membrane fractions were 
harvested as described previously, with some modifications [59]. Briefly, the cells were washed 
twice with cold PBS, scraped into 1.4mL homogenization buffer (10mM Tris-HCl pH 7.5, 5mM 
EDTA, protease inhibitors (Roche complete mini)), and lysed by 30 passages through a 22-gauge 
needle. The homogenates were spun to remove unlysed cells and cellular debris (600 x g, 15 
minutes, 4°C) and the resulting supernatants were spun to pellet total membranes (100,000 x g, 
1h, 4°C). Pellets were resuspended in 1X SDS sample buffer and analyzed by immunoblotting 
with anti-SLO antiserum (generated by Sigma-Genosys), and the supernatant was saved for 
analysis of CMT using anti-SPN as described above. E-cadherin antibody (Cell Signaling 
Technology) was used as a loading control for the total membrane fraction. Where indicated, 
5mM methyl-b-cyclodextrin (MβCD, Sigma) was added to the media 30 minutes prior to 
infection and remained in the media over the course of the infection. Immunoblots were 
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developed by chemiluminescence (SuperSignal® West Dura Extended Duration Substrate, 
Thermo Scientific) and images captured using a CCD camera-based system (ChemiDocTM, 
BioRad). Protein levels were quantitated by densitometry of captured images using Quantity One 
analysis software (version 4.6.9, BioRad) and data presented represent the mean and standard 
deviation derived from at least 3 independent experiments, presented in Table S3. For each 
experiment, a representative image is presented in the text, prepared for publication using Adobe 
Illustrator CS6.  
 
Proteinase K protection assay: Following a 3h infection of A549 cells in T75 flasks as 
described above, the media was removed and cells were washed once with 5mL DMEM and 
incubated in either 5mL DMEM alone or 5mL DMEM with a final concentration of 4ug ml-1 
proteinase K (Sigma). Cells were incubated at room temperature for 10 minutes. Following 
incubation, the media was removed and cells were gently washed twice with 5mL PBS before 
harvesting total membrane and cytosolic fractions as described above. 
 
Assessing A549 cell membrane integrity: Following infection A549 cell membrane integrity 
was assessed by visualizing the extent of exclusion of the fluorescent membrane-impermeable 
dye EthD-1, a component of the LIVE/DEAD viability/cytotoxicity kit for mammalian cells 
(Molecular Probes). The cells were incubated with the staining solution for 15 minutes at 37°C 
prior to visualization by fluorescence microscopy.   
 
Measuring membrane cholesterol concentration: A549 cells grown to near confluency in 
75cm2 flasks were left untreated or treated with 5mM MβCD for 3.5h at 37°C. Following this 
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incubation cells were washed with PBS, resuspended in 1.4mL homogenization buffer (10mM 
Tris-HCl pH 7.5, 5mM EDTA, protease inhibitors (Roche complete mini)), and spun at 500 x g 
for 10 minutes at 4°C. The pellet was resuspended in 1X reaction buffer from the Amplex Red 
cholesterol assay kit (Molecular Probes), and the level of membrane cholesterol was quantified 
by comparing samples to a cholesterol standard curve according to the manufacturer’s 
instructions. 
 
Statistical Analysis: Differences in mean values of the effect of MbCD treatment on pore 
formation and cell permeability were tested for significance by the Tukey-Kramer multiple 
comparisons test. The null hypothesis was rejected for p values less than 0.05.  
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Figure 1. Membrane binding by SLO is necessary but not sufficient for CMT. Immunoblot 
analyses of total membrane and cytosol prepared from A549 cells following 3 hrs of infection by 
the various S. pyogenes strains indicated at the top of the Figure that were developed with 
antisera against the proteins indicated on the right. Analyses of E-cadherin (membrane) and 
GAPDH (cytosol) were included as loading controls and the migration of several molecular 
weight standards (in kDa) are indicated at the left. Shown at the bottom are hemolytic titers of 
overnight culture supernatant for rabbit (Rb) and human (Hu) erythrocytes. ND, titer was below 
the limit of detection (sample undiluted); -, sample not tested. Immunoblots and rabbit titers are 
representative of a minimum of three independent experiments; human titers were performed 
once. Strains are: wild-type (SLO), a SLO-deficient mutant (SLO-), and mutants expressing: 
SLO lacking D4 (SLOΔD4), the SLO/ILY D4 chimera (SLO/ILYD4), the SLO/ILY D4 chimera 
with canonical undecapeptide sequence (SLO/ILYD4-ECW), and the SLO/PFO D4 chimera 
(SLO/PFOD4). 
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Figure 2. Domain 4 sequences of SLO and related CDCs: ClustalW alignment of the Domain 
4 amino acid sequences of SLO, PFO, and ILY. An asterisk, colon, or period below the 
alignment denotes identical, highly similar, and similar residues, respectively. Also shown is the 
undecapeptide sequence (dark bar above) and the atypical undecapeptide residues of ILY (dark 
bars below).  Residues swapped between SLO D4 and PFO in various SLO/ PFOD4 chimeras are 
shown by the shaded (Swap 1 and 3) and dashed-line (Swap 2) boxes.  Variant residues are 
shown by bars (Swap 1, Swap 3) and by filled circles (Swap 2).  Boxes outlined by solid lines 
indicate the three hydrophobic loops (loops 1-3), with the critical Loop 1 threonine and leucine 
of the cholesterol recognition motif highlighted.  The numbering of residues (shown at the right 
and left enclosed by parentheses) is based on the sequence of each respective protein (Genbank 
AAK33267.1, AAA23270.1, BAA89790.1; for SLO, PFO, ILY; respectively).   
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Figure 3. SLO membrane binding and CMT are not sensitive to the level of membrane 
cholesterol. (A) A549 cells were untreated (-) or treated (+) with 5mM MβCD to deplete 
membrane cholesterol for 30 minutes prior to infection with wild-type (SLO) or a strain 
expressing SLO/PFOD4. Following a 3h infection, total membranes and cytosol were harvested 
and subjected to immunoblot analyses as indicated, developed with antisera against the proteins 
specified to the right of the Figure. Analyses of E-cadherin (membrane) and GAPDH (cytosol) 
are included as loading controls and the migration of several molecular weight standards (in 
kDa) are shown at the left. Immunoblots shown are representative of at least three independent 
experiments. (B) Pore formation in A549 cells infected and treated as in (A) was quantitated by 
assessment of membrane permeability by staining with a fluorescent vital dye (Live/DeadTM). 
Data are presented as the percentage of cells that were membrane-permeable following infection 
and represent the mean and the standard deviation derived from three independent experiments. 
Differences between mean values were tested for significance by the Tukey-Kramer multiple 
comparisons test. The asterisks indicate p≤0.0005.    
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Figure 4. A direct interaction with cholesterol is not required for SLO binding or CMT. 
Immunoblot analyses of total membrane and cytosol prepared from A549 cells following 3 hrs of 
infection by the various strains indicated at the top of the Figure that were developed with 
antisera against the proteins indicated on the right. Analyses of E-cadherin (membrane) and 
GAPDH (cytosol) were included as loading controls and the migration of several molecular 
weight standards (in kDa) are indicated at the left. Shown at the bottom are hemolytic titers of 
overnight culture supernatant for rabbit (Rb) erythrocytes. ND, titer was below the limit of 
detection (sample undiluted). Immunoblots and titers are representative of at least three 
independent experiments.  
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Figure 5. SLO’s N-terminal extension and residues in Domain 4 are required for 
cholesterol-insensitive binding and CMT. A549 cells were untreated (-) or treated (+) with 
5mM MβCD to deplete membrane cholesterol for 30 minutes prior to infection with wild-type 
(SLO) and mutants expressing: SLO lacking its N-terminal extension (SLOΔNTE), SLO/PFOD4, 
SLO/PFOD4-swap1 (S1), SLO/PFOD4-swap2 (S2), and SLO/PFOD4-swap3 (S3). Following a 3h 
infection, total membranes and cytosol were harvested and subjected to immunoblot analyses as 
indicated, developed with the antisera against the proteins specified to the right of the Figure.  
Analyses of E-cadherin (membrane) and GAPDH (cytosol) were included as loading controls 
and the migration of several molecular weight standards (in kDa) are indicated at the left. Shown 
at the bottom hemolytic titers for rabbit erythrocytes (Rb). ND, titer is below the limit of 
detection (sample undiluted). Immunoblots and titers are representative of at least three 
independent experiments.  
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Figure 6. SLO’s N-terminal extension and residues in Domain 4 are required for SPN-
membrane localization. (A) A549 total cell membranes were harvested following a 3h infection 
with wild-type (SLO), a mutant that does not express SLO (SLO-), and mutants expressing: 
SLOΔNTE, SLO/PFOD4, SLO/PFOD4-swap1 (S1), SLO/PFOD4-swap2 (S2), and SLO/PFOD4-swap3 (S3) 
and subjected to immunoblot analyses as indicated, developed with the antisera specified to the 
right of the Figure. Analysis of E-cadherin is included as a loading control and the migration of 
several molecular weight standards (in kDa) are indicated at the left. Immunoblots are 
representative of at least three independent experiments. (B) Cells were treated with 4 ug ml-1 
proteinase K to cleave surface-exposed proteins following a 3h infection with wild-type bacteria. 
After incubation the protease was removed, and total cell membranes and cytosolic fractions 
were harvested and subjected to immunoblot analyses as indicated, developed with the antisera 
specified to the right of the Figure. The migration of several molecular weight standards (in kDa) 
are indicated at the left. Immunoblots are representative of at least three independent 
experiments. 
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Figure 7. SPN is required for the cholesterol-insensitive binding of SLO. A549 cells were 
untreated (-) or treated (+) with 5mM MβCD to deplete membrane cholesterol for 30 minutes 
prior to infection with wild-type (WT) or mutant lacking SPN (SPN-). Following a 3h infection, 
total membranes were harvested and subjected to immunoblot analyses as indicated, developed 
with the antisera against the proteins specified to the right of the Figure. Analysis of E-cadherin 
is included as a loading control and the migration of several molecular weight standards (in kDa) 
are indicated at the left. Immunoblots are representative of at least three independent 
experiments.  
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Figure S1. SLO variants and SPN are expressed and secreted. Shown are immunoblots of 
overnight culture supernatants from strains expressing the indicated proteins, developed with 
anti-SLO or anti-SPN antiserum. Proteins from supernatants were precipitated by the addition of 
trichloroacetic acid to a final concentration of 10%. Shown at the left of the figures is the 
migration of molecular weight standards in kDa. 
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Figure S2. MβCD treatment. A549 cells were treated with 5mM MβCD for 3.5 hours and the 
level of cholesterol was quantified as described in Materials and Methods. Cellular viability was 
assessed by staining with a fluorescent vital dye as described in the Materials and Methods to 
determine the percentage of cells that could exclude a fluorescent probe that is impermeable 
across an intact membrane. Data are presented as the percentage of total cells that were 
membrane-impermeable. For both determination of cholesterol content and viability, data 
represent the mean and the standard deviation derived from three independent experiments. 
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Figure S3. Altering the cholesterol-binding threshold of SLO and SLO/PFOD4 does not 
change membrane binding or CMT activity. A549 cells with (+) and without (-) pretreatment 
with 5mM MβCD were infected for 3 hours and cytosol (cytosol) and total membranes 
(membrane) were prepared and subjected to immunoblot analysis developed with the antisera 
shown to the right of the figure. Strains expressed: wild-type SLO (SLO), a S508D mutant SLO 
(SLOS508D), a SLO/PFO D4 chimera (SLO/PFOD4), and a D508S mutant of a SLO/PFO D4 
chimera (SLO/PFOD4 D508S). 
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CHAPTER 3 
 
Dual modes of membrane binding direct pore formation by 
Streptolysin O 
 
 
 
 
Adapted from 
Mozola, C.C., and Caparon, M.G. 2015. Dual modes of membrane binding direct pore formation 
by Streptolysin O. In revision. 
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SUMMARY 
Effector translocation is central to the virulence of many bacterial pathogens, including 
Streptococcus pyogenes, which utilizes the cholesterol-dependent cytolysin Streptolysin O (SLO) 
to translocate the NAD+ glycohydrolase SPN into host cells during infection. SLO’s 
translocation activity does not require host cell membrane cholesterol or pore formation by SLO, 
yet SLO does form pores during infection via a cholesterol-dependent mechanism. While 
cholesterol was considered the primary receptor for SLO, SLO’s membrane-binding domain also 
encodes a putative carbohydrate-binding site, implicating a potential glycan receptor in binding 
and pore formation. Analysis of carbohydrate-binding site SLO mutants and carbohydrate-
defective cell lines revealed that glycan recognition is involved in SLO’s pore formation 
pathway, and is an essential step when SLO is secreted by non-adherent bacteria, as occurs 
during lysis of erythrocytes. However, SLO also recognizes host cell membranes via a second 
mechanism when secreted from adherent bacteria, which requires co-secretion of SPN but not 
glycan binding by SLO. This SPN-mediated membrane binding of SLO correlates with SPN 
translocation, and requires SPN’s non-enzymatic domain, which is predicted to adopt the 
structure of a carbohydrate-binding module. SPN-directed membrane binding also promotes pore 
formation by SLO, demonstrating that pore formation can occur by distinct pathways during 
infection.  
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INTRODUCTION  
 The Gram-positive bacterium Streptococcus pyogenes is an extraordinarily versatile 
pathogen, with infection resulting in numerous manifestations of disease including bacterial 
pharyngitis, cellulitis, and invasive necrotizing fasciitis [1,2]. The bacterium produces an arsenal 
of virulence factors, contributing to its versatility as a pathogen [3]. Like many pathogenic 
bacteria, the translocation of effector proteins into host cells during infection contributes to the 
virulence of S. pyogenes. In contrast to Gram-negative organisms, which commonly accomplish 
effector translocation via Type III secretion [4], S. pyogenes utilizes a system termed cytolysin-
mediated translocation (CMT) to deliver the NAD+ glycohydrolase SPN into the host cell 
cytosolic compartment during infection, where it exerts its toxic effects [5,6]. The translocation 
of SPN requires the action of the cholesterol-dependent cytolysin Streptolysin O (SLO), although 
the mechanism of this process is still not fully understood [5]. 
 The cholesterol-dependent cytolysin (CDC) proteins, of which SLO is an archetypal 
member, are produced by several Gram-positive bacteria [7]. They are classified as CDCs by the 
presence of conserved structural features, including the undecapeptide and cholesterol-
recognition motif, as well as their ability to form pores on host cell membranes via a shared 
cholesterol-dependent mechanism [8]. Following secretion from bacteria as soluble monomers, 
CDCs bind to host cell membranes through their C-terminal domain (domain 4) and oligomerize 
to form the prepore complex, which subsequently undergoes significant structural 
rearrangements and collapses into the membrane to form the β-barrel pore [8]. While this 
transmembrane pore is theoretically large enough to allow the passive diffusion of SPN into the 
host cell cytosol, several studies have refuted this model for CMT and have revealed it to be a 
highly coordinated and complex process [9-13].  
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The study of multiple SLO mutants defective for pore formation has demonstrated that 
SLO’s ability to form pores is not required for SPN translocation [10,12]. These mutants include 
variants of SLO that are unable to progress past monomer-bound or prepore-complex stages, as 
well as SLO with a disrupted cholesterol recognition motif—the residues within domain 4 that 
directly interact with membrane cholesterol. While unable to form pores, these SLO mutants 
retain CMT activity, indicating that SPN translocation occurs via a pore-independent pathway 
[10,12]. Although historically considered a canonical CDC, SLO does not require cholesterol to 
bind to host cell membranes during infection. Instead, recent work establishes that cholesterol-
independent binding by SLO requires the concomitant binding of SPN, suggesting that the two 
toxins may interact with the membrane as a complex prior to the translocation of SPN into the 
host cytosol [12].  
The discovery that SLO does not rely on cholesterol for membrane binding contributes to 
an emerging body of work revealing more diversity in CDC-membrane interactions than 
previously appreciated. It is becoming increasingly clear that cholesterol, while essential for pore 
formation, does not always serve as the primary host cell receptor for CDCs. Intermedilysin 
(ILY), produced by Streptococcus intermedius, was the first CDC shown to recognize an 
alternative membrane receptor; the initial interaction between ILY and the membrane is 
mediated by the human-specific protein CD59 [14]. Since that finding, this CDC subset has 
expanded to include lectinolysin (LLY) and vaginolysin (VLY) [15-17]. For these CDCs, 
binding to CD59 orients the toxin in the proper conformation relative to the membrane so that it 
can subsequently interact with cholesterol to form the pore. Therefore, while not the primary 
receptor for these CDCs, membrane cholesterol is still critical for pore formation, as the prepore-
to-pore transition does not occur in the absence of cholesterol [18,19].   
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Recently, a study of the CDC pneumolysin (PLY), produced by Streptococcus 
pneumoniae, identified a carbohydrate-binding site with PLY’s domain 4 that recognizes the 
blood group antigens divalent-LewisX and sialyl LewisX glycans on erythrocyte membranes 
[20]. Mutation of the residues that occupy this binding site or competition with exogenous sialyl 
LewisX reduced membrane binding and hemolytic activity (a measure of pore formation) of 
PLY, revealing this to be a functional carbohydrate-binding site and indicating that the sialyl 
LewisX glycan may serve as the primary receptor for PLY on this cell type [20]. The in silico 
analysis used to identify the PLY carbohydrate-binding site also predicts a glycan-binding site 
within domain 4 of SLO, and purified SLO bound numerous carbohydrate structures by glycan 
array analysis. The majority of the glycans recognized by SLO contain galactose, including the 
carbohydrate lacto-N-neotetraose, which was bound by SLO with high affinity. Providing 
functional significance to this putative binding site, exogenous lacto-N-neotetraose impaired 
binding of SLO to erythrocytes and inhibited its hemolytic activity, suggesting that SLO’s 
recognition of a glycan receptor may be a critical step in the pathway to pore formation [20]. 
To assess a role for glycan binding by SLO during infection, we have mutated the 
residues occupying the predicted carbohydrate-binding site in SLO. These mutants are defective 
for hemolytic activity on red blood cells, indicating an impaired ability to form pores on this cell 
type. However, the same SLO mutants retain lytic activity on mammalian cells during bacterial 
infection, and translocate an equivalent amount of SPN as wild-type SLO. Surprisingly, the lytic 
activity of the SLO variants requires the co-expression of SPN, indicating that in the absence of 
glycan binding by SLO, SPN is able to direct SLO to the membrane for pore formation during 
infection. This mode of binding requires the non-enzymatic N-terminal domain of SPN, which is 
also predicted to be a carbohydrate-binding domain.  
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RESULTS 
SLO’s carbohydrate-binding site is required for hemolysis but not SPN translocation 
 The residues in domain 4 of SLO that are predicted to comprise the carbohydrate-binding 
site are Q476, W503, W537, and W538 [20]. Residues W537 and W538 are situated within the 
undecapeptide, which is a highly conserved feature of CDCs that stabilizes the protein in the host 
cell membrane and facilitates the structural transitions that lead to pore formation [21]. Amino 
acid changes in this region commonly result in a loss of lytic activity [22], so residues Q476 and 
W503, which are not within the undecapeptide, were targeted by mutagenesis to avoid potential 
conformational defects. Conservative (glutamine to asparagine, and tryptophan to tyrosine) and 
non-conservative mutations (both residues mutated to alanine) were introduced in SLO in the 
bacterial chromosome (SLOQ476N, SLOQ476A, SLOW503Y, SLOW503A; Table S1). To determine if 
these mutations inhibit SLO’s hemolytic activity, lysis of rabbit and human erythrocytes was 
measured using cell-free culture supernatants from wild-type bacteria and the SLO mutant 
strains. SLOQ476A, SLOQ476N, and SLOW503A had no detectable hemolytic activity on either rabbit 
or human red blood cells (Figure 1), although all SLO variants were expressed and secreted 
(Figure S1). In contrast, SLOW503Y was hemolytic, although it was less potent than wild-type 
SLO. The hemolysis defect of these mutants is consistent with the predicted role for these 
residues in glycan binding prior to pore formation. 
 Since SLO can bind to the membrane in a cholesterol- and pore-independent manner 
during infection [12], we assessed whether SLO’s carbohydrate-binding site plays a role in 
membrane binding in this context. Infections were performed on Chinese hamster ovary (CHO) 
cells, which support SLO binding and SPN translocation by wild-type bacteria in an identical 
manner to the human cell lines previously studied (Figure S2) [12]. Following infection with 
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wild-type S. pyogenes or strains expressing the SLO domain 4 mutants, the total host cell 
membrane fraction was harvested and immunoblot analysis was performed to detect SLO. 
Despite being hemolytically inactive (or impaired, for SLOW503Y), all SLO domain 4 variants 
localized to the membrane (Figure 1). Additionally, by probing the cytosolic fraction for the 
presence of SPN, it is evident that all domain 4 variants retain CMT activity (Figure 1). These 
data demonstrate that the putative carbohydrate-binding residues within SLO’s domain 4 are 
required for its ability to form pores on red blood cells, but that an intact glycan-binding site is 
dispensable for membrane binding and SPN translocation during infection. 
 
SPN can direct SLO to the membrane for pore formation during infection 
 The SLO domain 4 variants bound to CHO cell membranes during infection, but it was 
unclear if pore formation was occurring on these cells. To determine if the pathway leading to 
pore formation is active during infection with these mutants, we assessed the membrane integrity 
of cells following infection with wild-type bacteria or strains expressing the SLO domain 4 
variants. Despite being defective for hemolysis, all SLO domain 4 variants caused CHO cell 
membrane permeability, as the cells were unable to exclude the membrane-impermeable red 
fluorescent dye EthD-1 post-infection (Figure 2, panel A; quantified in panel D) Membrane 
permeability is known to be a consequence of pore formation by SLO in this infection system 
[5], indicating that the SLO domain 4 variants are able to form pores during infection. To verify 
that the loss of host cell membrane integrity is due to pore formation by SLO, infections were 
also performed with cells treated with the cholesterol-depleting agent methyl-β-cyclodextrin 
(MβCD), which blocks pore formation [12]. As expected, nearly all MβCD-treated cells were 
viable following infection with wild-type or the SLO domain 4 mutant strains (Figure 2, panel 
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B). The disparate lytic activity of these mutants on red blood cells and during infection separates 
glycan binding by SLO from the insertion of the pore, in stark contrast to an SLO mutant that is 
unable to interact with cholesterol (SLOL565G; Table S1), which does not lyse erythrocytes or 
form pores during infection (Figure S3) [12].  
The discovery that the SLO carbohydrate-binding site mutants are defective for 
hemolysis, but not pore formation during infection, suggests that SLO can interact with the 
membrane via multiple mechanisms for proper orientation and subsequent pore formation. One 
mechanism by which SLO interacts with the host cell membrane during infection is through co-
dependent binding with SPN [12]. To investigate whether SPN serves to position SLO at the 
membrane for pore formation, the SLO domain 4 carbohydrate-binding site mutants were 
constructed in a SPN deletion strain (Table S1), and CHO cell membrane integrity was 
visualized following infection with the SPN deletion (ΔSPN) or the ΔSPN/SLO domain 4 variant 
double mutant strains, all of which were expressed and secreted (Figure S1). In the context of 
ΔSPN, the SLOW503A, SLOQ476A, and SLOQ476N variants did not cause any membrane 
permeability, suggesting that SLO, when lacking a functional domain 4 carbohydrate-binding 
site, is unable to form pores in the absence of SPN (Figure 2, panel C; quantified in panel D). In 
contrast, the SLOW503Y mutant, which retained hemolytic activity, was able to form pores in the 
absence of SPN, indicating that this mutation does not significantly disrupt the carbohydrate-
binding site. The same phenotype is evident when infections are performed with the human lung 
fibroblast cell line A549 (Figure 3), indicating that this binding pattern is not cell type specific. 
Taken together, these data demonstrate that during infection, SPN-mediated binding is sufficient 
to orient SLO at the host cell membrane to trigger pore formation. 
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Galactose-containing carbohydrates are required for pore formation by SLO in the 
absence of SPN 
 The hemolytic defects of the SLO carbohydrate-binding site mutants and their 
dependence on SPN for pore formation during infection is consistent with the predicted role for 
this binding site in recognizing a carbohydrate receptor. However, it is possible that these amino 
acid substitutions are resulting in broader conformational defects, so carbohydrate-deficient 
CHO cell derivatives were utilized to further investigate a potential SLO-glycan interaction. 
Purified SLO was previously shown to bind galactose-containing carbohydrates with high 
affinity (Kd in the nanomolar range) by surface plasmon resonance analysis [20]. Therefore, two 
cell lines with different galactose deficiencies were pursued. Lec1 cells, defective for GlcNAc 
glycosyl transferase activity, lack galactose-containing complex and hybrid N-glycan structures 
on glycoproteins [23], which are terminated at the oligomannose intermediate. Conversely, Lec8 
cells do not transport UDP-galactose into the Golgi, so they are severely defective for galactose 
incorporation into all glycoproteins and glycolipids [24]. We confirmed the carbohydrate-
deficient phenotypes of these cell lines by visualizing binding of the FITC-conjugated lectin 
from Bandeiraea simplicifolia, comprised of isomers that recognize α-galactose, α-N-
acetylgalactosamine, and N-acetylglucosamine [25]. As expected, lectin binding does not occur 
on CHO and Lec1 cells, as the target sugars in these cells are either buried or absent, 
respectively. In contrast, Lec8 cells exhibit extensive lectin binding, as the absence of galactose 
exposes terminal N-acetylglucosamine residues (Figure S4). 
 To determine if galactose-containing membrane glycoconjugates play a role in pore 
formation by SLO during infection, CHO and Lec8 cells were infected with wild-type bacteria or 
the ΔSPN strain, and the extent of membrane permeability was assessed post-infection. CHO 
 77 
cells exhibited significant membrane permeability following infection with both the wild-type 
and ΔSPN strains, although more cytotoxicity results from the wild-type strain, as seen 
previously (Figure 4A, quantified in 4B) [5]. However, there is a striking difference in 
membrane permeability of Lec8 cells after infection with the wild-type or ΔSPN strains. While 
the wild-type lost membrane integrity to a level similar to infection of CHO cells, a minimal loss 
resulted from infection with the ΔSPN strain (Figure 4A, quantified in 4B). This trend is also 
consistent at later time points (3 and 5 hours post-infection; Figure S5), and is independent of 
SPN’s enzymatic NADase activity, as an enzymatically inactive variant of SPN retains the 
ability to promote pore formation by SLO on Lec8 cells (Figure 5). In all cases, loss of 
membrane integrity can be prevented by the addition of MβCD to remove cholesterol. These 
data demonstrate that in the absence of SPN, SLO is unable to form pores on cells lacking 
galactose-containing carbohydrates. In contrast, the strain expressing the SLO-PFOD4 chimeric 
protein, which encodes domain 4 from perfringolysin O and does not promote SPN translocation 
[12], effectively permeabilizes both CHO and Lec8 cells (Figure 4A), demonstrating that 
galactose binding is not a common feature of all CDCs. 
Infections were also performed on Lec1 cells to further characterize the putative 
carbohydrate receptor for SLO, and to assess whether insensitivity to SLO-mediated pore 
formation in the absence of SPN is a general phenotype of Lec derivative cell lines. In contrast to 
Lec8 cells, infection of Lec1 cells with wild-type, ΔSPN, or SLO-PFOD4 strains all resulted in 
membrane permeability (Figure S6). These data demonstrate that SLO’s inability to form pores 
on Lec8 cells in the absence of SPN is due to the lack of galactose-containing glycolipids or O-
linked glycoproteins on Lec8 cells, as galactose is absent from N-linked glycoproteins in both 
Lec1 and Lec8 cells. Taken together, these findings indicate that in the absence of SPN, SLO is 
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able to form pores in CHO cell membranes with normal carbohydrate composition, but is unable 
to efficiently permeabilize cells lacking galactose-containing glycolipids or O-linked 
glycoproteins. 
 
Galactose-containing carbohydrates are not required for SPN translocation 
 By flow cytometric analysis, exogenous lacto-N-neotetraose (which contains galactose) 
was found to competitively inhibit binding of SLO to the surface of red blood cells, resulting in 
decreased hemolytic activity of SLO in the presence of this glycan [20]. These data implicated 
the carbohydrate(s) recognized by SLO as the primary receptor on this cell type, and indicated 
that glycan binding is a requisite step in the pathway to pore formation [20]. To evaluate a role 
for the putative galactose-containing carbohydrate receptor in membrane binding of SLO during 
infection, CHO and Lec8 cells were infected with wild-type or the ΔSPN strain, and the host cell 
membrane fraction was probed for SLO post-infection. In accordance with SLO binding studies 
utilizing human A549 lung fibroblast cells [12], binding of SLO to CHO cells during infection 
with the wild-type strain is not inhibited by the removal of cholesterol by MβCD treatment 
(Figure 6). CHO cells further recapitulate two additional phenotypes of A549 cells: (i) SLO-
membrane binding is dependent on cholesterol during infection with the ΔSPN strain, and (ii) 
SPN translocation is not affected by cholesterol depletion (Figure 6) [12]. A similar binding 
pattern was observed when infections were conducted on Lec8 cells, with the exception that in 
the absence of SPN, SLO exhibited diminished binding to Lec8 cells (Figure 6). While a low 
level of membrane-localized SLO is apparent, there is essentially no cellular toxicity observed at 
this time point, indicating that this is likely unproductive binding without completion of pore 
formation. In contrast, when SLO was secreted by wild-type bacteria, there was no apparent 
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decrease in SLO binding to Lec8 cells compared to CHO cells. Moreover, an equivalent amount 
of SPN was translocated into CHO and Lec8 cells, demonstrating that SLO’s CMT activity is not 
perturbed by the lack of galactose-containing carbohydrates in Lec8 cells (Figure 6). These 
findings demonstrate that while a glycan receptor likely mediates SLO binding in the absence of 
SPN, it is not required for SLO binding during wild-type infection, nor does it contribute to SPN 
translocation.  
 
SPN’s putative carbohydrate-binding domain promotes its translocation and membrane 
binding of SLO  
SPN’s C-terminal domain encodes its enzymatic activity, which results in the cleavage of 
β-NAD+. SPN also encodes an N-terminal domain, and while not required for enzymatic activity, 
there is a strict requirement for this domain in SPN’s translocation into host cells [9]. Therefore, 
this domain seemed a likely candidate to encode a membrane-binding domain. Homology 
suggests that this domain adopts a “jelly-roll” fold, commonly found in carbohydrate-binding 
proteins [26]. This was supported by computationally derived homology modeling based on 
similar structures [27], which predicted with high confidence (99.8%) that a continuous sequence 
covering over 90% of this domain adopts the structure of a carbohydrate-binding module (Figure 
7).  
To assess whether SPN’s predicted carbohydrate-binding domain is involved in the 
targeting of SLO to the host cell membrane during infection, a tryptophan to alanine substitution 
was generated within SPN’s putative carbohydrate-binding site (SPNW81A; Table S1). Aromatic 
residues, most commonly tryptophan, are a conserved feature of carbohydrate-binding modules, 
as the aromatic ring promotes CH/pi stacking interactions with the apolar plane of sugar 
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molecules [28,29]. CHO cells, with and without MβCD treatment to deplete cholesterol, were 
infected with wild-type bacteria or the strain expressing SPNW81A, and the host cell membrane 
fraction was probed to assess SLO binding post-infection. As previously demonstrated, 
membrane binding by SLO produced from the wild-type strain is not inhibited by cholesterol 
depletion. In contrast, the strain expressing SPNW81A exhibits the same characteristics as the 
ΔSPN strain, in that SLO is unable to bind to the membrane in the absence of cholesterol when 
co-expressed with this SPN mutant (Figure 8A). Additionally, SPNW81A does not localize to the 
membrane fraction and is not translocated into the host cell (Figure 8A), although this mutant is 
expressed and retains enzymatic activity (Figure S7). The lack of membrane association of 
SPNW81A is consistent with the structural prediction and demonstrates that this predicted 
carbohydrate-binding site plays a critical role in membrane targeting of both SPN and SLO 
during infection. 
Since altering SPN’s putative N-terminal carbohydrate-binding site renders it 
nonfunctional for binding and translocation, we sought to determine whether SLO is dependent 
on the galactose-containing receptor for pore formation when co-expressed with this SPN 
mutant. To address this, SLO-induced membrane permeability of CHO and Lec8 cells was 
visualized following infection with wild-type bacteria or the SPNW81A mutant strain. SLO 
produced by the strain expressing SPNW81A was able to form pores on CHO cells, although to a 
lesser extent than the wild-type strain (Figure 8B, quantified in 8C), analogous to SLO expressed 
from the ΔSPN strain. Additionally, mirroring the ΔSPN strain, SLO co-expressed with SPNW81A 
was not able to effectively form pores on Lec8 cells (Figure 8B, quantified in 8C). Together, 
these data demonstrate that SPN’s putative carbohydrate-binding domain plays an essential role 
in its own translocation, and can also facilitate membrane binding and pore formation by SLO 
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during infection. This mode of binding for SLO is critical in the absence of galactose-containing 
glycoconjugates to serve as a host cell receptor. 
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DISCUSSION 
 While cholesterol-dependent cytolysins share many conserved features, it is becoming 
increasingly apparent that diversity exists among this protein family, particularly with respect to 
the initial binding event of the toxin to the host cell membrane. In this study, we interrogated 
SLO’s putative carbohydrate-binding site within domain 4, revealing it to be a functional glycan-
binding site that recognizes galactose-containing glycoconjugates on the host cell surface. An 
intact carbohydrate-binding site was necessary for SLO-mediated lysis of red blood cells, but 
was not required for lytic activity on cultured mammalian cells when co-secreted with SPN, 
demonstrating that SLO is able to bind to the membrane via distinct pathways to promote pore 
formation during infection. SPN’s ability to direct SLO to the membrane was reliant on its N-
terminal domain, which is predicted to be a carbohydrate-binding module.  
 The ability to utilize dual pathways to trigger pore formation may allow SLO to maintain 
lytic activity on various cell types and contribute to its multifunctionality as a toxin. Serving as 
both a hemolysin and a conduit for effector translocation, the lytic and CMT activities of SLO 
have different requirements; SLO free in solution can bind to cell membranes and form pores, 
whereas bacterial adherence to host cells is essential for SLO’s ability to translocate SPN [5]. 
CMT also requires that SPN and SLO be secreted from the same bacterial cell, as a mixed 
infection with ΔSPN and ΔSLO strains does not result in CMT [5]. Additionally, while data 
suggest that SPN and SLO interact at the host cell membrane [12], complex formation has not 
been detected in solution. Therefore, there must be a strict temporal or localization requirement 
for how SPN and SLO interact with the membrane that dictates which mode of membrane 
binding SLO will adopt, as illustrated in the proposed model (Figure 9). In the absence of 
formation of a complex with SPN, SLO may rapidly adopt the binding mode dependent on the 
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galactose-containing glycoconjugate(s). Thus, because SPN and SLO secreted by non-adherent 
bacteria are unlikely to efficiently coordinate co-association at the host cell membrane, SLO 
rapidly binds to galactose-containing glycoconjugate(s) for efficient membrane binding and pore 
formation (Figure 9A). Alternatively, SPN and SLO secreted by adherent bacteria are in close 
proximity to the host cell membrane, where they are able to associate in a manner dependent on 
SPN’s recognition of an unknown receptor to orient SLO for interaction with cholesterol and 
pore formation independent of SLO’s carbohydrate-binding site and galactose-containing 
glycoconjugate(s) receptor (Figure 9B). This latter mode of binding promotes the translocation 
of SPN into the host cell via a mechanism that is not fully defined (Figure 9B).  
 While pneumolysin (PLY) also appears to utilize host carbohydrate(s) for cell surface 
recognition [20], it is unlikely that this mode of binding is common to the majority of CDCs. 
PFO was predicted to encode a carbohydrate-binding site by in silico analysis [20], yet a 
substantial body of work suggests that cholesterol serves as the primary receptor for PFO. 
Depletion of cholesterol from erythrocyte membranes was shown to impair binding of PFO, but 
not ILY or SLO, due to the presence of its CD59 receptor for the former and likely due to its 
galactose-containing carbohydrate receptor for the latter [30]. Similarly, mutation of PFO’s 
cholesterol-recognition motif prevented membrane binding, but the equivalent mutations in ILY 
did not inhibit initial membrane binding, although they were required for maintaining membrane 
association during the prepore-to-pore transition [19]. Consistent with these findings, the current 
study demonstrates that the SLO-PFOD4 chimera is equally lytic on Lec1 and Lec8 carbohydrate-
defective cells, although it can not be ruled out that a glycan present in both Lec derivative cell 
lines may modulate PFO’s lytic activity.  
 84 
The recent determination of SLO’s tertiary structure [31] reveals structural differences 
between SLO and PFO that may contribute to their differential modes of membrane binding. The 
undecapeptide, one of the most highly conserved features of CDCs, plays a central role in 
coupling membrane binding and the structural rearrangements leading to the formation of the 
prepore complex [21]. Despite complete sequence identity between the undecapeptides of SLO 
and PFO, these regions adopt different conformations in the tertiary structure of the protein. The 
undecapeptide appears extended in SLO, while it is curled against domain 4 in PFO. As two of 
the four residues that comprise SLO’s carbohydrate-binding site are localized within the 
undecapeptide, the extended conformation of this region may be an important structural feature 
that contributes to SLO’s recognition of the glycan receptor. It has been proposed that PFO’s 
curled undecapeptide and surrounding structure results in a more stable conformation of the 
cholesterol-recognition motif, whereas this motif in SLO is more flexible [31]. Additionally, 
examination of PFO’s structure identified a hydrophobic pocket that was not observed in SLO’s 
domain 4, which may enable a more effective interaction between PFO and cholesterol [31], as 
would be expected of a CDC that utilizes cholesterol as its sole receptor.  
The findings in this study demonstrate that one of the pore formation pathways utilized 
by SLO resembles ILY’s mechanism. Typically, CDCs bind to cholesterol-rich membranes via 
the cholesterol-recognition motif, and this event leads to structural rearrangements propagated by 
the undecapeptide that result in oligomerization [21]. In contrast, CD59 binding by ILY is 
responsible for facilitating the conformational changes that lead to oligomerization and 
formation of the prepore complex [21,32]. These conformational changes are critical for prepore 
assembly and the subsequent insertion of the pore, as the cholesterol-recognition motif of ILY is 
unable to recognize cholesterol in the absence of CD59. Therefore, CD59 serves an essential role 
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to orient ILY at the host cell membrane so that it is able to interact with cholesterol for pore 
formation [14].  
The data presented in this study suggest that when SLO is unable to associate with SPN, 
glycan recognition by SLO serves a similar function to ILY-CD59 binding and is required for 
SLO to become properly oriented at the membrane for pore formation. The disparate 
susceptibilities of Lec1 and Lec8 cells indicate that this glycoconjugate is either a galactose-
containing glycolipid or O-linked glycoprotein; further experiments will be required to determine 
if SLO binds a particular glycosylated molecule or if it recognizes a common carbohydrate 
structure presented in multiple contexts. For ILY, binding to CD59 is not a sustained interaction 
as following prepore complex formation, ILY dissociates from CD59 to bind cholesterol and 
complete the process of pore formation [19]. Similarly, SLO does not remain bound to 
cholesterol-depleted CHO cells in the absence of SPN, indicating that while SLO may 
temporarily interact with the host cell surface via the galactose-containing receptor, this 
association is lost as it progresses through the pore formation pathway and is unable to bind 
cholesterol.  
Receptor dissociation prior to pore insertion is a common step in the pore formation by 
other toxins, including anthrax protective antigen [33] and diphtheria toxin [34]. However, to our 
knowledge, SLO’s bimodal membrane binding activities are unique among other toxin binding 
and translocation systems. The existence of these two modes raises the question of their 
relationship, particularly of whether they are mutually exclusive or can proceed simultaneously. 
As discussed above (also see Figure 7), temporal and positional factors likely dictate that the 
SLO-galactose receptor mode predominates when S. pyogenes is non-adherent to a target host 
cell. In contrast, membrane permeability on Lec8 cells is equivalent in magnitude to wild-type 
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cells during infection by adherent S. pyogenes, suggesting that the SPN-mediated mode may 
dominate during infection, since this is the only mode possible for pore formation on Lec8 cells. 
This would also imply that SLO uses different receptors for pore formation depending on 
whether S. pyogenes is adherent or non-adherent. If these two different receptors participate in 
signaling, then this may be a mechanism by which SLO can differentially modulate host cell 
responses in bystander vs. actively infected cells.  
The identity of the host cell receptor for the SPN-dependent binding mode is currently 
unknown, but likely holds important clues for the mechanism of SPN translocation. Available 
evidence indicates that recognition of this receptor requires the non-enzymatic N-terminal 
domain of SPN, which likely promotes binding via carbohydrate recognition. The data presented 
here indicate that this does not involve recognition of galactose. Attempts to identify a 
carbohydrate ligand for SPN by glycan array have not been successful (Mozola and Caparon, 
unpublished), which may be due to several factors. Low-affinity carbohydrate binding may be a 
necessary characteristic of this interaction, as SPN presumably dissociates from this receptor 
prior to its translocation into the host cell cytosol. SPN may exhibit higher avidity binding in 
vivo if SLO and SPN associate at the membrane as a complex that allows for oligomerization of 
SLO, which may cluster SPN to strengthen a putative SPN-carbohydrate interaction. Achieving a 
higher binding affinity by multivalent interaction is common among lectins with a single 
carbohydrate-binding site [35]. Therefore, carbohydrate binding by monomeric SPN may be low 
affinity and difficult to detect in vitro.  Additionally, the glycan array analysis may lack the 
proper conditions required for binding. For example, many carbohydrate-binding proteins also 
coordinate metal ions, and metal ion binding is important for proper conformation of the domain 
to allow for carbohydrate recognition. Alternatively, this interaction may be undetectable in vitro 
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because SPN may undergo a conformational change that only occurs during infection, or other 
bacterial factors may be required for this binding event. Future work will focus on further 
defining the mechanism of SLO’s SPN-dependent binding, and understanding which mode of 
binding predominates on different cell types during infection.  
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MATERIALS AND METHODS 
Bacterial strains: Molecular cloning experiments utilized Escherichia coli α-Select Gold 
competent cells (Bioline; Taunton, MA) cultured in Luria-Bertani broth at 37°C. The S. 
pyogenes strain used was M serotype 6 strain JRS4 [36], cultured in Todd-Hewitt broth (ThyB) 
(Becton Dickinson; Franklin Lakes, NJ) supplemented with 0.2% autolysed yeast extract (Becton 
Dickinson; Franklin Lakes, NJ). When necessary, erythromycin was added to the media to a final 
concentration of 500 µg ml-1 or 1 µg ml-1, for E. coli and S. pyogenes, respectively.  
 
Cell lines: Chinese hamster ovary CHO-K1 cells were a gift from the laboratory of Dr. Jean 
Schaffer (Washington University in St. Louis, St. Louis MO). The CHO-K1 derivative Lec1 cell 
line (CRL-1735TM; originally Pro-5WgaRI3C) and the Lec8 cell line (CRL-1737TM; originally 
Pro-5WgaRVIII3D) were purchased from American Type Culture Collection (ATCC). Cells 
were maintained at 37°C in the presence of 5% CO2 in α-MEM with L-glutamine, supplemented 
with 10% fetal bovine serum. Media and fetal bovine serum were purchased from Gibco (Grand 
Island, NY). 
 
Construction of SLO and SPN mutants: To facilitate mutagenesis of SPN, the chromosomal 
sequence of SPN’s N-terminal domain, as well as the flanking regions, was amplified from 
purified JRS4 chromosomal DNA and inserted into the temperature-sensitive shuttle vector 
pJRS233 by sequence overlap extension PCR [37]. Plasmid DNA was isolated and used to 
transform E. coli using standard techniques. The resulting construct was used as the template for 
introducing the W81A mutation using the Quikchange XL II mutagenesis kit (Agilent 
Technologies; Santa Clara, CA). The Q476A/N and W503A/Y mutations in SLO were 
 89 
constructed in a similar manner, except the SLO Domain 4 chromosomal sequence was inserted 
into the modified temperature-sensitive shuttle vector pGCP213 [38]. Electroporation was used 
to transform S. pyogenes [39], and the wild-type allele in JRS4 or SPN1 was replaced with the 
mutant versions as previously described [40]. All primers are listed in Table S2, with M13 
forward and reverse sequences (for insertion into shuttle vectors) underlined. Both plasmid 
constructs and chromosomal mutations were verified by DNA sequencing (Genewiz; South 
Plainfield, NJ). Note that since the convention for numbering SLO residues has recently been 
updated to reflect resolution of a formerly ambiguous start codon [31], the leucine mutant 
(SLOL565G) generated previously [12] is now listed at position 562.  
 
Analysis of hemolytic activity: The hemolytic activity of SLO mutants was assessed by 
incubating defibrinated rabbit erythrocytes (Hemostat Laboratories; Dixon, CA) or human 
erythrocytes with cell-free overnight S. pyogenes culture supernatants. The hemolytic titer is 
presented as the reciprocal of the dilution that produced 50% cell lysis [5,11]. If lysis was not 
observed upon incubation with undiluted supernatant, the hemolytic titer is presented as “not 
detected” (ND). Data presented are representative of at least three independent experiments. 
 
CHO cell infection: Streptococcal cultures were grown overnight in ThyB, back-diluted in fresh 
ThyB the morning of the infection, and were allowed to double twice before washing the cells 
with phosphate buffered saline and resuspending the pellet in medium to an OD600 of 0.2. For 
experiments determining the level of cell viability post-infection, CHO-K1 cells or the Lec cell 
derivatives were grown to near confluency in 12-well plates (CytoOne; USA Scientific, Ocala, 
FL). Cells were incubated with 60µL of the streptococcal strains plus 1mL of fresh medium for 
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1.5, 3, or 5 hours at 37°C with 5% CO2. For membrane and cytosolic fractionation of 
mammalian cells post-infection, cells were grown to near confluency in 75 cm2 flasks (TPP; 
Trasadingen, Switzerland), and streptococcal strains were subcultured as described above. The 
CHO-K1 or Lec8 cells were incubated with 1mL of the streptococcal strains at OD600 of 0.2 plus 
14mL fresh medium for 1.5h at 37°C in the presence of 5% CO2. Where indicated, 4mM methyl-
β-cyclodextrin (MβCD) (Sigma; St. Louis, MO) was added to the media 30 minutes prior to 
infection and remained in the media during the infection. 
 
Membrane extraction and cytosolic fractionation: Separation of total membranes from 
cytosolic components was performed as described previously [12]. Briefly, the cells were 
washed twice with phosphate buffered saline, resuspended in 1.3mL homogenization buffer 
(10mM Tris-HCl pH 7.5, 5mM EDTA, protease inhibitors (Roche complete mini)), and lysed by 
30 passages through a 22-gauge needle. Unlysed cells and cellular debris were removed by 
centrifugation (600 x g, 15 minutes, 4°C), and the resulting supernatants were subjected to 
ultracentrifugation (100,000 x g, 1h, 4°C) to harvest total membranes. Membrane pellets were 
resuspended in 1X SDS sample buffer and analyzed by immunoblotting with anti-SLO antiserum 
(generated by Sigma-Genosys) or commercial anti-SPN (Cosmo Bio Co.). Translocation of SPN 
was evaluated by immunoblotting of supernatant fractions using anti-SPN as described [12]. 
Antibody against human caveolin-1 (Cell Signaling Technology; Danvers, MA) was used as a 
loading control for the total membrane fraction, as it cross reacts with hamster caveolin-1. Actin 
AC40 was used as a loading control for the cytosolic fractions (Sigma; St. Louis, MO). 
Immunoblots were developed by chemiluminescence (SuperSignal® West Dura Extended 
Duration Substrate, Thermo Scientific; Waltham, MA) and images were taken with a CCD 
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camera-based system (ChemiDocTM, BioRad; Hercules, CA). For each experiment, a 
representative image is presented in the text, prepared for publication using Adobe Illustrator 
CS6. Images are representative of the results from at least three independent experiments.  
 
Assessment of membrane integrity: The membrane integrity of CHO-K1 or Lec cell 
derivatives following infection was assessed by visualizing the degree of exclusion of the 
membrane-impermeable fluorescent dye EthD-1, a component of the LIVE/DEAD 
viability/cytotoxicity kit for mammalian cells (Molecular Probes; Grand Island, NY). The cells 
were incubated with the staining solution prepared in Dulbecco’s modified phosphate buffered 
saline for 15 minutes at 37°C prior to visualization by fluorescence microscopy.  Cells were 
imaged using a Leica DMIRE2 fluorescent microscope, and images were captured using Q 
Imaging Retiga EX CCD digital camera and Volocity software (Perkin Elmer; Waltham, MA). 
For quantitation, permeable and impermeable cells were enumerated from captured images, with 
data presented representing the mean and standard error of the mean derived from at least three 
independent experiments and the examination of at least 2000 total cells. Images were prepared 
for publication using Adobe Illustrator CS6.  
 
Visualization of lectin binding: To validate the galactose-deficient phenotype in Lec8 cells, 
CHO-K1, Lec1 and Lec8 cells were stained with FITC-conjugated lectin from Bandeiraea 
simplicifolia (Sigma; St. Louis, MO). Cells were fixed with 4% formaldehyde for 10 minutes at 
room temperature, washed three times with phosphate buffered saline, and incubated with 10 mg 
mL-1 lectin for 1 hour at room temperature. Following incubation, the lectin solution was 
removed and cells were washed three times in phosphate buffered saline and cured with ProLong 
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Gold Antifade Mountant containing DAPI (Molecular Probes; Grand Island, NY) overnight 
before visualization by fluorescence microscopy. 
 
Assessment of SPN’s enzymatic activity: The enzymatic activity of SPNW81A from cell-free 
overnight culture supernatants was measured and compared to SPN produced by the wild-type 
strain, as described [5]. Briefly, overnight cultures were subjected to centrifugation (6,000 x g, 5 
minutes) to remove bacterial cells, and the remaining supernatant was serially diluted in 
phosphate buffered saline. Diluted supernatants were incubated with 0.5 mM β-NAD+ (Sigma; 
St. Louis, MO) at 37°C for 90 minutes. Following incubation, 5M sodium hydroxide was added 
to terminate the reaction, which was allowed to proceed for 1h at room temperature, before 
determining the level of uncleaved β-NAD+ by spectrofluorimetry (380nm excitation, 455nm 
emission, Tecan Infinite M200 Pro). Extent of β-NAD+ cleavage was normalized to either the 
OD600 of the culture or the amount of SPN detected in supernatants precipitated with 10% 
trichloroacetate, assessed by immunoblotting with anti-SPN (Cosmo Bio). The extent of 
cleavage by wild-type SPN was set to 100%. 
 
Statistical Analysis: Differences in mean values in the percent of permeabilized cells were 
tested for significance by the Tukey-Kramer multiple comparisons test. The null hypothesis was 
rejected for p values less than 0.05.  
 
 
 
 
 93 
ACKNOWLEDGEMENTS 
We thank Gary Port, Zac Cusumano, and Stuart Kornfeld for their interest and many helpful 
discussions. We thank George Caputa and Jean Schaffer for providing the CHO-K1 cells. This 
study was supported by Public Health Service Grant AI064721 from the National Institutes of 
Health and a predoctoral fellowship from the American Heart Association awarded to C.C.M. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 94 
REFERENCES 
1. Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, et al. (2014) Disease 
manifestations and pathogenic mechanisms of group a Streptococcus. Clin Microbiol Rev 
27: 264-301. 
 
2. Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol 
Rev 13: 470-511. 
 
3. Mitchell TJ (2003) The pathogenesis of streptococcal infections: from tooth decay to 
meningitis. Nat Rev Microbiol 1: 219-230. 
 
4. Izore T, Job V, Dessen A (2011) Biogenesis, regulation, and targeting of the type III 
secretion system. Structure 19: 603-612. 
 
5. Madden JC, Ruiz N, Caparon M (2001) Cytolysin-mediated translocation (CMT): a 
functional equivalent of type III secretion in gram-positive bacteria. Cell 104: 143-152. 
 
6. Bricker AL, Cywes C, Ashbaugh CD, Wessels MR (2002) NAD+-glycohydrolase acts as an 
intracellular toxin to enhance the extracellular survival of group A streptococci. Mol 
Microbiol 44: 257-269. 
 
7. Heuck AP, Moe PC, Johnson BB (2010) The cholesterol-dependent cytolysin family of 
gram-positive bacterial toxins. Subcell Biochem 51: 551-577. 
 
8. Hotze EM, Tweten RK (2012) Membrane assembly of the cholesterol-dependent cytolysin 
pore complex. Biochim Biophys Acta 1818: 1028-1038. 
 
9. Ghosh J, Caparon MG (2006) Specificity of Streptococcus pyogenes NAD(+) 
glycohydrolase in cytolysin-mediated translocation. Mol Microbiol 62: 1203-1214. 
 
10. Magassa N, Chandrasekaran S, Caparon MG (2010) Streptococcus pyogenes cytolysin-
mediated translocation does not require pore formation by streptolysin O. EMBO Rep 11: 
400-405. 
 
11. Meehl MA, Caparon MG (2004) Specificity of streptolysin O in cytolysin-mediated 
translocation. Mol Microbiol 52: 1665-1676. 
 
12. Mozola CC, Magassa N, Caparon MG (2014) A novel cholesterol-insensitive mode of 
membrane binding promotes cytolysin-mediated translocation by Streptolysin O. Mol 
Microbiol 94: 675-687. 
 
13. Rosch JW, Vega LA, Beyer JM, Lin A, Caparon MG (2008) The signal recognition 
particle pathway is required for virulence in Streptococcus pyogenes. Infect Immun 76: 
2612-2619. 
 95 
14. Giddings KS, Zhao J, Sims PJ, Tweten RK (2004) Human CD59 is a receptor for the 
cholesterol-dependent cytolysin intermedilysin. Nat Struct Mol Biol 11: 1173-1178. 
 
15. Gelber SE, Aguilar JL, Lewis KL, Ratner AJ (2008) Functional and phylogenetic 
characterization of Vaginolysin, the human-specific cytolysin from Gardnerella 
vaginalis. J Bacteriol 190: 3896-3903. 
 
16. Farrand S, Hotze E, Friese P, Hollingshead SK, Smith DF, et al. (2008) Characterization 
of a streptococcal cholesterol-dependent cytolysin with a lewis y and b specific lectin 
domain. Biochemistry 47: 7097-7107. 
 
17. Wickham SE, Hotze EM, Farrand AJ, Polekhina G, Nero TL, et al. (2011) Mapping the 
intermedilysin-human CD59 receptor interface reveals a deep correspondence with the 
binding site on CD59 for complement binding proteins C8alpha and C9. J Biol Chem 
286: 20952-20962. 
 
18. LaChapelle S, Tweten RK, Hotze EM (2009) Intermedilysin-receptor interactions during 
assembly of the pore complex: assembly intermediates increase host cell susceptibility to 
complement-mediated lysis. J Biol Chem 284: 12719-12726. 
 
19. Farrand AJ, LaChapelle S, Hotze EM, Johnson AE, Tweten RK (2010) Only two amino 
acids are essential for cytolytic toxin recognition of cholesterol at the membrane surface. 
Proc Natl Acad Sci U S A 107: 4341-4346. 
 
20. Shewell LK, Harvey RM, Higgins MA, Day CJ, Hartley-Tassell LE, et al. (2014) The 
cholesterol-dependent cytolysins pneumolysin and streptolysin O require binding to red 
blood cell glycans for hemolytic activity. Proc Natl Acad Sci U S A 111: E5312-5320. 
 
21. Dowd KJ, Tweten RK (2012) The cholesterol-dependent cytolysin signature motif: a critical 
element in the allosteric pathway that couples membrane binding to pore assembly. PLoS 
Pathog 8: e1002787. 
 
22. Polekhina G, Giddings KS, Tweten RK, Parker MW (2005) Insights into the action of the 
superfamily of cholesterol-dependent cytolysins from studies of intermedilysin. Proc Natl 
Acad Sci U S A 102: 600-605. 
 
23. Chen W, Stanley P (2003) Five Lec1 CHO cell mutants have distinct Mgat1 gene mutations 
that encode truncated N-acetylglucosaminyltransferase I. Glycobiology 13: 43-50. 
 
24. Oelmann S, Stanley P, Gerardy-Schahn R (2001) Point mutations identified in Lec8 
Chinese hamster ovary glycosylation mutants that inactivate both the UDP-galactose and 
CMP-sialic acid transporters. J Biol Chem 276: 26291-26300. 
 
25. Delmotte FM, Goldstein IJ (1980) Improved procedures for purification of the Bandeiraea 
simplicifolia I isolectins and Bandeiraea simplicifolia II lectin by affinity 
chromatography. Eur J Biochem 112: 219-223. 
 96 
26. Smith CL, Ghosh J, Elam JS, Pinkner JS, Hultgren SJ, et al. (2011) Structural basis of 
Streptococcus pyogenes immunity to its NAD+ glycohydrolase toxin. Structure 19: 192-
202. 
 
27. Kelley LA, Sternberg MJ (2009) Protein structure prediction on the Web: a case study 
using the Phyre server. Nat Protoc 4: 363-371. 
 
28. Malik A, Ahmad S (2007) Sequence and structural features of carbohydrate binding in 
proteins and assessment of predictability using a neural network. BMC Struct Biol 7: 1. 
 
29. Wimmerova M, Kozmon S, Necasova I, Mishra SK, Komarek J, et al. (2012) Stacking 
interactions between carbohydrate and protein quantified by combination of theoretical 
and experimental methods. PLoS One 7: e46032. 
 
30. Giddings KS, Johnson AE, Tweten RK (2003) Redefining cholesterol's role in the 
mechanism of the cholesterol-dependent cytolysins. Proc Natl Acad Sci U S A 100: 
11315-11320. 
 
31. Feil SC, Ascher DB, Kuiper MJ, Tweten RK, Parker MW (2013) Structural studies of 
Streptococcus pyogenes Streptolysin O provide insights into the early steps of membrane 
penetration. J Mol Biol. 426: 785-792. 
 
32. Soltani CE, Hotze EM, Johnson AE, Tweten RK (2007) Structural elements of the 
cholesterol-dependent cytolysins that are responsible for their cholesterol-sensitive 
membrane interactions. Proc Natl Acad Sci U S A 104: 20226-20231. 
 
33. Rainey GJ, Wigelsworth DJ, Ryan PL, Scobie HM, Collier RJ, et al. (2005) Receptor-
specific requirements for anthrax toxin delivery into cells. Proc Natl Acad Sci U S A 102: 
13278-13283. 
 
34. Brooke JS, Cha JH, Eidels L (1998) Diphtheria toxin:receptor interaction: association, 
dissociation, and effect of pH. Biochem Biophys Res Commun 248: 297-302. 
 
35. Varki A, Etzler ME, Cummings RD, Esko JD (2009) Discovery and Classification of 
Glycan-Binding Proteins. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P et 
al., editors. Essentials of Glycobiology. 2nd ed. Cold Spring Harbor (NY). 
 
36. Scott JR, Guenthner PC, Malone LM, Fischetti VA (1986) Conversion of an M- group A 
streptococcus to M+ by transfer of a plasmid containing an M6 gene. J Exp Med 164: 
1641-1651. 
 
37. Bryksin AV, Matsumura I (2010) Overlap extension PCR cloning: a simple and reliable 
way to create recombinant plasmids. Biotechniques 48: 463-465. 
 
 97 
38. Nielsen HV, Guiton PS, Kline KA, Port GC, Pinkner JS, et al. (2012) The metal ion-
dependent adhesion site motif of the Enterococcus faecalis EbpA pilin mediates pilus 
function in catheter-associated urinary tract infection. MBio 3: e00177-00112. 
 
39. Caparon MG, Scott JR (1989) Excision and insertion of the conjugative transposon Tn916 
involves a novel recombination mechanism. Cell 59: 1027-1034. 
 
40. Ji Y, McLandsborough L, Kondagunta A, Cleary PP (1996) C5a peptidase alters 
clearance and trafficking of group A streptococci by infected mice. Infect Immun 64: 
503-510. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 98 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Mutation of SLO’s putative carbohydrate-binding site disrupts hemolytic activity 
but not membrane binding or SPN translocation during infection. Immunoblot analyses of 
total membrane and cytosolic fractions harvested from CHO cells following a 90 minute 
infection with the S. pyogenes strains indicated at the top of the figure, developed with antisera 
against the proteins indicated on the right. Analyses of caveolin-1 (membrane) and actin 
(cytosol) were included as loading controls, and the migration of several molecular weight 
standards (in kDa) are shown to the left. Shown at the bottom are hemolytic titers of overnight 
culture supernatant for rabbit (Rb) and human (Hu) erythrocytes. ND, titer was below the limit of 
detection (sample undiluted). Immunoblots and titers are representative of a minimum of three 
independent experiments.  
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Figure 2. Co-expression of SPN promotes pore formation by SLO carbohydrate-binding 
site mutants during infection. The extent of pore formation was assessed on untreated (A) or 
MβCD-treated (B) CHO cells following a 90 minute infection with the S. pyogenes strains 
indicated at the top of the figure, visualized by staining with a fluorescent vital dye 
(Live/DeadTM). Intact membranes exclude the red fluorescent membrane-impermeable dye EthD-
1 and appear green; cells with compromised membranes appear red. White bars measure 70µm.  
(C) CHO cells post-infection with ΔSPN/SLO domain 4 double mutant strains. (D) Quantitation 
of permeable cells. Data are presented as the mean and the standard error of the mean, derived 
from at least three independent experiments. “X” denotes below 0.5%. 
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Figure 3. Co-expression of SPN promotes pore formation by SLO carbohydrate-binding 
site mutants during infection of A549 cells. The extent of pore formation was assessed on 
untreated (top) or MβCD-treated (middle) A549 cells following a 90 minute infection with the 
S. pyogenes strains indicated at the top of the figure, visualized by staining with a fluorescent 
vital dye (Live/DeadTM). (bottom) A549 cells post-infection with ΔSPN/SLO domain 4 double 
mutant strains. Intact membranes exclude the red fluorescent membrane-impermeable dye EthD-
1 and appear green; cells with compromised membranes appear red. White bars measure 70µm.  
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Figure 4. A galactose-containing glycoconjugate is required for pore formation by SLO in 
the absence of SPN. (A) The extent of pore formation was assessed on CHO cells or the 
galactose-deficient CHO cell derivative Lec8 line following a 90 minute infection with the S. 
pyogenes strains indicated at the top of the figure, visualized by staining with a fluorescent vital 
dye (Live/DeadTM). Intact membranes exclude the red fluorescent membrane-impermeable dye 
EthD-1 and appear green; cells with compromised membranes appear red. For both cell lines, 
infection of untreated cells or MβCD-treated cells are shown, as indicated to the right of the 
figure. White bars measure 70µm. (B) Quantitation of permeable cells. Data are presented as the 
mean and the standard error of the mean, derived from at least three independent experiments.  
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Figure 5. SPN-mediated pore formation by SLO is independent of SPN’s enzymatic 
activity. MβCD treated or untreated Lec8 cells were infected with strains expressing wild-type 
SPN or the NADase negative version of SPN. Following a 90 minute infection, membrane 
integrity was visualized by staining with a fluorescent vital dye (Live/DeadTM). Intact 
membranes exclude the red fluorescent membrane-impermeable dye EthD-1 and appear green; 
cells with compromised membranes appear red. 
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Figure 6. SLO’s galactose-containing receptor is not required for membrane binding or 
SPN translocation during infection. Immunoblot analyses of total membrane and cytosolic 
fractions harvested from untreated or MβCD-treated CHO cells or the galactose-deficient Lec8 
cell line following a 90 minute infection with the wild-type or ΔSPN strains. Immunoblots were 
developed with antisera against the proteins indicated on the right. Analyses of caveolin-1 
(membrane) and actin (cytosol) were included as loading controls, and the migration of several 
molecular weight standards (in kDa) are shown to the left. Immunoblots are representative of at 
least three independent experiments.  
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Figure 7. SPN encodes a putative carbohydrate-binding domain. Shown is a model of SPN’s 
N-terminal domain, generated by Phyre2 tertiary structure homology modeling [27]. The 
tryptophan residue predicted to mediate carbohydrate recognition is highlighted. Amino acid 
numbering is based on the GenBank AAK33265.1 sequence. 
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Figure 8. SPN’s carbohydrate-binding site is necessary for its translocation and pore 
formation by SLO in the absence of galactose-containing glycoconjugates. (A) Immunoblot 
analyses of total membrane and cytosolic fractions harvested from untreated or MβCD-treated 
CHO cells following a 90 minute infection with wild-type bacteria or the SPNW81A strain. 
Immunoblots were developed with antisera against the proteins indicated to the right. Analyses 
of caveolin-1 (membrane) and actin (cytosol) were included as loading controls, and the 
migration of several molecular weight standards (in kDa) are shown to the left. Immunoblots are 
representative of at least three independent experiments. (B) The extent of pore formation was 
assessed on CHO cells (top panel) or the galactose-deficient CHO cell derivative Lec8 line 
(bottom panel) following a 90 minute infection with the S. pyogenes strains indicated, visualized 
by staining with a fluorescent vital dye (Live/DeadTM). Intact membranes exclude the red 
fluorescent membrane-impermeable dye EthD-1 and appear green; cells with compromised 
membranes appear red. White bars measure 70µm. (C) Quantitation of permeable cells. Data are 
presented as the mean and the standard error of the mean, derived from at least three independent 
experiments.  
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Figure 9. Model for SLO’s dual modes of membrane binding. (A) When S. pyogenes is not 
adherent to host cells, SPN and SLO are secreted by the bacterium but are not able to associate at 
the host cell membrane. In this event, SLO’s recognition of the galactose-containing receptor is a 
critical step in the pore formation pathway, prior to engagement of cholesterol and insertion of 
the transmembrane pore. (B) When S. pyogenes is adherent to host cells, SPN and SLO are 
secreted and co-associate at the membrane through SPN’s recognition of an unknown receptor 
via its N-terminal domain. This mode of binding promotes the translocation of SPN (denoted by 
pink arrow), and also can orient SLO at the membrane for pore formation. 
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Figure S1. SLO variants are expressed and secreted and produce wild-type levels of SPN. 
Shown are immunoblots of overnight culture supernatant from strains expressing the indicated 
proteins developed with anti-SLO or anti-SPN antiserum. Proteins from supernatants were 
precipitated by the addition of trichloroacetic acid to a final concentration of 10%. Shown at the 
left of the figure is the migration of molecular weight standards in kDa. 
 
 
 
 
 
 
 
 
 
 
 
 110 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. SLO/SPN membrane binding and CMT occur in CHO cells. Immunoblot 
analyses of total membrane and cytosolic fractions harvested from CHO cells following a 90 
minute infection with wild-type or the ΔSLO strain, developed with antisera against the proteins 
indicated on the right. Analyses of caveolin-1 (membrane) and actin (cytosol) were included as 
loading controls, and the migration of several molecular weight standards (in kDa) are shown to 
the left. 
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Figure S3. SLO cholesterol-recognition motif mutant does not form pores. The extent of 
pore formation was assessed on CHO cells following a 90 minute infection with the wild-type or 
SLO cholesterol-recognition motif mutant SLOL565G, visualized by staining with a fluorescent 
vital dye (Live/DeadTM). Intact membranes exclude the red fluorescent membrane-impermeable 
dye EthD-1 and appear green; cells with compromised membranes appear red. White bars 
measure 70µm. As mentioned in Materials and Methods, the SLOL565G mutant was generated 
previously (Mozola et al., 2014) prior to the resolution of an ambiguous start site; the numbering 
according to the current study would be residue 562.  
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Figure S4. Confirmation of carbohydrate-deficient phenotypes by lectin staining. CHO, 
Lec1, and Lec8 cells grown on glass slides were fixed with 4% formaldehyde and incubated with 
the FITC-conjugated lectin from B. simplifolia before being mounted with ProLong Gold 
Antifade with DAPI and visualized by fluorescence microscopy. White bars measure 37µm. 
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Figure S5. Lec8 cell resistance to pore formation in the absence of SPN is consistent during 
extended infections. The extent of pore formation on Lec8 cells following a 1.5, 3, or 5 hour 
infection with the wild-type of ΔSPN strain was visualized by staining with a fluorescent vital 
dye (Live/DeadTM). Intact membranes exclude the red fluorescent membrane-impermeable dye 
EthD-1 and appear green; cells with compromised membranes appear red. White bars measure 
70µm. Percent permeable cells are quantified and presented as the mean and standard error of the 
mean, derived from at least three independent experiments.  
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Figure S6. Lec1 cells are sensitive to pore formation by SLO. The extent of pore formation 
was assessed on Lec1 cells following a 90 minute infection with the S. pyogenes strains indicated 
at the top of the figure, visualized by staining with a fluorescent vital dye (Live/DeadTM). Intact 
membranes exclude the red fluorescent membrane-impermeable dye EthD-1 and appear green; 
cells with compromised membranes appear red. White bars measure 70µm. Percent permeable 
cells are quantified and presented as the mean and the standard error of the mean, derived from at 
least three independent experiments. 
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Figure S7. SPNW81A is enzymatically active. Quantitation of the enzymatic activity of SPNW81A 
from overnight culture supernatant, compared to wild-type SPN, which was normalized to 100%. 
 116 
 
 
 
 
 
CHAPTER 4 
 
Calcium coordination by SPN’s metal ion-dependent adhesion site is 
required for membrane binding and CMT 
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SUMMARY 
Cytolysin-mediated translocation (CMT) is a unique effector translocation system utilized by the 
Gram-positive bacterium Streptococcus pyogenes by which the NAD+ glycohydrolase SPN is 
translocated into host cells during infection via a mechanism requiring the cholesterol-dependent 
cytolysin Streptolysin O (SLO). The initial model for this mechanism proposed that SLO binds 
to cholesterol in host cell membranes as its primary receptor, triggering the conformational 
changes in SLO required for its oligomerization and formation of large transmembrane pores, 
allowing the passive diffusion of SPN into the host cell cytosol. However, several studies have 
demonstrated that SPN plays an active role in its own translocation. Cholesterol was considered 
the sole host cell receptor for SLO, yet we have identified a cholesterol-independent mode of 
SLO binding that is strictly dependent on the co-secretion and host cell membrane binding of 
SPN. This SPN-dependent binding mode for SLO correlates with its translocation activity, 
demonstrating that SPN plays a direct role in its translocation and is not passive cargo. 
Computationally derived tertiary structure modeling predicts that SPN’s N-terminal domain 
adopts the structure of a carbohydrate-binding module, and by ligand site prediction we 
identified a putative metal ion-dependent adhesion site (MIDAS) within this domain. Mutation 
of the residues expected to coordinate a divalent cation had no effect on the secretion or stability 
of SPN, but abolished its ability to bind host cell membranes during infection and undergo 
translocation. Similarly, infections performed in calcium-free medium did not support SPN 
binding and translocation, suggesting that calcium coordination by SPN is critical for its 
function.  
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INTRODUCTION 
 The Gram-positive bacterium Streptococcus pyogenes produces myriad virulence factors 
during infection, enabling it to effectively infect many different body sites and cause numerous 
diseases such as bacterial pharyngitis, cellulitis, and necrotizing fasciitis [1,2]. One critical 
virulence factor is the effector protein SPN, an NAD+ glycohydrolase that is translocated into the 
host cell cytosol, which has been demonstrated to contribute to S. pyogenes virulence in models 
of infection [3-5]. This process is termed cytolysin-mediated translocation (CMT), as it requires 
the co-secretion of the cholesterol-dependent cytolysin (CDC) Streptolysin O (SLO). While the 
mechanism of this toxin translocation system is still not fully understood, it has been established 
that the canonical cholesterol recognition and pore-forming activity of SLO is not required for its 
ability to translocate SPN, refuting a simple model where SPN passively diffuses through 
transmembrane pores formed by SLO [6,7]. Instead, SPN appears to play an active role in its 
own translocation. 
 Cholesterol-dependent cytolysins exhibit a strict dependency on cholesterol for pore 
formation [8], and purified SLO can bind directly to cholesterol and cholesterol-containing 
liposomes [9], leading to the long-standing assumption that cholesterol serves as the sole host 
cell receptor for SLO. However, our previous studies demonstrate that SLO can bind to the 
membrane via a cholesterol-independent mode during infection that requires the co-secretion of 
SPN [7]. This cholesterol-independent, SPN-dependent mode of SLO binding correlates with 
SLO’s SPN translocation activity; depletion of membrane cholesterol or mutation of SLO’s 
cholesterol-recognition motif does not inhibit CMT, although cholesterol is absolutely required 
for pore formation [7]. Therefore, we proposed a new model to explain SLO’s bifunctional 
activities, where SLO engages in alternative modes of binding to accomplish different activities: 
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cholesterol recognition for pore formation, and SPN-dependent binding to recognize an 
alternative receptor, triggering the subsequent translocation of SPN.  
 While this was an attractive model to explain the dual modes of binding and 
bifunctionality of SLO, recent data suggests that membrane recognition by SLO is even more 
complex, with the SPN-mediated binding mode resulting in membrane damage despite pore 
formation being dispensable for the translocation of SPN [10]. Additionally, while cholesterol is 
required to maintain SLO at the membrane in the absence of SPN, cholesterol does not serve as 
the initial membrane receptor for SLO, at least on the cell lines studied [10,11]. Computational 
analysis identified a putative carbohydrate-binding site for SLO within its membrane-binding 
domain, and purified SLO was found to bind galactose-containing carbohydrates with nanomolar 
affinity by glycan array screening, implicating a host cell glycan as a potential receptor for SLO 
[11]. We subsequently demonstrated that mutation of the predicted carbohydrate-binding 
residues or infection of a galactose-defective cell line prevents SLO’s pore-forming activity in 
the absence of SPN, indicating that galactose binding by SLO precedes its interaction with 
cholesterol for pore formation. However, when co-secreted with SPN, the SPN-dependent mode 
of SLO binding also results in pore formation, bypassing the need for galactose recognition prior 
to an interaction with cholesterol [10].  
 SPN’s membrane recognition requires its N-terminal domain, suggesting that this domain 
functions to bind the host cell surface [10]. SPN’s C-terminal domain encodes the enzymatic 
NADase activity of SPN, but this domain is not translocated without an intact N-terminal 
domain; deletions within SPN’s N-terminus abolish translocation but have no effect on 
enzymatic activity [12]. We have also demonstrated that SPN’s N-terminal domain is required 
for SLO’s galactose- and cholesterol-independent mode of membrane binding, further supporting 
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a role for this domain in membrane recognition [10]. Tertiary structure modeling of this domain 
based on homology to known structures predicts that this domain adopts a sugar-binding 
structure, with the majority of hits to family 32 carbohydrate-binding modules (CBM32).  
 Family 32 carbohydrate-binding modules are an extremely diverse collection of proteins 
that share structural features despite exhibiting minimal sequence identity (as low as 10%) [13]. 
The localization of many of these domains within modular carbohydrate-active enzymes 
distinguishes these modules from lectins, which bind carbohydrates but lack enzymatic activity 
[14]. The dogma is that carbohydrate-active enzymes flank carbohydrate-binding modules with 
matching specificities, which bind to their ligand and cluster the enzymatic domain in close 
proximity to its substrate. Most carbohydrate-binding modules recognize plant polysaccharides, 
yet many CBM32 proteins bind eukaryotic glycans, and are frequently encoded by pathogenic 
organisms such as Clostridium perfringens, Burkholderia cepacia, Streptococcus pneumoniae, 
and Yersinia species [13]. While many of these CBM32 domains are appended to glycan-
degrading enzymes, it is becoming apparent that this family likely encompasses more diverse 
functions than previously anticipated [13,14]. 
 The ligand binding sites of CBM32 members vary due to the high level of sequence 
diversity, but they (and other carbohydrate-binding proteins) commonly have at least one 
aromatic residue to participate in pi stacking interactions with sugar rings [13,15,16]. Consistent 
with structural prediction, SPN’s N-terminal domain has a tryptophan residue that may 
participate in carbohydrate recognition, and we have recently shown that this tryptophan residue 
is required for SPN’s membrane binding and subsequent translocation [10]. Another common 
feature of CBM32 domains is the coordination of a divalent cation, which is often achieved by 
heptahedryl coordination [14,17,18]. Cation binding usually serves a structural role to stabilize 
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these domains, with the cation coordination site located distal to the carbohydrate-binding pocket 
[14]. SPN’s N-terminal domain is also predicted to coordinate a divalent cation, although the 
geometry of this coordination may be distinct from other CBM32 proteins. Ligand site prediction 
models a divalent cation within a putative metal ion-dependent adhesion site (MIDAS) sequence 
motif [19]. To our knowledge, this motif has only been identified in the A domain superfamily, 
such as von Willebrand A (VWA) and integrin I domains, which are structurally very different 
from the predicted structure of SPN’s N-terminal domain. 
 In this study, we investigate a role for SPN’s putative MIDAS motif in membrane 
binding and SPN translocation. Mutation of this motif did not impact SPN secretion, protein 
stability, or SPN’s enzymatic activity, but membrane binding and translocation of SPN were 
nearly abolished. Similarly, when co-secreted with versions of SPN with an altered MIDAS 
motif, SLO exhibited galactose- and cholesterol-dependency, as is seen with SLO produced by a 
SPN deletion strain. Further analyses demonstrated that extracellular calcium is required for SPN 
binding and translocation, suggesting that the MIDAS motif is a bona fide cation-binding site. 
These data indicate that an intact MIDAS motif is necessary for the function of SPN, and that 
calcium coordination is critical for the membrane association of SPN and SLO preceding SPN 
translocation. 
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RESULTS 
SPN’s N-terminal domain encodes a putative MIDAS motif 
 As previously described, computationally derived homology modeling based on similar 
structures predicted with high confidence (99.8%) that a continuous sequence covering over 90% 
of SPN’s N-terminal domain adopts the structure of a carbohydrate-binding protein [20]. 
Specifically, the majority of hits were to family 32 carbohydrate-binding modules (CBM32). 
Analysis of these models using ligand site prediction identified a cation-binding site within this 
domain [19], with calcium present in the majority of models (11 of 13), and magnesium and zinc 
coordinated in the remaining 2 models. This analysis predicted residues H71, D74, S76, and T79 
to coordinate the ion, and we observed that three of these residues overlap with a putative metal 
ion-dependent adhesion site (MIDAS) sequence (Figure 1), known to coordinate divalent cations 
in von Willebrand A/integrin-like domains [21]. These domains are involved in cell-cell and cell-
matrix adhesion, and are structurally very different from SPN’s predicted CBM32 structure [21]. 
The canonical MIDAS motif sequence is DXSXS…T…D, where “X” represents any amino acid, 
and the threonine and second aspartate are not continuous in the primary sequence. The three 
continuous residues comprise the core motif, whereas the downstream threonine and aspartic 
acid residues can be substituted and in some cases are even dispensable for cation-binding 
function [21]. SPN’s predicted cation binding site is close to the consensus sequence by having a 
perfect core MIDAS motif, in addition to a threonine residue immediately adjacent to the third 
serine (highlighted residues in Figure 1), suggesting that these residues may form a cation-
binding site. 
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An intact MIDAS motif is required for SPN translocation and cholesterol-independent 
binding of SLO 
 To investigate a role for the putative MIDAS motif in SPN’s membrane binding and 
translocation, a triple mutant was generated in residues comprising the core motif (D74A, S76A, 
S78A; SPNMIDAS), or the first aspartic acid alone (D74A; SPND74A) in SPN in the bacterial 
chromosome (Table 1). These mutants were expressed, secreted, and retained a level of 
enzymatic activity similar to wild-type SPN (Figure 2), indicating that these mutations do not 
result in overall conformational defects. SPNMIDAS and SPND74A migrate further in the SDS-
PAGE gel, but we verified by N-terminal sequencing that this is due to the loss of the negative 
charge (allowing more SDS molecules to bind), and not cleavage of the protein.  
 To determine if an intact MIDAS motif is important for SPN’s function during infection, 
CHO cells, with and without MβCD treatment to deplete cholesterol, were infected with wild-
type bacteria or strains expressing SPNMIDAS or SPND74A, and the host cell membrane fraction 
was probed to assess SPN binding post-infection. Both the triple mutation (SPNMIDAS) and single 
mutation (SPND74A) rendered SPN incapable of membrane association (Figure 3). Consistent 
with this finding, it was evident by probing the host cell cytosolic fraction for the presence of 
SPN that SPNMIDAS and SPND74A are not translocated during infection. As previously 
demonstrated, membrane binding by SLO produced from the wild-type strain is not inhibited by 
cholesterol depletion. In contrast, the strains expressing SPNMIDAS or SPND74A exhibit the same 
characteristics as a ΔSPN strain, in that SLO is unable to bind to the membrane in the absence of 
cholesterol when co-expressed with these SPN mutants (Figure 3). The lack of membrane 
association and translocation of SPNMIDAS and SPND74A is consistent with the ligand site 
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prediction, and demonstrates that this putative MIDAS motif plays a critical role in membrane 
targeting of both SPN and SLO during infection. 
 
An intact MIDAS motif is required for SLO pore formation on galactose-deficient cells 
We have previously demonstrated that SPN plays a critical role in the membrane binding 
and pore forming activity of SLO when SLO’s carbohydrate-binding site is mutated, or when 
Lec8 cells are used for infection, which lack galactose-containing cell surface glycoconjugates 
[10]. Since altering SPN’s putative N-terminal MIDAS motif renders it nonfunctional for 
binding and translocation, we sought to determine whether SLO is dependent on its galactose-
containing receptor for pore formation when co-expressed with SPN MIDAS mutants. To 
evaluate this possibility, SLO-induced membrane permeability of parental CHO or galactose-
deficient Lec8 cells was visualized following infection with wild-type bacteria or strains 
expressing SPNMIDAS or SPND74A. SLO produced by the strains expressing SPNMIDAS or SPND74A 
was able to form pores on CHO cells, although to a lesser extent than the wild-type strain (Figure 
4), analogous to SLO expressed from the ΔSPN strain. However, SLO co-expressed with SPN 
MIDAS mutants was not able to effectively form pores on Lec8 cells (Figure 4). Together, these 
data demonstrate that SPN’s putative MIDAS motif plays an essential role in its own 
translocation, and can also facilitate membrane binding and pore formation by SLO during 
infection. This mode of binding for SLO is critical in the absence of galactose-containing 
glycoconjugates to serve as a host cell receptor. 
 
 
 
 125 
Calcium is required for SPN-membrane binding and CMT 
 The majority of models generated by ligand site prediction modeled a calcium ion within 
the MIDAS motif. Therefore, CHO and Lec8 cells were infected with wild-type bacteria or the 
SPN deletion strain in calcium-free medium to determine if extracellular calcium is required for 
SPN binding and translocation. SPN was not observed in CHO or Lec8 cell total membrane or 
cytosolic fractions post-infection in the absence of calcium (Figure 5), resembling the MIDAS 
motif mutants. However, the addition of calcium to this medium permitted SPN binding and 
translocation into CHO and Lec8 cells (Figure 5). These data indicate that extracellular calcium 
is required for SPN binding and translocation during infection regardless of the presence of 
SLO’s galactose-containing receptor. 
 
Calcium is required for SLO pore formation on galactose-deficient cells 
 Since SPN was unable to bind host membranes and undergo translocation in the absence 
of extracellular calcium, it seemed likely that calcium would be necessary for SPN-dependent 
pore formation by SLO on galactose-deficient Lec8 cells. To test this hypothesis we evaluated 
Lec8 membrane integrity following infection with wild-type bacteria in calcium-free or calcium-
supplemented media. Similar to the SPN MIDAS motif mutants, SLO was unable to efficiently 
permeabilize Lec8 cells in calcium-free medium (Figure 6). However, the addition of calcium 
enabled pore formation by SLO, indicating that calcium coordination by SPN is required for this 
mode of binding (Figure 6). In addition, supplementation of calcium-free medium with an 
equivalent concentration of magnesium chloride did not promote pore formation by SLO, 
demonstrating specificity of this cation-binding site. 
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DISCUSSION 
 SPN was initially assumed to gain access to the host cell cytosolic compartment via 
passive diffusion through pores formed by SLO, yet it is becoming increasingly apparent that 
SPN is actively involved in its own membrane targeting, as well as mediating SLO’s SPN-
dependent mode of membrane binding preceding SPN translocation. SPN’s non-enzymatic N-
terminal domain is required for its translocation [12], and we have recently demonstrated that the 
requirement for this domain is likely due to its role in membrane recognition [10]. When a 
tryptophan residue predicted to be involved in carbohydrate binding by this domain is mutated, 
SPN is unable localize to the host cell membrane during infection and undergo translocation 
[10]. In the current study, we further characterized the role for this domain in membrane binding 
and CMT by investigating the necessity of its metal ion-dependent adhesion site (MIDAS). 
While a native MIDAS motif was not necessary for the secretion or enzymatic activity of SPN, it 
was essential for its membrane targeting and subsequent translocation. Extracellular calcium was 
necessary for this process, implicating a role for calcium coordination by SPN in membrane 
binding and CMT. 
Computational tertiary structure modeling predicts that SPN’s N-terminal domain adopts 
the structure of a family 32 carbohydrate-binding module (CBM32), one of the largest and most 
diverse families of carbohydrate-binding modules [13]. These domains are often encoded within 
bacterial enzymes that interact with human glycans [13], where their presumed role is to target 
the carbohydrate-active enzyme component of these modular proteins to the host cell surface for 
glycan cleavage, tissue destruction, and bacterial spread [22]. A primary example is CBM32 
membrane targeting of the large sialidases NanJ and NanI produced by Clostridium perfringens, 
where sialic acid removal by these proteins enhances the lytic phospholipase activity of alpha 
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toxin [23]. Despite SPN’s lack of carbohydrate-degrading activity, its predicted CBM32 may 
have a similar targeting function to mediate binding of SPN and SLO to the host cell membrane, 
resulting in extensive membrane damage by SLO and increased cytotoxicity upon SPN 
translocation.  
Most characterized CBM32 domains have been shown to bind galactose. However, the 
subset of domains that have been studied in detail are closely related phylogenetically and may 
not be representative of the more diverse members of this protein family [13,24]. Utilization of 
the galactose-deficient Lec8 cell line revealed that if SPN is a bona fide carbohydrate-binding 
module, it is not galactose-specific, as the lack of galactose-containing glycoconjugates on this 
cell type did not influence the level of SPN binding and translocation [10]. While uncommon, 
this would not be the first example of a non-galactose binding CBM32 domain; NagH from C. 
perfringens exhibits specificity for non-reducing terminal N-acetylglucosamine residues [24]. As 
SPN displays very low sequence identity to other CBM32 domains (9-20%), it is conceivable 
that it exhibits different ligand specificity. Attempts to identify a carbohydrate ligand for SPN by 
glycan array screening have been unsuccessful, which may be due to the low affinity interactions 
common to this family of proteins [17,18]. In cases where glycan array screening was 
inconclusive, ligand determination was possible via UV difference spectroscopy [17,18,25], 
which may be a suitable technique for SPN ligand identification.  
SPN’s N-terminal domain is also unique among CBM32s due to the presence of a 
putative MIDAS motif sequence. Divalent cation coordination is a common feature of these 
carbohydrate-binding modules, yet ion binding is typically achieved via heptahedryl 
coordination by residues that vary among these domains. Cation coordination primarily serves a 
stabilizing role, and ion removal does not significantly inhibit these apo-CBMs from binding 
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their carbohydrate ligand [18]. In contrast, ligand site prediction identified a putative MIDAS 
motif as a cation-binding site within SPN’s N-terminal domain. To our knowledge, this motif has 
only been described in von Willebrand/integrin-like domains [21], which adopt a Rossman fold 
structure with multiple α-helices and are structurally distinct from the CBM32 fold comprised of 
β-sheets and disordered loops.  
von Willebrand/integrin A (VWA) domains belong to a large protein family common to 
all domains of life and function in various adhesive protein-protein interactions between cell and 
extracellular matrix components [21]. The MIDAS motif was originally described in the integrin 
CR3 α chain, which binds to multiple ligands including fibrinogen and the complement opsonin 
iC3b [26]. This motif is present in all β integrin and α subunit VWA domains, and ligand 
recognition involves the joint coordination of a divalent cation by integrin MIDAS residues and a 
ligand carboxylate group [27,28]. This metal ion coordination has also been described for the 
anthrax toxin receptor and protective antigen, which exhibit cation-dependent binding via the 
anthrax toxin receptor MIDAS residues and an aspartate provided by protective antigen [29]. In 
these cases, mutation of MIDAS residues prevents the protein-protein interaction, demonstrating 
a critical role for this motif [29-31]. Many prokaryotic VWA domains exist in addition to the 
eukaryotic integrin-like proteins, and more than 80% of these domains encode at least an 
imperfect MIDAS sequence [21].  
Despite a lack of structural similarity to MIDAS-containing domains based on SPN’s 
predicted N-terminal domain structure, it encodes a near consensus MIDAS motif. It lacks the 
terminal downstream aspartic acid residue (DXSXST), but other studies indicate that even 
imperfect MIDAS motifs can accomplish divalent cation coordination [21]. This is supported by 
the necessity of an intact MIDAS sequence and the presence of extracellular calcium for SPN 
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binding and translocation during infection. These data suggest that similar to other characterized 
MIDAS motifs, cation coordination by SPN plays a critical role in its function. This is in contrast 
to cation-binding by CBM32 members, where glycan binding is typically enhanced but not 
absolutely dependent on metal ion coordination [18]. Therefore, several questions remain 
regarding the structure of SPN’s N-terminal domain and the function of its MIDAS motif. Does 
this domain adopt the predicted CBM32-like structure? It is possible that the structural prediction 
for this domain is incorrect, since SPN exhibits very low sequence identity to other CBM32 
proteins. While this is not uncommon among members of this protein family, we have not 
identified a host cell carbohydrate necessary for CMT. Resolving the structure of this domain 
will be critical to understanding its function and potential ligand(s). Establishing whether SPN’s 
MIDAS residues coordinate calcium independently or in conjunction with its ligand will also 
require ligand identification and structural determination. However, the findings in this study 
demonstrate that SPN’s MIDAS motif is a functional cation-binding site. To our knowledge, this 
is the first example of a MIDAS motif encoded by a bacterial toxin. 
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MATERIALS AND METHODS 
Bacterial strains: α-Select Gold competent cells (Bioline; Taunton, MA) were used for 
molecular cloning experiments. The S. pyogenes strain used was M serotype 6 strain JRS4 [32], 
cultured in Todd-Hewitt broth (ThyB) (Becton Dickinson; Franklin Lakes, NJ) supplemented 
with 0.2% autolysed yeast extract (Becton Dickinson; Franklin Lakes, NJ). When necessary, 
erythromycin was added to the media to a final concentration of 500 µg ml-1 or 1 µg ml-1, for E. 
coli and S. pyogenes, respectively.  
 
Cell lines: Chinese hamster ovary CHO-K1 cells were a gift from the laboratory of Dr. Jean 
Schaffer (Washington University in St. Louis, St. Louis MO). The CHO-K1 derivative Lec8 cell 
line (CRL-1737TM; originally Pro-5WgaRVIII3D) was purchased from American Type Culture 
Collection (ATCC). Cells were maintained at 37°C in the presence of 5% CO2 in α-MEM with 
L-glutamine, supplemented with 10% fetal bovine serum. To evaluate a role for calcium during 
infection, custom calcium-free α-MEM was supplemented with 10% dialyzed fetal bovine serum 
(molecular weight cutoff 10 kDa). Where indicated, 1.8mM calcium chloride (Sigma; St. Louis, 
MO) was added prior to infection. Media and fetal bovine serum were purchased from Gibco 
(Grand Island, NY). 
 
Construction of SPN mutants: To facilitate mutagenesis of SPN, the chromosomal sequence of 
SPN’s N-terminal domain, as well as the flanking regions, was amplified from purified JRS4 
chromosomal DNA and inserted into the temperature-sensitive shuttle vector pJRS233 by 
sequence overlap extension PCR [33]. Plasmid DNA was isolated and used to transform E. coli 
using standard techniques. The resulting construct was used as the template for introducing the 
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D74A and the D74A, S76A, S78 triple mutation using the Quikchange XL II mutagenesis kit 
(Agilent Technologies; Santa Clara, CA). Electroporation was used to transform S. pyogenes 
[34], and the wild-type allele in JRS4 was replaced with the mutant versions as previously 
described [35]. All primers are listed in Table 2, with M13 forward and reverse sequences (for 
insertion into shuttle vectors) underlined. Both plasmid constructs and chromosomal mutations 
were verified by DNA sequencing (Genewiz; South Plainfield, NJ).  
 
CHO cell infection: Streptococcal cultures were grown overnight in ThyB, subcultured in fresh 
ThyB the day of the infection, and were allowed to double twice before washing the cells with 
phosphate buffered saline and resuspending the pellet in medium to an OD600 of 0.2. For 
experiments determining the level of cell viability post-infection, CHO-K1 cells or the Lec cell 
derivatives were grown to near confluency in 12-well plates (CytoOne; USA Scientific, Ocala, 
FL). Cells were incubated with 60µL of the streptococcal strains plus 1mL of fresh medium for 
1.5 hours at 37°C with 5% CO2. For membrane and cytosolic fractionation of mammalian cells 
post-infection, cells were grown to near confluency in 75 cm2 flasks (TPP; Trasadingen, 
Switzerland), and streptococcal strains were subcultured as described above. The CHO-K1 cells 
were incubated with 1mL of the streptococcal strains at OD600 of 0.2 plus 14mL fresh medium 
for 1.5h at 37°C in the presence of 5% CO2. For cells utilizing calcium-free medium, the 
infections were allowed to proceed for 2 hours due to the slower growth of the bacteria in the 
dialyzed serum. Where indicated, 4mM methyl-β-cyclodextrin (MβCD) (Sigma; St. Louis, MO) 
was added to the media 30 minutes prior to infection and remained in the media during the 
infection. 
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Membrane extraction and cytosolic fractionation: Separation of total membranes from 
cytosolic components was performed as described previously [7]. Briefly, the cells were washed 
twice with phosphate buffered saline, resuspended in 1.3mL homogenization buffer (10mM Tris-
HCl pH 7.5, 5mM EDTA, protease inhibitors (Roche complete mini)), and lysed by 30 passages 
through a 22-gauge needle. Unlysed cells and cellular debris were removed by centrifugation 
(600 x g, 15 minutes, 4°C), and the resulting supernatants were subjected to ultracentrifugation 
(100,000 x g, 1h, 4°C) to harvest total membranes. Membrane pellets were resuspended in 1X 
SDS sample buffer and analyzed by immunoblotting with anti-SLO antiserum (generated by 
Sigma-Genosys) or commercial anti-SPN (Cosmo Bio Co.). Translocation of SPN was evaluated 
by immunoblotting of supernatant fractions using anti-SPN as described [7]. Antibody against 
human caveolin-1 (Cell Signaling Technology; Danvers, MA) was used as a loading control for 
the total membrane fraction, as it cross reacts with hamster caveolin-1. Actin AC40 was used as 
a loading control for the cytosolic fractions (Sigma; St. Louis, MO). Immunoblots were 
developed by chemiluminescence (SuperSignal® West Dura Extended Duration Substrate, 
Thermo Scientific; Waltham, MA) and images were taken with a CCD camera-based system 
(ChemiDocTM, BioRad; Hercules, CA). For each experiment, a representative image is presented 
in the text, prepared for publication using Adobe Illustrator CS6. Images are representative of the 
results from at least three independent experiments.  
 
Assessment of membrane integrity: The membrane integrity of CHO-K1 or Lec8 cells 
following infection was assessed by visualizing the degree of exclusion of the membrane-
impermeable fluorescent dye EthD-1, a component of the LIVE/DEAD viability/cytotoxicity kit 
for mammalian cells (Molecular Probes; Grand Island, NY). The cells were incubated with the 
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staining solution prepared in Dulbecco’s modified phosphate buffered saline for 15 minutes at 
37°C prior to visualization by fluorescence microscopy.  Cells were imaged using a Leica 
DMIRE2 fluorescent microscope, and images were captured using Q Imaging Retiga EX CCD 
digital camera and Volocity software (Perkin Elmer; Waltham, MA). For quantitation, permeable 
and impermeable cells were enumerated from captured images, with data presented representing 
the mean and standard error of the mean derived from at least three independent experiments and 
the examination of at least 2000 total cells. Images were prepared for publication using Adobe 
Illustrator CS6.  
 
Assessment of SPN’s enzymatic activity: The enzymatic activity of SPN MIDAS mutants from 
cell-free overnight culture supernatants was measured and compared to SPN produced by the 
wild-type strain, as described [5]. Briefly, overnight cultures were subjected to centrifugation 
(6,000 x g, 5 minutes) to remove bacterial cells, and the remaining supernatant was serially 
diluted in phosphate buffered saline. Diluted supernatants were incubated with 0.5 mM β-NAD+ 
(Sigma; St. Louis, MO) at 37°C for 90 minutes. Following incubation, 5M sodium hydroxide 
was added to terminate the reaction, which was allowed to proceed for 1h at room temperature, 
before determining the level of uncleaved β-NAD+ by spectrofluorimetry (380nm excitation, 
455nm emission, Tecan Infinite M200 Pro). Extent of β-NAD+ cleavage was normalized to 
either the OD600 of the culture or the amount of SPN detected in supernatants precipitated with 
10% trichloroacetate, assessed by immunoblotting with anti-SPN (Cosmo Bio). The extent of 
cleavage by wild-type SPN was set to 100%. 
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Statistical Analysis: Differences in mean values in the percent of permeabilized cells were 
tested for significance by the Tukey-Kramer multiple comparisons test. The null hypothesis was 
rejected for p values less than 0.05.  
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Figure 1. SPN’s N-terminal domain encodes a putative MIDAS motif. Shown is a model of 
SPN’s N-terminal domain, generated by Phyre2 tertiary structure homology modeling [20]. The 
residues comprising the putative MIDAS motif, predicted to coordinate a divalent cation by 
ligand site prediction [19], are highlighted in green. A calcium ion is shown in blue. Amino acid 
numbering is based on the GenBank AAK33265.1 sequence. 
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Figure 2. SPN MIDAS mutants retain enzymatic activity. Quantitation of the enzymatic 
activity of SPND74A and SPNMIDAS from overnight culture supernatant, compared to the activity 
of wild-type SPN, which was normalized to 100%. Shown below is overnight culture supernatant 
from the wild-type or SPN mutant strains, precipitated with 10% trichloroacetate and 
immunoblotted with antiserum against SPN. 
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Figure 3. SPN MIDAS mutants do not bind host cell membranes or undergo translocation. 
Immunoblot analyses of total membrane and cytosolic fractions harvested from untreated or 
MβCD-treated CHO cells following a 90 minute infection with the wild-type or SPN mutant 
strains indicated at the top of the figure. Immunoblots were developed with antisera against the 
proteins indicated on the right. Analyses of caveolin-1 (membrane) and actin (cytosol) were 
included as loading controls, and the migration of several molecular weight standards (in kDa) 
are shown to the left. Immunoblots are representative of at least three independent experiments. 
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Figure 4. An intact MIDAS motif is required for SPN-mediated pore formation by SLO. 
(Top) The extent of pore formation was assessed on CHO cells or the galactose-deficient CHO 
cell derivative Lec8 line following a 90 minute infection with the S. pyogenes strains indicated at 
the top of the figure, visualized by staining with a fluorescent vital dye (Live/DeadTM). Intact 
membranes exclude the red fluorescent membrane-impermeable dye EthD-1 and appear green; 
cells with compromised membranes appear red. White bars measure 70µm. (Bottom) 
Quantitation of permeable cells. Data are presented as the mean and the standard error of the 
mean, derived from at least three independent experiments. 
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Figure 5. Extracellular calcium is required for SPN-membrane binding and translocation. 
Immunoblot analyses of total membrane and cytosolic fractions harvested from CHO or 
galactose-deficient Lec8 cells following a 2  hour infection with the wild-type or SPN mutant 
strains in the absence of extracellular calcium or in calcium-free medium supplemented with 
1.8mM CaCl2. Immunoblots were developed with anti-SPN antiserum.  
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Figure 6. Extracellular calcium is required for SPN-mediated pore formation by SLO. The 
extent of pore formation was assessed on galactose-deficient Lec8 cells following a 2 hour 
infection with wild-type bacteria in the absence of extracellular calcium or in calcium-free 
medium supplemented with 1.8mM CaCl2, visualized by staining with a fluorescent vital dye 
(Live/DeadTM). Intact membranes exclude the red fluorescent membrane-impermeable dye EthD-
1 and appear green; cells with compromised membranes appear red.  
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CHAPTER 5 
 
SPN modulates the interaction between Streptolysin O and the host 
cell membrane 
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SUMMARY 
The Gram-positive bacterium Streptococcus pyogenes translocates the NAD+ glycohydrolase 
effector protein SPN into host cells during infection by the process of cytolysin-mediated 
translocation, leading to rapid death of the infected cell. The cholesterol-dependent cytolysin 
(CDC) Streptolyin O (SLO) is strictly required for this process, yet the canonical pore-forming 
activity of SLO is dispensable for the translocation of SPN, demonstrating bifunctionality of 
SLO. SLO’s CMT activity can also be uncoupled from the recognition of its galactose-
containing glycoconjugate receptor that functions to orient SLO at the membrane prior to its 
interaction with cholesterol. Instead, SLO engages in a co-dependent mode of binding with SPN 
at the host cell membrane that correlates with SPN translocation. This mode of binding is 
sufficient for CMT and can bypass the requirement for recognition of SLO’s galactose receptor 
for pore formation, but its role during a normal infection was unclear. In this study we exploited 
the differential detergent solubility of SPN-mediated and galactose- and cholesterol-mediated 
membrane-localized SLO to demonstrate that SPN modulates the membrane interaction of SLO 
during a normal infection, at least on some cell types. Additionally, the evaluation of various cell 
lines for their susceptibility to SLO-induced membrane damage revealed that some cell lines 
were susceptible to membrane damage regardless of the co-expression of SPN, but others were 
efficiently permeabilized only in the presence of SPN. However, SLO still localized to the 
plasma membrane, indicating that SPN may enhance pore formation or interfere with the 
downstream pore healing response in these cell types. 
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INTRODUCTION 
 Effector translocation is a common tactic employed by bacteria to disrupt various host 
cell processes and promote pathogenesis. The Gram-positive bacterium Streptococcus pyogenes 
translocates the NAD+ glycohydrolase SPN into host cells during infection by the process of 
cytolysin-mediated translocation (CMT) [1]. While functionally analogous to the Gram-negative 
Type III secretion system, CMT is mechanistically disparate and utilizes the cholesterol-
dependent cytolysin (CDC) Streptolysin O to promote the translocation of SPN instead of 
assembling a needle-like apparatus, although the details of this process are still unclear. SLO 
induces cytotoxicity by forming transmembrane pores and damaging host cell membranes, which 
is exacerbated by the toxic activity of translocated SPN, leading to rapid death of the infected 
cell [1]. The high level of conservation of SPN and SLO and the virulence defect exhibited by 
SPN and SLO mutants in tissue culture and animal models of infection suggest that CMT 
contributes to the pathogenesis of S. pyogenes [1,2]. 
 SLO is a member of the cholesterol-dependent cytolysin family of proteins, comprised of 
over 30 proteins produced by numerous Gram-positive bacteria. CDCs are highly similar at both 
the primary sequence and structural level, and also share a common mechanism of pore 
formation [3]. They are secreted from bacteria as soluble monomers, which recognize the host 
cell membrane via their C-terminal domain (domain 4), triggering multidomain conformational 
changes that facilitate interactions between adjacent monomers. The assembly of 35-50 
monomers completes the prepore complex, which undergoes extensive structural rearrangements 
to collapse into the membrane in a cholesterol-dependent manner to form the transmembrane 
pore [3]. Since pore formation is strictly dependent on cholesterol, it has been assumed that 
cholesterol serves as the host cell receptor for CDCs. While this is true for many CDCs, such as 
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PFO produced by Clostridium perfringens [4], other CDCs require the recognition of an 
alternative receptor prior to the engagement of cholesterol. A growing body of data indicates that 
the mechanism of membrane recognition by CDCs is more diverse than previously anticipated. 
  The first description of a CDC to recognize an alternative receptor was ILY, produced by 
Streptococcus intermedius, which utilizes the human-specific protein CD59 as its receptor [5]. 
Binding to CD59 orients ILY at the membrane and triggers the conformational changes that 
promote monomer-monomer association and prepore complex formation [6,7]. Following 
assembly of the completed prepore complex, it disengages from CD59 to bind cholesterol and 
insert into the membrane. For ILY and other CD59-binding CDCs, binding to CD59 induces the 
same structural changes and functional consequences as PFO’s recognition of cholesterol, with 
both binding events culminating in pore formation [6,7]. LLY, produced by Streptococcus mitis, 
also exhibits noncanonical binding by recognizing difucosylated host cell glycans via its N-
terminal lectin domain, which enhances the hemolytic activity of this protein [8]. 
 SLO’s mode of binding to the host cell membrane has been controversial. While SLO can 
directly bind purified cholesterol and cholesterol-rich liposomes, cholesterol depletion from 
erythrocyte membranes does significantly inhibit binding of SLO to the membrane, suggesting 
that SLO may recognize an alternative receptor similar to ILY [6]. We have recently determined 
that this alternative receptor is a galactose-containing glycoconjugate, which is functionally 
analogous to CD59 binding by ILY as it orients SLO at the host cell membrane prior to its 
interaction with cholesterol for pore formation [9]. A putative carbohydrate-binding site was 
identified in SLO’s domain 4 [10], and mutation of these residues inhibits membrane binding 
and pore formation by SLO in the absence of SPN. Similarly, a galactose-deficient cell line is 
resistant to pore formation by SLO in the absence of SPN [9]. However, SLO carbohydrate-
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binding site mutants can still form pores in a cholesterol-dependent manner when co-expressed 
with SPN during epithelial cell infection, demonstrating that SLO can utilize different modes of 
binding to achieve proper orientation at the membrane for pore formation [9].  
 The SPN-dependent mode of binding for SLO correlates with its SPN translocation 
activity. Cholesterol recognition and pore formation by SLO are not required for CMT [11,12], 
and we have demonstrated that SPN and SLO co-dependently bind to the host cell membrane to 
initiate SPN translocation, at least in the absence of cholesterol [12]. This mode of binding 
requires the non-enzymatic domain of SPN, which is predicted to be a carbohydrate-binding 
module that coordinates calcium via its metal ion-dependent adhesion site [9] (Chapter 4). 
Mutation of putative functional residues abolishes the membrane localization and translocation 
of SPN, and membrane binding by SLO under cholesterol-limiting conditions. However, SPN is 
not targeted to the membrane via this domain unless it is co-expressed with SLO, and the co-
dependent binding and subsequent translocation of SPN requires SLO’s unique N-terminal 
extension [12].  This domain has no homology or predicted structure, and is not shared by any 
other CDCs. Therefore, its role in membrane binding and SPN translocation is unknown [13]. 
 While SLO’s SPN-mediated mode of membrane binding is sufficient for SPN 
translocation and pore formation, it is unclear if this mode of binding occurs during a normal 
infection, or if this pathway is only active if the galactose- and cholesterol-dependent pathway is 
disrupted. To address this question we developed an assay to distinguish these two modes of 
binding, and demonstrated that SPN does modulate SLO’s membrane association during a wild-
type infection. SPN-mediated binding results in a weaker interaction between SLO and the 
membrane, similar to a peripheral membrane protein. We also evaluated the sensitivity of 
various cell lines to pore formation by SLO in the presence and absence of SPN. Some cell lines 
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were efficiently permeabilized by SLO regardless of the co-expression of SPN, while others, 
such as the physiologically relevant human HaCaT keratinocytes, were much more resistant to 
membrane damage in the absence of SPN.   
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RESULTS 
Membrane-associated SLO is detergent-soluble when co-expressed with SPN: We 
developed a detergent solubilization assay to investigate whether the SPN-mediated mode of 
SLO binding can be distinguished from the SPN-independent mode, and to determine if the 
SPN-mediated mode of binding occurs during a normal infection. The incubation of mammalian 
cells with a low concentration of the detergent saponin (0.025%) and subsequent fractionation of 
the membrane did not result in the extraction of the integral membrane proteins E-cadherin, 
Na+/K+ ATPase, or caveolin-1, but did result in the significant reduction of membrane-associated 
annexin A2, a peripheral membrane protein (Figure 1). The inclusion of both membrane raft-
specific (caveolin-1) and non-raft integral membrane proteins (E-cadherin, Na+/K+ ATPase) 
suggests that saponin is not preferentially solubilizing specific membrane domains but is likely 
extracting more weakly associated proteins. We applied this technique to assess the membrane 
association of SLO following infection of A549 cells with wild-type bacteria, the SPN deletion 
strain, or a strain expressing SLO lacking its N-terminal extension (SLOΔNTE), which does not 
translocate SPN [12,13] (Table 1). Total membrane fractions were harvested and probed for SLO 
following incubation with the saponin lysis buffer or PBS alone. For the wild-type infection, the 
amount of membrane-associated SLO was significantly decreased following saponin treatment, 
similar to the peripheral protein annexin A2 (Figure 2). In contrast, saponin incubation did not 
affect the level of membrane-associated SLOΔNTE or wild-type SLO produced from the SPN 
deletion strain, similar to the integral membrane proteins (Figure 2). CMT does not result from 
infections with the SPN deletion strain or the strain expressing SLOΔNTE, since SPN is absent 
or co-expressed with a CMT-incompetent version of SLO, respectively. These data demonstrate 
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that CMT competence correlates with a differential interaction between SLO and the host cell 
membrane. 
 
Inhibiting SLO’s interaction with cholesterol increases its solubility: The saponin extraction 
pattern of SLO expressed from the wild-type strain resembles the peripheral protein annexin A2, 
indicating that SLO may be engaging in a weaker association with the membrane in the presence 
of SPN. In contrast, SLO resembles an integral membrane protein when binding independently 
of SPN. While SLO does not require cholesterol for binding and CMT, it may stabilize SLO at 
the membrane, and the disruption of SLO’s interaction with cholesterol may further weaken 
SLO’s membrane association. To test this hypothesis we evaluated the saponin extraction of 
SLO from cells depleted for cholesterol using methyl-β-cyclodextrin (MβCD), and also assessed 
the solubilization of SLOL565G (Table 1), which has an altered cholesterol-recognition motif. To 
determine if SLO is more weakly associated with the membrane during these infections, we 
probed the supernatant fraction for SLO following incubation with 0.005% (0.2X) or 0.025% 
(1X) saponin buffer. As demonstrated in Figure 2, wild-type SLO was solubilized from the 
membrane by 0.025% (1X) saponin regardless of membrane cholesterol concentration. However, 
the same amount of soluble SLO was observed from MβCD-treated cells incubated with 0.005% 
(0.2X) saponin. Similarly, SLOL565G was solubilized by 0.2X and 1X saponin from both 
untreated and MβCD-treated cells. Together, these data demonstrate that interfering with SLO’s 
interaction with cholesterol weakens its interaction with the membrane, and that cholesterol may 
stabilize SLO at the membrane during a normal infection. 
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Identification of the translocation domain in SLO’s N-terminal extension: We investigated 
the residues within SLO’s NTE required for SPN translocation in an attempt to understand the 
function of the NTE in this process. Multiple alignment of SLO protein sequences demonstrated 
that the entire NTE is highly conserved (Figure 4, highlighted in purple). Therefore, we took an 
unbiased approach by generating multiple deletion constructs and performing alanine scanning 
mutagenesis to identify the critical residues within this domain. Assessing the level of SPN 
translocation by SLO with nested deletions in the NTE (strains listed in Table 1, mutagenesis 
primers listed in Table 2) demonstrated that residues 70-87 are required for CMT, as the deletion 
of this stretch of amino acids renders SLO as defective for SPN translocation as the ΔSLO strain 
(Figure 5A). We further investigated this region by mutating the amino acids to alanine, except 
for residue A82, which was mutated to valine. Surprisingly, none of these point mutants were 
defective for SPN translocation (Figure 5B), indicating that SLO can tolerate substitutions within 
this translocation domain despite the conservation of this region in sequenced isolates. 
 
SPN modulates SLO-induced membrane permeability on distinct cell types: As an 
alternative approach to assess the role for SPN during infection, we visualized the level of 
cytotoxicity following infection of different host cell lines with wild-type bacteria, the SPN 
deletion strain, or the SLOΔNTE-expressing strain. All infections were conducted in the same 
medium, but A549 and CHO-K1 cell membrane integrity was visualized following a 1.5 hour 
infection, whereas HeLa and HaCaT cells, which are more resistant to cell death in all cases, 
were visualized following a 2 hour infection. For human lung fibroblast A549 cells and Chinese 
hamster ovary CHO-K1 cells, SLO induced extensive membrane permeability regardless of the 
co-expression of SPN. However, the translocation of SPN significantly exacerbated membrane 
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damage, apparent from the increased intensity of staining by the EthD-1 membrane-impermeable 
probe. In contrast, while HeLa and HaCaT cells exhibited significant membrane damage with the 
wild-type strain, minimal loss of membrane integrity was observed following infection with the 
strains that do not conduct CMT, despite the production of lytic versions of SLO. These data 
demonstrate that SPN enhances cytotoxicity during all infections, but plays a critical role in 
inducing damage to cells that exhibit increased resistance to pore formation by SLO. 
 
SPN enhances SLO’s toxicity subsequent to membrane binding by SLO: We assessed 
membrane binding of SLO to HeLa cells to investigate the basis for the resistance of this cell 
type to pore formation by SLO in the absence of SPN. The total membrane fraction of untreated 
or MβCD-treated cells was probed for membrane-localized SLO following infection with wild-
type bacteria or the SPN deletion strain. As shown previously, SLO binding to cholesterol-
depleted membranes was inhibited when produced by the SPN deletion strain (Figure 7), in 
contrast to SLO produced by the wild-type strain, which still bound to the membrane, albeit to a 
lower level on this cell type. Surprisingly, there was no observable defect in SLO binding to 
untreated HeLa cells regardless of the co-expression of SPN, despite the striking differences in 
membrane permeability resulting from these infections. These data demonstrate that while SPN 
plays an important role in inducing membrane damage to this cell type, its major role occurs 
subsequent to membrane binding by SLO. 
 
SPN disrupts the calcium-dependent pore healing response in HeLa cells: One mechanism 
by which SPN may cause cytotoxicity is by disrupting the cellular pore healing pathway in 
response to pore formation by SLO. This response to mechanical and toxin-mediated membrane 
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damage is stimulated by an influx of extracellular calcium, leading to signaling changes that 
result in the simultaneous endocytosis of membrane lesions and membrane patching via 
lysosomal exocytosis [14]. We evaluated the activity of this pathway in HeLa cells by 
modulating the level of extracellular calcium during infection, and assessed whether SPN 
sensitizes HeLa cells to SLO-induced membrane damage by interfering with this response. 
Calcium is required for the initiation of the pore healing, but is also necessary for membrane 
binding and translocation of SPN, which coordinates calcium via its metal ion-dependent 
adhesion site (Chapter 3). Therefore, calcium may have disparate effects on the host cell 
depending on the presence of SPN. To address this question, we performed experiments utilizing 
calcium-free medium supplemented with dialyzed fetal bovine serum, which does not contain 
low molecular weight molecules such as ions, simple sugars, and amino acids. The bacteria grow 
more slowly in this medium, necessitating a longer infection. Membrane integrity was assessed 
following a 4 hour infection of HeLa cells with wild-type bacteria, the SPN deletion strain, or the 
SLO/PFOD4 chimera, which is lytic but does not translocate SPN. Nearly all cells maintained 
membrane integrity following infection with the wild-type or SPN deletion strain in calcium-free 
medium. As SPN is not translocated in the absence of calcium, the wild-type infection is 
functionally equivalent to the SPN deletion strain under these conditions. In stark contrast, the 
SLO/PFOD4 chimera resulted in the complete destruction of HeLa cells in calcium-free medium 
due to the potent lytic activity of this chimera. However, a lower level of cell death was observed 
following infection with SLO/PFOD4 in calcium-supplemented medium, indicating that 
extracellular calcium might be stimulating the pore healing response. In contrast, exogenous 
calcium greatly increased the level of membrane damage resulting from the wild-type infection, 
as this condition promotes the translocation of SPN, whereas membranes were intact following 
 157 
infection with the SPN deletion strain. Together, these data indicate that HeLa cells can respond 
to membrane damage via the calcium-dependent pore healing response, but that membrane-
bound or translocated SPN interferes with this process to exacerbate cytotoxicity. 
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DISCUSSION 
 Previous studies have demonstrated that SLO and SPN are able to co-dependently 
localize to the host cell membrane during infection, allowing SLO to bypass its characteristic 
galactose- and cholesterol-dependent mode of binding. While this SPN-mediated binding mode 
correlates with SLO’s CMT activity, it has not been established whether this pathway is active 
during a wild-type infection. In this study we describe the differential solubilization of SLO by 
the detergent saponin depending on whether it is co-expressed with SPN. The majority of SLO is 
extracted from the membrane in the presence of SPN, whereas it remains membrane bound in the 
absence of SPN, suggesting that SPN modulates the membrane interaction of SLO during a wild-
type infection. Additionally, SPN induces cytotoxicity in some cell types that are not efficiently 
damaged by SLO pore formation alone, demonstrating the importance of CMT for pathogenesis.    
 The similarity of SLO’s saponin solubilization pattern to that of the peripheral protein 
annexin A2 suggests that SPN may be promoting a weaker interaction between SLO and the host 
cell membrane. This hypothesis is supported by the increased solubility of the SLO cholesterol-
recognition motif mutant or native SLO from cholesterol-depleted membranes, indicating that 
while not serving as the primary host cell receptor, cholesterol may stabilize SLO at the 
membrane. However, we cannot rule out the possibility that SPN alters SLO’s localization to a 
more soluble fraction of the membrane, or that SLO is localized to a subcellular fraction in the 
presence of SPN that is liberated by detergent treatment. The similar membrane retention of the 
raft-localized integral membrane protein caveolin-1 to that of non-raft integral protein markers 
argues against the preferential extraction of specific membrane fractions. Additionally, it is 
unlikely that the low concentrations of saponin used in these studies specifically lysed 
subcellular vesicles, as similar concentrations of saponin are commonly used to permeabilize the 
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plasma membrane for immunofluorescence of intracellular compartments. However, these 
possibilities need to be carefully addressed by further separation of the total membrane fraction 
to more precisely determine the localization of SPN and SLO during infection.  
 If the differential saponin solubility of SLO cannot be explained by altered membrane 
localization, SPN may be influencing the level of SLO oligomerization or its degree of insertion 
into the membrane. In the absence of SPN, or when SLO is unable to translocate SPN, its 
saponin insolubility phenotype resembles that of an integral protein, which may be explained by 
the formation of a fully inserted pore complex. As these pores vertically collapse into the 
membrane and span the bilayer, they may be physically similar to intergral membrane proteins. 
While SLO clearly causes membrane damage in a wild-type infection when co-expressed with 
SPN, it may be forming a different type of pore that is smaller or not fully inserted, making it 
more soluble. The formation of incomplete arcs has been demonstrated for purified SLO on 
erythrocyte membranes by electron microscopy [15,16], and several studies suggest that this 
phenomenon is common to CDCs and may occur in a natural context [17]. For example, LLO, 
the CDC produced by Listeria monocytogenes, creates small perforations in the phagosomal 
membrane that allows flux of a small dye prior to the leakage of a larger molecule, presumably 
through the fully formed pore [18]. This body of data is controversial and its relevance during 
infection has not been adequately addressed, but SPN may alter the stoichiometry of SLO 
oligomerization. 
SLO’s N-terminal extension does not influence its pore-forming activity but is required 
for the translocation of SPN and cholesterol-independent binding, suggesting that it may promote 
an interaction with SPN at the host cell membrane. Despite the strong conservation of the full 
length of the NTE, the residues critical for the translocation of SPN are localized to a relatively 
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small region of this domain. Surprisingly, the mutation of any single amino acid in this sequence 
does not result in a loss of CMT activity. One possible explanation for this is the hydrophobicity 
of this region. Many of the residues within this translocation domain are hydrophobic, which 
would not be altered by mutagenesis to alanine. Therefore, SLO may be promoting an interaction 
with SPN and/or cell surface components via hydrophobic interactions. Analysis of the crystal 
structure of SPN’s C-terminal domain and the predicted structural model for its N-terminal 
domain may identify similarly hydrophobic regions in SPN that may potentially be involved in 
this interaction. While it remains unclear how SLO’s NTE is involved SPN binding and 
translocation, these studies have identified a critical region in SLO’s NTE, and have also 
demonstrated that this region is tolerant to mutation. This may facilitate co-immunoprecipitation 
studies, as a cysteine residue may be introduced near this sequence that could be crosslinked to 
interacting partners at the host cell surface via a specific crosslinker. SLO encodes only one 
cysteine at the opposite terminus of the protein, and therefore introducing a cysteine in the NTE 
is unlikely to cause misfolding. 
In addition to demonstrating that SLO has different biochemical properties depending on 
the co-expression of SPN, we also determined that various host cell lines are differentially 
sensitive to membrane damage by SLO. The efficient permeabilization of A549 and CHO-K1 
cells regardless of the co-expression of SPN suggests that the canonical galactose- and 
cholesterol-dependent mechanism of pore formation is active on these cell types. In contrast, 
HeLa and HaCaT cells are relatively insensitive to SLO-mediated membrane damage in the 
absence of SPN. The simplest explanation for this discrepancy is that the SPN-dependent mode 
of binding is required for SLO to bind to these cell types, and that the galactose-containing 
receptor is either not abundant or inaccessible on these membranes. However, SLO was 
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membrane-localized following infection of HeLa cells with the SPN deletion strain, refuting this 
hypothesis. Therefore, SPN may be enhancing the oligomerization or membrane insertion of 
SLO on these cell types.  
SPN also appears to disrupt the calcium-dependent pore healing response in HeLa cells in 
addition to promoting a more productive interaction between SLO and the host cell membrane. 
This response has been described for cells exposed to purified SLO, but has not been 
demonstrated in the context of infection. Exogenous calcium provided a protective effect during 
infection with the SLO/PFOD4-expressing strain, which is lytic but does not translocate SPN, 
likely by stimulating the pore healing pathway in response to SLO/PFOD4-induced membrane 
damage. In contrast, exogenous calcium rendered HeLa cells markedly more susceptible to 
membrane damage during infection with wild-type bacteria, suggesting that SPN’s ability to bind 
calcium and undergo translocation disrupts the pore healing response. This effect is clearly due 
to SPN, as the level of extracellular calcium had no effect on membrane integrity of HeLa cells 
infected with the SPN deletion strain. The lack of SLO-induced membrane damage observed in 
the absence of both SPN and calcium indicates that SLO is not effectively forming pores in the 
absence of SPN, since the pore healing response is not activated in calcium-free media and cells 
would be more sensitive to pore formation under these conditions. It remains to be determined 
whether this disruptive effect is due to membrane-localized or translocated SPN, and if it 
requires the enzymatic activity of SPN.  
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MATERIALS AND METHODS 
Bacterial strains: Molecular cloning experiments utilized Escherichia coli α-Select Gold 
competent cells (Bioline; Taunton, MA) cultured in Luria-Bertani broth at 37°C. The S. 
pyogenes strain used was M serotype 6 strain JRS4 [19], cultured in Todd-Hewitt broth (ThyB) 
(Becton Dickinson; Franklin Lakes, NJ) supplemented with 0.2% autolysed yeast extract (Becton 
Dickinson; Franklin Lakes, NJ). When necessary, erythromycin was added to the media to a final 
concentration of 500 µg ml-1 or 1 µg ml-1, for E. coli and S. pyogenes, respectively.  
 
Cell lines: Experiments utilized human lung A549 cells [12], HaCaT keratinocytes [1], cervical 
HeLa cells [20], and Chinese hamster ovary CHO-K1 cells [9]. A549, HaCaT, and HeLa cells 
were maintained at 37°C in the presence of 5% CO2 in Dulbecco’s Modified Eagle’s Medium 
(DMEM) supplemented with L-glutamine, 10% fetal bovine serum, and 50mM HEPES. CHO-
K1 cells were maintained in α-MEM supplemented with L-glutamine and 10% FBS. Studies 
assessing the calcium-dependent pore healing response utilized custom calcium-free α-MEM 
medium supplemented with 10% dialyzed FBS, which has a molecular weight cutoff of XX kDa 
to remove ions and small molecules. Media and fetal bovine serum were purchased from Gibco 
(Grand Island, NY). 
 
Construction of SLO mutants: To facilitate the mutagenesis of SLO’s N-terminal extension, 
chromosomal sequence flanking SLO’s N-terminal domain was amplified from genomic JRS4 
DNA and inserted into the modified temperature-sensitive shuttle vector pGCP213 [21]. Plasmid 
DNA was isolated and used to transform E. coli using standard techniques. The resulting 
construct was used as the template for generating the deletions and point mutations using the 
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Quikchange XL II mutagenesis kit (Agilent Technologies; Santa Clara, CA). Electroporation was 
used to transform S. pyogenes, and the wild-type allele in JRS4 was replaced with the mutant 
versions as previously described [22]. All primers are listed in Table 2, with M13 forward and 
reverse sequences (for insertion into shuttle vector) underlined. Both plasmid constructs and 
chromosomal mutations were verified by DNA sequencing (Genewiz; South Plainfield, NJ).  
 
Streptococcal infection of mammalian cells: For all infections, streptococcal cultures were 
grown overnight in ThyB, back-diluted in fresh ThyB the morning of the infection, and were 
allowed to double twice before washing the cells with phosphate buffered saline and 
resuspending the pellet in medium to an OD600 of 0.2. For experiments determining the level of 
cell viability post-infection, mammalian cells were grown to near confluency in 12-well plates 
(CytoOne; USA Scientific, Ocala, FL). Cells were incubated with 60µL of the streptococcal 
strains plus 1mL of fresh α-MEM for 1.5 hours (CHO-K1 and A549 cells) or 2 hours (HaCaT 
and HeLa cells) at 37°C with 5% CO2. For membrane fractionation of A549 or HeLa cells post-
infection, cells were grown to near confluency in 75 cm2 flasks (TPP; Trasadingen, Switzerland). 
A549 cells were incubated with 1mL of the streptococcal strains plus 14mL fresh DMEM 
medium for 3h, and HeLa cells were incubated with 1mL of the streptococcal strains plus 14mL 
fresh α-MEM medium for 2h. For studies of detergent-solubilized SLO and the analysis of CMT, 
A549 or CHO-K1 cells were grown to near confluency in 6-well plates (CytoOne; USA 
Scientific, Ocala, FL) in DMEM or α-MEM, respectively. Cells were incubated with 120µl of 
the streptococcal strains plus 2mL of fresh medium for 3 hours (A549 cells) or 1.5 hours (CHO-
K1). For studies of the pore healing response, HeLa cells were grown in 12-well plates 
(CytoOne; USA Scientific, Ocala, FL). Cells were incubated with 60µL of the streptococcal 
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strains plus 1mL of fresh calcium-free α-MEM (with 10% dialyzed FBS) or calcium-free 
medium supplemented with 1.8mM calcium chloride for 4 hours. Where indicated, 5mM methyl-
β-cyclodextrin (MβCD) (Sigma; St. Louis, MO) was added to the media 30 minutes prior to 
infection and remained in the media during the infection. 
 
Saponin membrane extraction: To assess the solubilization of SLO post-infection, A549 cells 
were washed twice with PBS before being incubated with either 0.005% (0.2X) or 0.025% (1X) 
saponin lysis buffer at 37°C for 5 minutes. To assess the level of extracted SLO, infections were 
performed with A549 grown to near confluency in 6-well plates, and cells were resuspended in 
150µl saponin lysis buffer. Following the 5 minute incubation at 37°C, cell debris was pelleted 
by centrifugation (18,000 x g, 10 minutes, 4°C), and the supernatant was subjected to further 
clarification by ultracentrifugation (100,000 x g, 30 minutes, 4°C). The supernatant was mixed 
with 4X SDS sample buffer and analyzed by immunoblotting with anti-SLO antiserum 
(generated by Sigma-Genosys). To assess the level of SLO retained at the membrane, infections 
were performed with A549 cells grown to near confluency in 75 cm2 flasks, and cells were 
incubated with 4mL saponin lysis buffer or PBS alone. Following the 5 minute incubation at 
37°C, the supernatant was removed, cells were washed once with PBS, and the total membrane 
fraction was mechanically harvested in detergent-free homogenization buffer as described below 
and analyzed by immunoblotting with anti-SLO antiserum. 
 
Detergent-free membrane extraction: The total membrane fraction was harvested from HeLa 
cells post-infection as described previously for A549 cells [12]. Briefly, the cells were washed 
twice with phosphate buffered saline, resuspended in 1.3mL homogenization buffer (10mM Tris-
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HCl pH 7.5, 5mM EDTA, protease inhibitors (Roche complete mini)), and lysed by 30 passages 
through a 22-gauge needle. Unlysed cells and cellular debris were removed by centrifugation 
(600 x g, 15 minutes, 4°C), and the resulting supernatants were subjected to ultracentrifugation 
(100,000 x g, 1h, 4°C) to harvest total membranes. Membrane pellets were resuspended in 1X 
SDS sample buffer and analyzed by immunoblotting with anti-SLO antiserum. Immunoblots 
were developed by chemiluminescence (SuperSignal® West Dura Extended Duration Substrate, 
Thermo Scientific; Waltham, MA) and images were taken with a CCD camera-based system 
(ChemiDocTM, BioRad; Hercules, CA). A representative image is presented in the text, prepared 
for publication using Adobe Illustrator CS6.  
 
Analysis of CMT: Following infection of CHO-K1 cells, the supernatant was removed and cells 
were washed twice with PBS. Cells were resuspended in 150µl saponin lysis buffer (0.025% 
saponin in PBS with protease inhibitors (Roche complete mini tablet)) and incubated in a 37°C 
water bath for 5 minutes. Cellular debris and insoluble material was removed by centrifugation 
(18,000 x g, 10 minutes, 4°C), and further clarified by ultracentrifugation (100,000 x g, 30 
minutes, 4°C). Supernatants were mixed with 4X SDS sample buffer and analyzed by 
immunoblotting with anti-SPN antiserum (Cosmo Bio). Immunoblots were developed by 
chemiluminescence (SuperSignal® West Dura Extended Duration Substrate, Thermo Scientific; 
Waltham, MA) and images were taken with a CCD camera-based system (ChemiDocTM, 
BioRad; Hercules, CA). A representative image is presented in the text, prepared for publication 
using Adobe Illustrator CS6.  
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Assessment of membrane integrity: The membrane integrity of CHO-K1, HeLa, A549, or 
HaCaT cells following infection was assessed by visualizing the degree of exclusion of the 
membrane-impermeable fluorescent dye EthD-1, a component of the LIVE/DEAD 
viability/cytotoxicity kit for mammalian cells (Molecular Probes; Grand Island, NY). The cells 
were incubated with the staining solution prepared in Dulbecco’s modified phosphate buffered 
saline for 15 minutes at 37°C prior to visualization by fluorescence microscopy.  Cells were 
imaged using a Leica DMIRE2 fluorescent microscope, and images were captured using Q 
Imaging Retiga EX CCD digital camera and Volocity software (Perkin Elmer; Waltham, MA). 
Images were prepared for publication using Adobe Illustrator CS6.  
 
Multiple alignment of SLO’s N-terminal extension from sequenced S. pyogenes strains: S. 
pyogenes Streptolysin O sequences were retrieved from the NCBI protein database using the 
query (streptolysin O slo) AND “Streptococcus pyogenes”[porgn:__txid1314]. A multiple 
alignment of full-length proteins was generated using ClustalW2.  
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Figure 1. Saponin extraction preferentially solubilizes peripheral membrane markers. 
Immunoblot analyses of the total membrane fraction following a 5 minute incubation at 37°C 
with PBS alone (-) or PBS containing 0.025% saponin (+), developed with the antisera indicated 
to the right. The migration of several molecular weight standards (in kDa) is shown on the left.    
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Figure 2. Saponin treatment extracts membrane-associated SLO when co-expressed with 
CMT-competent SPN. Immunoblot analysis of the total membrane fraction from A549 cells 
infected with the strains indicated at the top of the figure following a 5 minute incubation at 
37°C with PBS alone (-) or PBS containing 0.025% saponin (+). The immunoblot was developed 
with anti-SLO antiserum. The migration of molecular weight standards (in kDa) is shown on the 
left.    
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Figure 3. Disrupting SLO’s interaction with cholesterol increases detergent solubility. 
Immunoblot analysis of the supernatant fraction from untreated or MβCD-treated A549 cells 
infected with the strains indicated at the top of the figure following a 5 minute incubation at 
37°C with 0.005% (0.2X) or 0.025% (1X) saponin. The immunoblot was developed with anti-
SLO antiserum. The migration of a molecular weight standard (in kDa) is shown on the left.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 172 
 
Figure 4. Multiple alignment of SLO’s N-terminal extension from sequenced S. pyogenes 
strains: S. pyogenes Streptolysin O sequences were retrieved from the NCBI protein database 
using the query (streptolysin O slo) AND “Streptococcus pyogenes”[porgn:__txid1314]. A 
multiple alignment of full-length proteins was generated using ClustalW2. Residues 1-35 
comprise the signal sequence, and the NTE is highlighted in purple. 
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Figure 5. Identification of the translocation domain in SLO’s N-terminal extension. 
Immunoblot analyses of the cytosolic fractions from A549 cells infected with the NTE deletion 
strains (A) or strains expressing SLO NTE point mutants (B), developed with anti-SPN 
antiserum. The migration of a molecular weight standard (in kDa) is shown on the left.    
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Figure 6. HeLa and HaCaT cells are resistant to SLO-mediated membrane damage in the 
absence of SPN. The extent of pore formation was assessed on the cells indicated to the right 
following a 1.5 hour infection (A549 and CHO-K1) or 2 hour infection (HeLa and HaCaT) with 
the S. pyogenes strains indicated at the top of the figure, visualized by staining with a fluorescent 
vital dye (Live/DeadTM). Intact membranes exclude the red fluorescent membrane-impermeable 
dye EthD-1 and appear green; cells with compromised membranes appear red.  
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Figure 7. SLO binds to HeLa membranes in the absence of SPN. Immunoblot analysis of the 
total membrane fraction from untreated or MβCD-treated HeLa cells infected with the strains 
indicated at the top of the figure, developed with anti-SLO antiserum. The migration of a 
molecular weight standard (in kDa) is shown on the left.     
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Figure 8. Translocated SPN disrupts calcium-dependent membrane repair in HeLa cells. 
The extent of membrane damage was assessed on HeLa cells following a 4 hour infection with 
the S. pyogenes strains indicated to the left of the figure, conducted in either calcium-free or 
calcium-supplemented medium. Membrane integrity was visualized by staining with a 
fluorescent vital dye (Live/DeadTM). Intact membranes exclude the red fluorescent membrane-
impermeable dye EthD-1 and appear green; cells with compromised membranes appear red. 
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CONCLUSIONS  
 The mechanism of CMT has been very difficult to elucidate, in part because there is no 
known analogous toxin translocation system on which to base hypotheses, and initial models for 
CMT have proven incorrect. Discovering that pore formation by SLO is not required for SPN 
translocation refuted the passive diffusion model for CMT [1], creating confusion as to how SLO 
was functioning as a translocator in this system. To further understand this mechanism we 
performed detailed analyses of the interactions between SPN, SLO, and the host cell membrane. 
By removing SLO’s membrane-binding domain 4 we demonstrated that membrane binding by 
SLO is necessary for its CMT activity. However, binding is not sufficient, as SLO chimeras 
encoding domain 4 from homologous CDCs and SLO lacking its N-terminal extension were not 
competent for SPN translocation despite being functional cytolysins [2]. Contrary to dogma, we 
discovered that SLO’s interaction with cholesterol was not required for membrane binding 
during infection or the translocation of SPN. This cholesterol-independent binding of SLO 
necessitated the concurrent binding of SPN to the membrane, which also required co-secretion of 
a CMT-competent version of SLO, suggesting that they co-dependently interact at the host cell 
surface to recognize an alternative receptor for CMT [2]. 
 SPN encodes an N-terminal non-enzymatic domain previously shown to be necessary for 
its translocation [3], indicating that it may be involved in the targeting of SPN to the membrane 
prior to its uptake. This domain is predicted to adopt the structure of a carbohydrate-binding 
protein, implicating a potential host cell surface carbohydrate as the receptor for CMT. To probe 
the function of this domain we mutated a conserved tryptophan residue (W81), as aromatic 
amino acids (most commonly tryptophan) are a common feature of carbohydrate-binding sites. 
This point mutation did not affect SPN’s secretion or enzymatic activity but rendered SPN 
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unable to bind the host cell membrane and undergo translocation, and also prevented SLO’s 
cholesterol-independent mode of membrane binding [4]. Carbohydrate-binding proteins also 
commonly coordinate a divalent cation, and further analysis of this domain by computational 
ligand site prediction identified a putative cation-binding site that is close to the consensus 
sequence of the metal ion-dependent adhesion site (MIDAS) encoded by structurally divergent 
von Willebrand factor A/integrin-like domains [5]. Similar to the tryptophan mutant, mutation of 
this putative cation-binding site rendered SPN nonfunctional, suggesting that there may be a 
critical role for cation coordination in membrane binding and SPN translocation. 
 During the course of this study it was also postulated that cholesterol might not serve as 
the primary host cell receptor for SLO on red blood cells. This hypothesis was based on the 
identification of a predicted carbohydrate-binding site within SLO’s domain 4 and the discovery 
that exogenous galactose-containing sugars inhibited the hemolytic activity of purified SLO [6]. 
We corroborated this hypothesis by generating mutations within SLO’s predicted glycan-binding 
site, which rendered SLO from overnight culture supernatants defective for lysis of red blood 
cells. Surprisingly, these SLO variants retained pore-forming activity on epithelial cells during 
infection, but only when co-expressed with SPN [4]. Similarly, a galactose-deficient cell line was 
only susceptible to membrane permeabilization by SLO when co-expressed with SPN, 
demonstrating that the SPN-mediated mode of binding can properly orient SLO at the membrane 
for pore formation in addition to promoting CMT [4]. This required CMT-competent SPN, as co-
secretion with the SPN tryptophan or MIDAS mutants did not facilitate pore formation by SLO. 
These data indicated that SLO recognizes a galactose-containing receptor prior to interacting 
with cholesterol, but that this step can be bypassed in the presence of SPN. 
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 The level of SLO-induced membrane permeability was evaluated on multiple cell types 
to determine if SPN influences SLO’s interaction with the host cell membrane under normal 
conditions. Some cells, like human lung fibroblast A549s and CHO cells, were highly sensitive 
to pore formation by SLO with or without the co-expression of SPN, while other cell types, such 
as HeLas and HaCaT keratinocytes, exhibited very little cytotoxicity in the absence of SPN. 
However, this decreased susceptibility was not a result of impaired membrane binding by SLO. 
SLO was localized to HeLa cell membranes regardless of the co-expression of SPN, indicating 
that SPN significantly enhances membrane permeabilization at a step subsequent to membrane 
binding of SLO. For A549 cells, which were sensitive to pore formation by SLO even in the 
absence of SPN, we developed a detergent solubilization assay to assess whether SLO’s 
membrane association is modulated by the co-expression of SPN. In the absence of SPN, SLO 
remained membrane-associated following saponin extraction, resembling an integral membrane 
protein. Conversely, when SLO was co-expressed with SPN, the majority of SLO was extracted 
from the host cell membrane, similar to a peripheral membrane protein. These data demonstrated 
that SPN influences the interaction between SLO and the host cell membrane, and that this 
occurs during a normal infection, at least for some cell types.  
 
MODELS 
 SLO is able to recognize the host cell membrane via distinct mechanisms, and the 
predominant mode of membrane binding during infection may differ depending on the proximity 
of the bacterial cell to the host cell surface, the concentration of SPN and SLO receptors at the 
surface of the infected cell, or the accessibility of these receptors. SPN is not translocated, and 
presumably does not bind to the host cell membrane, unless the bacterium is adherent to the 
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infected host cell. Therefore, SLO secreted by non-adherent bacteria likely only interacts with 
the membrane via the SPN-independent pathway. For this mode of binding, SLO is secreted 
(Figure 1A, step 1) and contacts the host cell membrane via its carbohydrate-binding site in 
domain 4 (Figure 1A, step 2), which data suggests recognizes a galactose-containing glycolipid 
or O-linked glycoprotein. This interaction orients SLO at the membrane and facilitates 
oligomerization of the prepore complex (Figure 1A, step 3), which disengages from the glycan 
receptor and binds to cholesterol during the prepore-to-pore conversion (Figure 1A, step 4).  
It is likely that both the galactose-dependent and the SPN-dependent modes of binding 
are available to SLO when co-secreted with SPN from adherent bacteria. Whether these modes 
of binding occur simultaneously or one mode predominates in this scenario is not yet understood 
and will be the subject of future experiments. Determining the kinetics of this SPN-mediated 
mode of binding also requires further study. However, multiple models exist to explain the co-
dependent interaction of SPN and SLO at the host cell surface. One model proposes that 
following secretion (Figure 1B, step 1), SLO makes weak contacts with the host cell membrane 
(Figure 1B, step 2), allowing recruitment of SPN and the formation of a SPN-SLO complex, 
which recognizes the CMT receptor and stabilizes SLO at the membrane (Figure 1B, step 3). 
This mode of binding promotes the translocation of SPN (Figure 1B, step 4a) and is also 
sufficient for pore formation by SLO (Figure 1B, step 4b). We believe that this is the most 
plausible model, since we observe a low level of membrane-localized SLO in the absence of 
SPN on Lec8 cells, where neither the SPN-mediated or galactose-dependent modes of binding 
are available (Chapter 3, Figure 6). However, another potential model is that following secretion 
(Figure 1C, step 1) SPN makes the first contacts with the host cell membrane via its receptor 
(Figure 1C, step 2) and recruits SLO (Figure 1C, step 3). The recruitment of SLO may promote a 
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more stable SPN-membrane interaction, which would otherwise be transient, and promotes SPN 
translocation (Figure 1C, step 4a) and pore formation by SLO (Figure 1C, step 4b). A third 
possibility is that SPN and SLO form a complex in solution immediately following secretion 
(Figure 1D, step 1), which binds to the host cell membrane via SPN’s receptor (Figure 1D, step 
2), leading to the same outcomes described above. If this model is correct this interaction is 
likely weak and transient before stabilization at the membrane, as complex formation between 
SPN and SLO has not been detected in solution. Further experiments are required to determine 
the order of events for this membrane interaction, and also to determine which mode of binding 
predominates during different types/stages of infection. 
 
FUTURE DIRECTIONS 
 The primary objective of future work will be the identification of SPN’s receptor to 
elucidate how SPN facilitates SLO’s galactose- and cholesterol-independent mode of binding. 
The mutagenesis studies of SPN’s N-terminal domain presented in this work are consistent with 
tertiary structure modeling, which predicts that this domain adopts the structure of a 
carbohydrate-binding module. Therefore, SPN may target itself and SLO to the host cell 
membrane during infection by recognizing a host cell surface carbohydrate. However, we have 
not identified a host cell glycoconjugate required for this process. Lec1, Lec13, Lec8, Lec15, and 
ldlD CHO cell lines all support CMT, despite lacking complex N-glycans, fucosylated structures, 
galactose and sialic acid carbohydrates, O-mannose linked glycans/GPI anchors, and galNac O-
linked glycoproteins, respectively. Attempts to identify a carbohydrate ligand by glycan array 
screening using purified SPN have also not been successful. However, this approach often fails 
for carbohydrate-binding modules due to their low-affinity binding interactions. In some 
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instances, UV difference spectroscopy has been a successful technique for ligand identification, 
which measures changes in UV absorbance by aromatic side chains upon ligand binding [7]. 
This technique may be used to screen SPN’s ability to bind various glycans, since we have 
identified a tryptophan residue in SPN’s N-terminal domain that is likely to be either directly 
involved in ligand recognition or situated in close proximity to the ligand-binding site. To 
facilitate these studies we have generated various constructs of full-length SPN and its N-
terminal domain in isolation, and have also used these constructs for multiple crystallization 
trials. While past attempts were unsuccessful, resolving the structure of SPN’s N-terminal 
domain would allow us to assess the accuracy of the structural prediction, and may facilitate the 
identification of SPN’s ligand.   
Determining the structure of SPN’s N-terminal domain would also provide insight as to 
whether SPN’s putative MIDAS motif is a bonafide cation-binding site, since this would be the 
first example of a MIDAS motif encoded by a bacterial toxin. Mutagenesis of the putative 
MIDAS sequence demonstrates that it is critical for SPN’s function, and extracellular calcium is 
required for SPN binding and translocation. However, we have not demonstrated direct cation 
coordination by these residues. Resolving the structure of this domain would permit 
computational modeling of cation coordination by this site. However, if future crystallization 
trials are unsuccessful, inductively coupled plasma mass spectrometry (ICP-MS) of the purified 
native domain compared to MIDAS mutants may be another approach to assess cation binding. 
This was attempted once, and all ions were below the limit of detection besides cobalt, which 
likely was stripped from the resin during purification. Future experiments should be performed 
with more concentrated protein samples. 
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 While we have not directly shown the formation of a SPN-SLO complex, the co-
dependent binding of SPN and SLO suggests that they interact at the host cell surface. SLO does 
not oligomerize prior to membrane recognition since it requires membrane-induced conformation 
changes to facilitate monomer-monomer interactions. Similarly, an interaction between SPN and 
SLO has not been detected in solution and may only occur at the host cell surface. Crosslinking 
surface proteins with a membrane-impermeable linker following infection and 
immunoprecipitating SPN and/or SLO may detect an interaction between these proteins. We 
have generated strains to facilitate these studies that encode CMT-competent SPN that is HA-
tagged at either the N- or C-terminus, since anti-HA is a more effective antibody than those 
targeting SPN or SLO. In addition to detecting an interaction between SPN and SLO, this 
approach may potentially identify additional binding partners, which would contribute to our 
understanding of this mechanism.   
 We hypothesize that the SPN-mediated mode of binding only occurs when SPN and SLO 
are secreted by adherent bacteria, as SPN is not translocated into cultured host cells infected with 
non-adherent bacteria. This was discovered by measuring CMT following an infection of HaCaT 
keratinocytes with an M protein deletion strain, which is required for bacterial adherence to this 
cell type. SPN membrane localization should be assessed following an infection of HaCaT cells 
with the M protein deletion strain to strengthen our argument that SPN-mediated binding 
correlates with adherence. Additionally, the SLO domain 4 carbohydrate-binding site mutants 
could be generated in the M protein deletion strain background. Since pore formation by these 
variants requires SPN, they would likely not cause damage to HaCaT membranes in the absence 
of bacterial adherence. 
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The membrane localization of SPN and SLO requires a more detailed analysis, since the 
total membrane fractions assessed in these studies are likely comprised of both plasma 
membrane and intracellular vesicle components. Precise determination of SPN and SLO 
localization will require a second round of fractionation by Opti-Prep or sucrose gradient 
ultracentrifugation after harvesting the total membrane fraction. These subfractions should be 
probed for SPN and SLO, as well as multiple plasma membrane and vesicular markers including 
E-cadherin, caveolin-1, EEA-1, and LAMP1 to assess co-localization. Results from the 
proteinase K susceptibility assay performed in Chapter 2 suggest that membrane-associated SPN 
likely represents a surface-exposed population and a population protected within a subcellular 
vesicle. Determining if a fraction of SPN is localized to a subcellular vesicle before its release 
into the cytosol may help explain the mechanism of uptake. Performing this experiment at 
various time points post-infection may also reveal the kinetics of SPN’s membrane association 
and cytosolic release, since analysis of SPN’s localization has been limited to the end point of 
infection. Quantitatively assessing the amount of membrane-associated vs. cytosolic SPN over 
the course of the experiment may provide more details into the kinetics of this mechanism.  
Detailed fractionation and localization studies of SLO will also be critical for 
understanding how SPN affects SLO’s interaction with the membrane. Membrane-localized SLO 
is extracted from A549 cells by detergent treatment only when co-expressed with SPN, which 
may be due to the differential localization of SLO, its oligomerization state, or its level of 
membrane insertion. If it is determined that SLO localizes to the same fraction of the membrane 
regardless of the co-expression of SPN, then SPN likely modulates either the level of SLO 
oligomerization or the extent of membrane insertion. The efficiency of oligomerization may be 
assessed by SDS agarose gel electrophoresis. This assay is normally performed with purified 
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proteins on artificial or erythrocyte membranes, but it may be possible to adapt this to monitor 
SLO oligomer formation post-infection [8]. It may also be possible to assess a difference in 
membrane insertion of SLO by protease susceptibility. SLO may be more fully inserted in the 
membrane and less susceptible to protease cleavage if it behaves like an integral membrane 
protein in the absence of SPN. Conversely, if SPN promotes a more peripheral membrane 
association of SLO, it may be more exposed and targeted for cleavage.  
 Another avenue for future studies is to determine the molecular basis for the insensitivity 
of HaCaT and HeLa cells to pore formation by SLO in the absence of SPN. These cell lines 
exhibit minimal loss of membrane integrity following infection with the SPN deletion strain, 
whereas a wild-type infection produces extensive membrane damage at the same time point. 
SLO still binds to these cells in the absence of SPN, suggesting that SPN is promoting a more 
productive interaction between SLO and the membrane by facilitating oligomerization or 
transition to the transmembrane pore. Oligomerization of SLO can be evaluated if the SDS-AGE 
assay described above is developed to assess SLO oligomerization post-infection.  
SPN also appears to disrupt the calcium-dependent pore healing response in HeLa cells 
[9]. The addition of extracellular calcium promotes the survival of cells infected with the 
SLO/PFOD4 chimera, which is lytic but not CMT-competent, whereas calcium increases host cell 
cytotoxicity following infection with wild-type bacteria due to the translocation of SPN. The 
activity of the pore healing response in other cell types should be examined in calcium-free and 
calcium-supplemented media. It will also be important to determine the concentration of calcium 
necessary to promote SPN binding and translocation, and the concentration required to initiate 
the pore healing response. If they are similar, it would suggest that SPN may co-opt the pore 
healing response to gain access to the host cell cytosol. However, preliminary experiments 
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suggest that CMT occurs independently of the pore healing response, as SPN is translocated into 
Niemann Pick Type A cells, which are defective for this pathway. These experiments should also 
be repeated with bacteria expressing the NADase inactive version of SPN to determine if its 
disruption of the pore healing response is due to NAD+ depletion or an independent activity. 
 Finally, future work should address the mechanism of SPN’s translocation into the host 
cell cytosol. The identification of SPN’s receptor will likely be informative, but steps subsequent 
to membrane binding will also be required to fully elucidate this process. Previous studies have 
demonstrated that the inhibition of actin polymerization by cytochalasin D treatment does not 
prevent SPN translocation, suggesting that this process does not occur by clathrin-mediated 
endocytosis [1]. Other endocytic pathways have been more difficult to assess, since most 
chemical inhibitors of endocytosis were also inhibitory to bacterial growth and protein secretion. 
Therefore, we utilized siRNA to knock down the levels of dynamin and cdc42, two other 
important mediators of endocytosis, which also did not inhibit CMT. However, the interpretation 
of these experiments needs to be reconsidered in light of more current knowledge. For these 
experiments, CMT was measured probing the host cell cytosolic fraction for SPN post-infection, 
which was obtained by lysing the host cells with saponin. However, SPN does not remain 
membrane-localized following detergent treatment, so it is possible that what was considered to 
be cytosolic SPN was membrane-bound SPN stripped from the membrane during lysis. These 
experiments should be repeated following detergent-free lysis to rule out this possibility. 
Additionally, other mediators of endocytosis, such as Arf6 and flotilin, should be evaluated for a 
role in CMT. 
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Figure 1. Models of SPN/SLO membrane interaction. (A) SLO’s SPN-independent mode of 
membrane binding requires recognition of a galactose-containing glycoconjugate, 
oligomerization of the prepore complex, and insertion of the transmembrane pore in a 
cholesterol-dependent manner. (B)-(D) Possible models for the co-dependent membrane binding 
of SPN and SLO. (B) SLO may weakly contact the host cell membrane and recruit SPN, 
resulting in a more stable membrane interaction mediated by SPN’s receptor and leading to SPN 
translocation and pore formation by SLO. (C) SPN may make initial contact with the membrane 
via its receptor, recruiting SLO and facilitating pore formation and CMT. (D) SPN and SLO may 
transiently interact in solution immediately following secretion, forming a complex that 
recognizes the membrane via SPN’s receptor. 
